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ABSTRACT 
Introduction 
The objective of this thesis was to delineate aspects of the 
control mechanisms of mammalian pepsinogen secretion. In order 
to accomplish this goal, a comprehensive study was undertaken 
which would establish an historical perspective of the subject, 
validate appropriate methodology and then seek to answer 
specific questions regarding the physiology and pathophysiology 
of pepsinogen secretion. More specifically, the objectives of 
this thesis were: 
1. To review the historical background of the subject of 
pepsinogen in the context of the physiology of 
digestion with specific emphasis on the work and lives 
of the two major initial proponents of pepsinogen 
research (Schwann and Langley). 
2. To provide a contemporary overview and evaluation of 
the current status of pepsinogen pathophysiology. 
3. To modify and adapt experimental models necessary for 
the study of pepsinogen and acid secretion in 
mammalian gastric mucosa and cells. 
4. To establish and validate a pepsinogen assay sensitive 
and reproducible enough for use in mammalian mucosa! 
and cellular secretory systems. 
5. To delineate the fundamental (second messenger) 
control mechanisms (cyclic AMP and calcium calmodulin) 
of pepsinogen secretion in the isolated gastric gland 
model. 
6. To define whether the process of pepsinogen secretion 
is independent of acid secretion in intact mucosa! 
preparations. 
7. To identify different classes of pharmacological 
agents which would inhibit pepsinogen secretion and/or 
release. 
8. To identify whether conditions present in critically 
ill patients liable to mucosa! "stress ulceration" 
might influence the release of pepsinogen. 
Historical 
The introductory chapters provide an historical background of 
digestion. Particular attention has been paid to the evolution 
of the understanding of digestion as a physiological process, 
the recognition of acid secretion as an active process, the 
subsequent identification of hydrochloric acid and the eventual 
realization that "pepsin" is involved in the digestive process. 
The history of pepsinogen is considered with respect to both its 
discovery and the development of the different methodologies 
utilized for its measurement. Langley & Schwann's contribution 
and contrasting backgrounds are considered in detail. 
Overview 
The overview section considers the current state of knowledge of 
pepsinogen and covers a wide spectrum of biochemical, 
pathophysiological and clinical aspects. It provides a basic 
framework against which the specific areas addressed in this 
thesis should be viewed. 
Methodology 
The comprehensive methodology section includes a number of 
innovative procedures utilized in the thesis. "The microtitre 
plate" was developed to facilitate the study of parietal and 
chief cells, and the isolated gastric gland technology adapted 
for usage in the microtitre plate system. The Ussing chamber 
preparation was modified for a guinea pig model, and the system 
adapted to enable generation of a measurable pepsinogen signal. 
The original hemoglobin substrate-pepsinogen assay of Anson was 
modified substantially by use of isotope-labelled albumin as 
substrate. The resultant increase in sensitivity allowed for 
more accurate measurement of pepsinogen secretion or release by 
mammalian mucosa under experimental conditions. 
Experimental 
The first two chapters of the experimental section describe the 
validation of the gland and cell systems in terms of both 
secretory capacity and the ability to respond to different 
agonists. The pepsinogen assay was also validated. In 
addition, evidence in support of the interaction of the cyclic 
AMP and calcium calmodulin systems in the chief cell in the 
regulation of pepsinogen secretion is presented. No unique data 
was obtained and the results confirmed that the work was 
consistent with that reported by other investigators. 
The effect of a putative specific calmodulin antagonist on 
pepsinogen secretion was examined. This experiment was based on 
the rationale that one of the most potent agonists of pepsinogen 
secretion was cholecystokinin and that this peptide functioned 
via the calcium calmodulin system. Trifluperazine, however, 
resulted in a paradoxical increase in measured pepsinogen. It 
is possible that the results observed reflect the nonspecific 
effects of trifluperazine and are more suggestive of release via 
cell damage rather than a physiological secretory response. 
Since the prostaglandin El analogue (misoprostol) had been 
widely reported to be efficacious in peptic ulcer disease, an 
investigation of its effect on acid and pepsin secretion was 
undertaken. The inhibitory effect on acid secretion was 
confirmed. Prostaglandin El, however, was demonstrated to be a 
significant agonist of pepsinogen secretion. 
A different line of investigation was pursued in an attempt to 
define an agent capable of adequately inhibiting pepsinogen 
secretion. Firstly, the question of whether pepsinogen 
secretion by the chief cell could be completely dissociated from 
parietal cell acid secretion was addressed. In Ussing chamber-
mounted mucosal sheets, the proton pump inhibitor omeprazole was 
used both alone and in conjunction with the pepsinogen agonist, 
cholecystokinin. These studies demonstrated that histamine-
stimulated acid secretion and cholecystokinin-stimulated 
pepsinogen secretion were separate and independent events. With 
this information as a baseline, a second series of studies was 
undertaken using the specific cholecystokinin receptor 
antagonist L364718. The results obtained demonstrated that the 
agonist effect of cholecystokinin on pepsinogen secretion could 
be selectively and effectively blocked by a specific 
cholecystokinin receptor antagonist used at dosages which were 
physiologically acceptable. In addition, when contrasted with 
pepsinogen secretion stimulated by a cholinomimetic, it was 
evident that this inhibition was cholecystokin receptor 
specific. 
The final experiment examined the possibility of a significant 
increase in pepsinogen release when gastric mucosa is 
compromised by either hypoxia or endotoxemia. The guinea pig 
Ussing chamber mucosal model provided both morphological and 
biochemical evidence of mucosal damage and increased pepsinogen 
release under these circumstances. A correlation was attemped 
by contrasting pepsinogen levels in the gastric juice of 
critically ill ICU patients with samples obtained from 
postoperative patients in relatively healthy and stable 
condition. This last study, while failing to provide 
irrefutable evidence of a role for pepsinogen in a damaged or 
"stressed" mucosa provides some information consistent with the 
hypothesis that increased levels of pepsinogen occur and may 
well be related to the pathophysiological evolution of mucosal 
damage in critically ill patients. 
Section I 
HISTORY AND REVIEW 
CHAPTER 1 
History of Digestion 
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As one wanders down the corridors and shelf stacks of the 
library one is left in awe at the compendium of man's 
knowledge. It is here that the heritage of civilization and 
science is studied, interpreted and handed on to succeeding 
generations. In the environment of the laboratories and 
libraries of great institutions of learning throughout the 
world, scholars work to extend the frontiers of thought and 
to enlarge man's perception of his world and the processes 
involved in its function. The labors are often mighty yet the 
information gleaned in many instances only minuscule. Indeed, 
as Thomas Gray so aptly framed it, 
"But knowledge to their eyes her ample page. 
Rich with the spoils of time did ne'er unroll ...• " 
History is however replete with wonderful examples of the 
mysteries of the pursuit of information, and the 
extraordinary and often turbulent lives of those who sought 
to frame the questions of life. 
The particular area that has interested me for some 
considerable time has been the science and history of 
digestion. The exact origins of human knowledge regarding 
the intake of food and the speculations on the digestive 
process are lost in the mists of antiquity. Hippocrates 
(460-377 B.C.) in De Prisca Medicina states: "It was the 
necessity which men in the first stages of society must have 
felt of ascertaining the properties of vegetable productions 
as articles of food that gave rise to the science of 
dietetics; and the discovery having been made that the same 
system of regimen does not apply in a disordered as in a 
healthy condition of the body, men felt compelled to study 
what changes of the aliment are proper in disease and it was 
the accumulation of facts bearing on this subject which gave 
rise to the Art of Medicine." (translated by Francis Adams -
1849). 
THE NATURE OF DIGESTION 
In the earliest of times physicians had believed that the 
different organs were the seat of separate spiritual agencies 
which in a divine fashion controlled bodily function. The 
Ancient Greeks had proposed that digestion was in fact a 
process of concoction or heating, and in this evolution food 
was converted initially to chyle and then to the four 
humors: blood, phlegm, yellow and black bile prior to 
utilization by the mortal body. Hippocrates had in fact 
called the process of digestion pepsis and proposed that it 
was not dissimilar to the preparation of food by cooking 
(1). He felt that this conversion was accomplished by the 
heat of the stomach. Galenic physiology proposed a similar 
theory but in a more complex form. It held that successive 
cooking processes occurred sequentially in the stomach, 
intestine, and liver until food was finally converted into 
blood. Alternative doctrines as suggested by Plistonicus, a 
pupil of Praxagorus indicated that digestion might be due to 
putrefaction. This proposal was still entertained as late as 
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1763 by the English physician William Cheselden. 
The concept of the stomach as an organ actively secreting 
acid and pepsin which was responsible for digestion was not 
appreciated until the early 19th century. The early Greeks 
were not aware of acids in the modern chemical sense but 
identified them only as bitter-sour liquids. Thus, Diocles 
of Carystos (circa 350 B.C.) specified sour eructations, 
watery spitting, gas, heartburn, and epigastric hunger pains 
radiating to the back, with occasional splashing noises and 
vomiting as symptoms of a melancholic gassy illness 
originating in the stomach (2). Some 300 years later Celsus 
(30 B.C. - 25 A.D) recognized that certain foods were acidic 
and recommended that "if the stomach is infested with an 
ulcer ... light and gelatinous food must be used ... and 
everything acrid and acid is to be avoided" (3). 
There appears to have been little further development in 
understanding the function of the stomach and the nature of 
digestive processes until the 16th century. Aureolus 
Theophrastus Bombastus von Hohenheim, (Paracelsus), was born 
in Ensiedeln near Zurich in 1493 (4). He was an alchemist 
physician and a proponent of chemical pharmacology and 
therapeutics who proposed some major reforms in medical 
thinking. After training in Ferrara (1515) he taught at 
Freiburg and Strassbourg (1525) and was appointed Professor 
of Medicine in Basel in 1527. He publically burnt the books 
of Galen and Avicenna and rejected the old notion of four 
elements (earth, air, fire, and water). Instead he proposed 
that the forces of energy that governed the universe were 
archaei and maintained that physiological processes, diseases 
and drugs were chemical changes governed by the chief 
archaeus. Paracelsus believed there to be acid in the 
stomach and that it was necessary for digestion. He 
considered that the acid in the stomach of humans came from 
the drinking of acidic spa waters (acetosum ensurinum, hungry 
acid) and that its action was part of a catalytic process 
necessary to prevent the formation of precipitations and 
concretions within the body. As a response to his novel 
assertions and his forthright style, the authorities of Basel 
forced him to leave. He subsequently died from a wound 
sustained in a tavern brawl at Salzburg in 1541. Paracelsus' 
observations were, however, far in advance of his time and 
although many of his assertions appear as successful guesses 
or evidence of remarkable intuition, he clearly recognized 
the importance of chemistry and its relation to disease; 
rejecting Galenism and the mysticism of humors and health. 
The question of acid in the stomach and its exact nature was, 
however, still moot (5). Alchemists and chemiatrists had 
made progress in the identification of many substances. 
Johann Tholle who wrote under the pseudonym of the mythical 
15th century monk Basil Valentine had published extensively 
regarding ammonia, sulfuric acid, and sugar of lead. He is 
reported to have identified hydrochloric acid and prepared it 
by mixing oil of vitriol (sulfuric acid) with common salt 
(6). Thus, by the middle of the 17th century Jean Baptiste 
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von Helmont was able to write of an acid ferment in the 
stomach responsible for digestion. Von Helmont was born in 
Brussels in 1577 and became a Doctor of Medicine in 1609 
after spending some time as a Capuchin friar (7). Von 
Helmont was a mystic and like his master Paracelsus, believed 
that each material process of the body was presided over by a 
special archaeus or spirit which he named Blas. His doctrine 
held that physiological processes are in themselves purely 
chemical, being due in each case to the agency of a specific · 
ferment ( or gas). Von Helmont founded the IatroChemical 
School of Physicians which maintained that the principal 
archaeus (Blas) was controlled by the sensitive and motive 
soul, anima sensitiva motivaque, in the pit of the stomach 
(solar plexus) and that from this site all chemical 
physiological processes were regulated (8). He believed that 
digestion began in the stomach by the intermittent 
fermentation of acid and a ferment and that thereafter a 
number of other fermentation processes including that of bile 
in the duodenum took place. As a child, von Helmont had 
observed "a great sharpness in the throat of sparrows" which 
he fed. He presumed this to be part of the acid digestive 
process of the bird. In addition, he had noted that 
distilled liquid of sulfur could digest his leather glove. 
In further observations he recognized that acid alone did not 
digest food in vitro and he postulated the existence of 
another agent typified as a ferment. Von Helmont proposed 
the existence of an acid ensurinum as a normal component of 
the human stomach although he felt that it was derived from 
the spleen. He proposed that gastric acid was a requirement 
for digestion and that it was neutralized by the alkaline 
gall in the duodenum (9). In subsequent studies he proposed 
that this acid might be a mineral acid such as nitric or 
hydrochloric acid. He produced spirit us salis marini 
(spirits of sea salt) (hydrochloric acid) by distillation of 
salt and clay and noted that it could dissolve human kidney 
stones (Duelech) in much the same manner as juice from a 
bird's stomach. The son of von Helmont published his work -
Ortus Medicinae - four years after his death in 1648 (10). 
The physiological chemistry of von Helmont was divested of 
much of its mystic and spiritual overtones by the Leyden 
Professor Francois de la Boe-DuBois better known as Sylvius 
(1614-1672). Nevertheless, as late as 1757, Stahl considered 
the role of the supernatural to be of some importance in the 
physiology of digestion. Sylvius however, explained 
digestion on a chemical basis but excluded the mysticism 
which had permeated von Helmont's work (11). As Professor of 
Medicine at Leyden from 1658-1672 he was in charge of the 
first chemical laboratory and had learned from Glauber about 
the interaction of acids and alkalis. He ignored von 
Helmont's suggestions of a specific gastric ferment and 
maintained that digestion took place in the stomach by saliva 
which was also the major source of intestinal juice. At this 
time, considerable attention had been focused on the salivary 
glands by the studies of Niels Stensen of Copenhagen who was 
a pupil of Sylvius. This physician-priest described the 
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excretory duct of the parotid gland in 1661 prior to 
proceding on to numerous other important physiological 
observations. He achieved immortality as one of the fathers 
of modern geology and was ultimately appointed Bishop of 
Titiopolis in 1667. Sylvius supported pancreatic juice as 
the main factor in the digestive process and his pupil Regner 
de Graaf in 1664 produced experimental pancreatic fistulae to 
study this proposal. Unfortunately, de Graaf concluded that 
pancreatic juice was acid in character and he and Sylvius 
hypothesized that bile and pancreatic acid in combination 
fermented and digested food. 
These chemical views as propounded by Paracelsus, von Helmont 
and Sylvius represented the doctrine of the Iatrochemists. 
They were, however, strongly opposed by the Iatromathematical 
school who maintained that all physiological happenings 
should be treated as rigid consequences of the laws of 
physics. This group included men such as Descartes, Borelli, 
s anctorius, Pitcairn, and Boerhaave. Giovanni Alphonso 
Borelli (1608-1679) was a Neapolitan mathematician who 
published De Motu Animalium in 1680. He regarded all 
physiologic processes as mechanical in nature and he proposed 
the erroneous idea that a contracting muscle increased in 
bulk due to the fermentation within its substance which was 
initiated by a liquid discharged into it by nerves (12). The 
existence of the Iatrophysical doctrine was further 
propounded by a pupil of Malpighi-Georgio Baglivi (1668-1706) 
whom Clement XI had appointed to the chair of Medical 
Theory in the Collegio Della Sapienza. Baglivi experimented 
on muscular physiology and was the first to distinguish 
between smooth and striated muscle. "He pushed the 
mechanical allegory to the extent of dividing the human 
machine into innumerable smaller machines: likened the teeth 
to scissors, the chest to a bellows, the stomach to a flask, 
the vicera and glands to sieves, the heart and vessels to a 
water work" (12). Baglivi, however, dispensed with all these 
esoteric theories when he looked after patients. He was an 
extremely effective physician and a true follower of 
Hippocrates at the bedside. "To frequent societies" he said, 
"to visit libraries, to own valuable, unread books, or shine 
in all the journals does not in the least contribute to the 
comfort of the sick" (12). 
Thus, Borelli and his disciples favored the view that the 
stomach was but a mechanical mill grinding up its contents 
into chyme. Mobius denied the existence of gastric acid and 
Archibald Pitcairn interpreted all function in terms of 
mechanical activity. The members of the Iatromathematical 
school cared little for the new science of chemistry and 
their postulates faded into such sterile eccentricities as 
Archibald Pitcairn's proposal to base the whole of medical 
practice upon mechanical principles. Thus, in 1727, Pitcairn 
questioned the Iatrochemical group 11 ••• why upon the digestion 
of food upon the stomach, which is easily (as) digestible as 
the food, yet the stomach itself should not be dissolved" 
(13). Despite the fact that he was a successor of Sylvius, 
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held the Professorship of Medicine at Leyden, and wrote 
Elementa Chemia in 1732, Boerhaave, a pupil of Pitcairn also 
denied the idea of either a gastric acid (von Helmont) or a 
pancreatic acid {Sylvius). 
Albert von Haller (1708-1777) was a pupil of Boerhaave and 
Professor of Anatomy, Medicine and Botany in Gottingen from 
1736-1753. He was an infant prodigy who wrote Latin verses 
and a Chaldee grammar at ten years of age. In his seventeen 
years in Gottingen he wrote some 13,000 scientific papers and 
ultimately produced his Elementa Physiologicae Corporis 
Humanae (1759-1766) which confirmed his reputation as the 
master physiologist of his time. Von Haller recognized the 
use of bile in the digestion of fat but declared that gastric 
juice was not acid, alkaline, or a ferment and believed that 
any acid found in the gastric juice was from the degeneration 
of food. 
THE NATURE OF DIGESTIVE AGENTS 
Thus, by the end of the 17th century, there were two main 
schools of thought regarding the nature of digestion. The 
one maintaining it as an act of trituration while the other 
perceived it as a chemical action occurring either via 
fermentation or, alternatively, by substances either in 
saliva or secreted by the lining of the stomach. 
Attempts to define the nature of digestive agents were aided 
by the ingenuity of investigators in developing methods of 
obtaining gastric juice and secondly, by the development and 
recognition of indicator dyes. These vegetable derived 
substances changed color when exposed to appropriate acids or 
alkali and allowed for identification of the nature of the 
material being tested. In particular, controversy centered 
around the chemical nature of the acid in the stomach and the 
debate as to whether it was primarily secreted by the stomach 
or in fact derived in some way from ingested food. 
METHODS OF OBTAINING GASTRIC SECRETION 
A. Animal Necropsy 
In 1692, Viridet experimented upon dogs, cats, squirrels, 
hares, pigs, and eagles (14). He killed the animals either 
after a meal or fasting, opened the abdomen and collected the 
gastric contents. Viridet noted that "solutio heliotropii" 
could, by turning red, indicate the presence of acid. In a 
classic study, he killed a specially fattened pig and poured 
solutio heliotropii down its throat. The blue color was 
noted preserved even to the entrance of the stomach, but that 
in the stomach an intense red solution was evident. Viridet 
noted that the stomach smelled of acid and that this 
resembled the odor of fermentation. He also noted that in 
humans one might recognize acid in the esophagus but this was 
in fact due to regurgitation of stomach contents. "We 
experience it by an acid in the mouth. The condition was not 
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a natural one." 
B. The Use of Sponges 
In 1752, Reaumur, the French naturalist noted that birds of 
prey vomited indigestible objects such as feathers and bones 
(15). He therefore experimented on a tame buzzard by feeding 
it small hollow metal tubes containing different varieties of 
food. When the tubes were recovered, it was apparent that 
the food had dissolved without putrefaction leaving a bitter 
yellow fluid. In order to study the nature of this fluid, 
Reaumur placed sponges in the small metal tubes and on 
recovery squeezed these to obtain the gastric juice. The 
latter was a sour fluid which turned blue paper red. Reaumur 
attempted to study in vitro digestion by incubating the 
gastric juice with meat. The meat, however, failed to 
completely digest although he noted that the gastric juice 
had prevented the "onset of corruption". He interpreted the 
failure of this study to indicate that either digestion 
required a high temperature or that the gastric juice 
required constant renewal. Alternatively, it was possible 
that in the in vitro situation the evaporation of a volatile 
acid had taken place. At this stage, Reaumur's pet buzzard 
died and he thereafter ceased his studies in birds. 
c. Self Emesis 
In 1760, Reuss found that even with preliminary alkalization 
of the stomach, the ingestion of a meal of meat and 
vegetables resulted in acid secretion: "the vomit, having an 
acid taste and turning an infusion of 'campanules a f euilles 
rondes' red" (16). Gosse in 1783 repeated these studies more 
elegantly. He had as a child developed the faculty of 
aerophagy and self-induced emesis, whereas Reuss required to 
take an emetic. By inducing emesis at specific times after 
eating, Gosse was able to demonstrate that digestion began 
within thirty minutes of eating and was concluded by 
approximately two hours. Gosse, however, was not able to 
find acid or alkaline gastric juice, and suggested that 
secretion occurred by a mechanical process whereby food 
stretched the internal lining of the stomach. He was, 
however, able to report that there were different varieties 
of food, some of which were partially digestible and others 
completely digestible ( 1 7). 
In 1777 Edward Stevens presented his inaugural thesis "De 
Alimentorum Concoctione" to the University of Edinburgh 
(18). This young man, who may have been the half-brother of 
Hamilton, had been born in the Leeward Islands (British 
possession) graduated from Kings College in New York (now 
Columbia University) and pursued his studies in Scotland. He 
was the first to apply Reaumur's studies to humans and was 
the first person to perform an in vitro digestion experiment 
successfully. He thus proved that the gastric juice itself 
contained the active principle necessary for the assimilation 
of food. Stevens obtained the services of a Hungarian, 
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Hussar, who was visiting Edinburgh and whose means of 
livelihood was to entertain the populace by swallowing stones 
and then rejecting them. Using perforated silver spheres so 
constructed as to hold meats, vegetables, worms and leeches, 
Stevens observed that all were digested when passed through 
the rectum. He did not use a sponge and thus, did not 
attempt to extract gastric juice and evaluate the presence of 
acid (19). 
In 1780, Lazzaro Spallanzani who was the Professor of Natural 
History in Pavia, published his extensive observations in 
this area (20). He had used Reaumur's methods in fish, 
frogs, snakes, cattle, horses, cats, dogs, and himself. In 
1783 he finally proved that digestion in vitro as well as in 
vivo was a chemical process but he asserted that gastric 
juice was neutral (21). Spallanzani's studies bear comment 
since they were performed in great detail and with 
considerable care. He himself initially swallowed linen bags 
containing food and bread and collected them for examination 
after they had been passed per anum. Later, he substituted 
small metal tubes to avoid any possibility of trituration. 
In both instances, he could find no trace of food remaining. 
At this time it was felt that there existed three types of 
fermentation - vinous, acid, and putrid. Since he could find 
no evidence of fermentation, he postulated that digestion was 
by an acid or a putrefactive principle. The latter he 
disregarded since gastric juice prevented putrefaction and in 
his experiments, there had been no evidence of putrefaction 
(22). In his own experience, he noted that ingestion of 
large quantities of strawberries and wine interfered with his 
sleep by producing severe eructation from the stomach to 
mouth accompanied by a sharp acid taste. He interpreted this 
acidity, however, to be an abnormal phenomenon (23). In 
1784, he collaborated with his colleague Scopoli who was 
Professor of Chemistry in an attempt to elucidate the nature 
of gastric juice. Scopoli reported that the juice from the 
crows which Spallanzani was studying contained pure water, 
some soapy and gelatinous animal substances, sal ammoniam, 
and earthy matter similar to that found in all animal liquids 
(24). 
Spallanzani, however, obviously was uncertain as to his 
findings regarding the acidity of gastric juice. He 
corresponded and worked with a number of colleagues in an 
attempt to resolve this question. In 1785, Spallanzani 
collaborated with Carminati who was the Professor of Medicine 
at Pavia. Carminati was the first to detect the acidity of 
the contents of a meal (25). He said "it is clear that the 
human gastric juice is neutral as the physiologists such as 
von Haller and Spallanzani have taught; that this is true in 
crows, in dogs, and in cats which eats and digests with equal 
facility both animal and vegetable substances; and that in 
fact this humor consists of a water, a small amount of marine 
salt, and an animal substance ... ! had already recognized in 
twenty crows that the gastric juice was neutral when I 
obtained in July two crows whose gastric juice distinctly 
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turned tincture of heliotrope red, produced immediate and 
complete curdling of milk, and in every way proved similar to 
that of carnivorous animals. The novelty of this led me to 
enquire into its cause and I found that the birds for many 
days past had been fed exclusively on meat ... The same 
happened in dogs and cats fed entirely on meat for ten or 
more days as in the crows. Their gastric juice had all the 
properties of that of crows on a meat diet". Spallanzani was 
advised to test birds on a meat-free diet and he too found 
marine acid in the juice squeezed from sponges fed to five 
ravens fed on vegetables for fifteen days. Later, 
Brugnatelli in 1786 and some years afterwards Werner in 1800 
found the contents of the stomachs of sheep, cats, fish and 
birds to be acid. At one stage, Brugnatelli who had used the 
metal tube technique of Reaumur, noted the presence of iron 
in the stomach of one owl. After correspondence with 
Carminati who suggested the use of wooden tubes, all trace of 
iron disappeared. 
Despite the relatively clear evidence produced by Scopolli 
and Spallanzani that there was acid in the stomach and that 
it was, in fact, hydrochloric acid, considerable controversy 
existed. Indeed, many of the investigators of this area 
reversed themselves a number of times during the study of the 
subject. Of particular interest are the comments of the 
eminent British investigator, John Hunter (26). In 1772, he 
stated, "In all animals, whether carnivorous or not upon 
which I made observations or experiments to discover whether 
or not there was an acid in the stomach (and I tried these in 
a great variety), I consistently found that there was an acid 
but not a strong one, in the juices contained in that viscus 
in a natural state". After more than a decade of further 
experimentation, John Hunter, in 1786, assessed the situation 
somewhat differently in that he regarded gastric acid as 
originating from a sugar which is secreted by the stomach 
(27). "I should not be inclined to suppose that there is any 
acid in the gastric juice as a component or an essential part 
of it." Thus, even amongst the minds of the most eminent 
physicians of the day confusion reigned, not only as to the 
presence of acid but the exact nature of the substance. 
DIGESTION AND PEPSIN 
One of the first persons to formally recognize the existence 
of a basic digestive process was Johan Van Helmont 
(1577-1644) (10). It is reported that his initial interest 
was aroused by the fact that when as a young child he had fed 
sparrows and let them get hold of his tongue he had noticed 
an intense acidity in the bird's throat. Subsequently he 
noted that the sulphurous substance present in the digestive 
juice of these birds was able to partially dissolve the 
leather of his glove to a fluid. Based on the current 
chemical knowledge of his time he therefore believed that the 
digestive agent present in the stomach might be an acid. He 
also postulated that this acid would be specific for each 
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species of animal studied. Of particular relevance however 
was the fact that Van Helmont was strongly opposed to 
Paracelsus' theory of heat as a digestive agent. He stated 
that "Hunger and strong and molesting digestion should be 
accompanied by excessive heat. This is not the case ..... 
when food is brought into contact with a warm surface there 
is no trace of digestion and it putrifies" (28). Van Helmont 
went on to state that "Warmth acts in a uniform way, the 
specific vital ferments act according to the exigency of the 
species and living being in question". Thus Van Helmont, 
although he had no formal biochemical evidence recognized 
that it was probable that there was a specific digestive 
agent(s) in the digestive juice. The vital faculty of 
transforming food ("Vera atque formaliter") Van Helmont 
called "Ferment" ("Eamque fermentorum nomine designavi"). In 
further discussion of the issue he stated that "a digestive 
ferment, the ref ore, has the essential power by reason of its 
vital acidity of causing transmutations". As one can easily 
recognize Van Helmont at this stage had confused fermentation 
with digestion and was unable to separate the two different 
processes simply because of the lack of biochemical 
information available at this time. His observations however 
were substantive for the 16th century and a gigantic leap 
forward in the understanding of digestion as compared to the 
previous demonic interpretations of the process. He thus 
broke through the mythological fabric of medical science 
which had been erected by the Greeks and Romans over the 
previous 1000 years. Subsequently Descartes, Sylvius and 
Willis further interpreted his views and correlated the 
theory of digestion with that of fermentation. At this stage 
most investigators were still concerned with the digestive or 
fermentative process in the stomach being related to an acid 
compound. The idea of alternative agents being capable of 
participating in the digestion of food q,ad not been formally 
appreciated. 
Nehemiah Grew (1626-1711) had observed the glands in the 
stomach and in a published lecture stated "By the joynt 
assistance of the glandulous and nervous membranes, the 
business of chylification seems to be performed. The mucous 
excrement provided by the former, as an animal corrosive, 
preparing, and the excrement of the nerve by the latter as an 
animal ferment, perfecting the work" (29). There was thus 
some preliminary contemplation of the possibility of animal 
ferments in the subject of digestion. Subsequent 
contributions by the Iatro-Mathematical school of 
physiologists attempted to explain digestion on a mechanical 
basis. Thus Pitcairn suggested that digestion in the stomach 
took place by a grinding force and that this explanation was 
sufficient to allow the discard of the previous theory which 
required "the assistance of a Daemon or a Stygian Liquor" 
(13). Theories of digestion ebbed and flowed over the next 
100 years. Herman Boerhaave (1668-1738) of the Eclectic 
School supported the mechanical theories of digestion and 
spoke with some considerable authority for Dutch medicine of 
the early 18 Century. The French as represented by Borden of 
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Montpelier (1722-1776) supported vitalism and believed that a 
"vital principle" was the cause of all the phenomena of life 
including digestion. In England Edward Rigby (174 7-1821) 
stated that the stomach was the seat of "phlogistication" 
where free heat was produced. Some few years after the death 
of Rigby, Prout in his epic presentation of 1823 before the 
Royal Society would demonstrate the gastric secretion of 
hydrochloric acid and relate its presence to the clinical 
symptomatology of dyspepsia (30). 
It is clear from the preceeding information that up until the 
early 19th Century there had been little formal understanding 
of the process of digestion. Although demons and spirits 
were now relegated to a background position, the science of 
digestion was as yet poorly defined (31). Prout, Tiedemann 
and Gmelin had independently identified free hydrochloric 
acid in gastric secretion. In a separate but subsequent 
publication William Beaumont had confirmed these observations 
in man (32). The postulate of a separate animal ferment or 
digestive agent was substantiated in 1831 by the 
identification of the diastatic action of saliva by Leuchs. 
Subsequently in 18 34 Eberle had prepared an artificial 
gastric juice. The quintessential observation however was 
made in 1836 by Schwann who postulated the existence of 
pepsin (discussed in detail Chapter 2). Subsequently in 1839 
W asmann isolated pepsin and established the premise for 
protein digestion. Claude Bernard in 1846 commented 
extensively on the digestive ferments of the pancreas and in 
1854 Epstein and Grutzner postulated the existence of 
pepsinogen. In 1859 Meisner investigated the products of the 
gastric digestion of proteins. The nature of the secretory 
mechanisms of the proteolytic zymogens were first clearly 
evaluated by Heindenhein when he studied proteolytic zymogens 
in the pancreas. 
It remained however for Langley of Trinity College, Cambridge 
to formalize the study of pepsinogen and the mechanisms of 
its secretion from the gastric mucosa (discussed in detail 
Chapter 3). Although to Schwann must go the credit for first 
postulating the existence of the digestive enzyme, Langley 
deserves full credit for his meticulous analysis of the 
morphology of the chief cells and their mechanisms of 
secretion. His observations though almost 100 years old have 
stood the test of time and proved to be valid far beyond what 
he could have believed possible at the time that he studied 
the question with the primitive means at his disposal. In 
1880 Langley published and presented a series of precise and 
detailed observations which concluded "The fresh gastric 
glands contain no pepsin; they do however, contain a large 
quantity of pepsinogen; consequently the granules of the 
chief cells consist wholly or in part of pepsinogen". His 
drawings and sketches quite clearly attest to his clear 
understanding of the nature of zymogen secretion and some of 
the mechanisms of its stimulation. In 1898 Gillespie 
published the first photograph of pepsinogen granules in the 
gastric mucosa of Salmo Salar (29). Little was written on 
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the subject of pepsinogen for the subsequent 30 years until 
Herriot in 1938 was able to isolate it in a crystalline form 
(33). He studied the chemical properties of the enzyme and 
confirmed many of Langley's observations on the activation of. 
pepsinogen. 
Although Brucke (1861) had first proposed the theory that 
pepsin was reabsorbed from the gut lumen into the blood and 
subsequently excreted in the urine, little further· 
understanding of this process has been acquired (34). There 
still remains some controversy as whether pepsinogen is 
directly secreted into the blood or whether it represents an 
ill understood backdiffusion process. Initial work had 
suggested that it might be transported on white blood cells 
or alternatively absorbed on to fibrin. Some investigators 
(Van Slyke 1893) believed that pepsin circulated combined 
with an inhibitor complex and Fuld and Hirayma (1912) had 
demonstrated to their satisfaction the existence of 
anti-pepsin - pepsin complexes (31). It was theorized that 
these complexes were set free in the kidney and that this 
accounted for the ability to measure pepsinogen in the urine. 
Indeed the physiological explanation for the existence of a 
proteolytic enzyme of this type in the blood has not yet been 
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Theodor Ambrose Hubert Schwann was born in Neuss, Germany on 
the seventh of December 1810. At primary school and at the 
progymnasium, Schwann was a delightful and brilliant child 
who was both diligent and modest. He had, however, little 
interest in the attractions of society and lacked self 
confidence. Indeed, his shyness and withdrawn manner, 
coupled with his close family life and religious background, 
led to a somewhat sheltered and separate upbringing. He was, 
however, brilliant in all "branches of learning and showed a 
major aptitude for mathematics and physics. As a result of 
his quiet personality and his intellectual brilliance it was 
not surprising that he moved towards the church and in 1826 
entered the Jesuit College of Three Crowns in Cologne (1). 
His early life is almost saintly in its configuration and 
proceeded predictably until he came under the influence of an 
exceptional religious teacher, Wilhelm Smets. Until then 
Schwann had only been acquainted with the strict aspects of 
piety although he was endowed with a brilliant intelligence 
and a lively sensibility. Smets, however, taught him a 
completely different kind of religion (2). He revealed an 
entirely new aspect of God and especially the singular fact 
of the liberty of man with regard to the whole of nature. 
During his exposure to Smets, Schwann learned the concept of 
the elevation of man by personal perfection. As a result of 
this interaction Schwann became further enamoured with the 
study of reason as opposed to pure theology and decided to 
pursue a medical career. At this time his personal 
philosophical position focused towards that of Christian 
rationality and he based his philosophy more on the tradition 
of Descartes and Leibniz. To further his medical studies he 
moved to Bonn where in October 1829 he entered the University 
and enrolled in the premedical curriculum. In 1831 he 
obtained his bachelors degree and in the autumn of 18 31 he 
moved to Wurzburg where he studied for three semesters and 
attended numerous clinical lectures (3). 
While at the University of Bonn, Schwann had spent time in 
the laboratory of Johannes Muller and had also extensively 
attended his lectures on physiology. When Schwann left 
Wurzberg in 1833 for Berlin it was to work with Muller, who 
had since been appointed to the chairs of anatomy and 
physiology. In Berlin, Schwann attended clinical 
demonstrations and under Muller's guidance prepared a 
dissertation on the necessity of air for the development of 
chicken eggs. On 31 May, 1834 he obtained his M.D. degree 
and subsequently on 26 July of that year he passed the state 
examination. Immediately thereafter Schwann became one of 
Muller's assistants and subsequently devoted all his time and 
efforts to research ( 4). Schwann worked for Muller in Berlin 
from 18 3 4 until 1839. During this time he was helpful in 
writing sections of the Handbuch Der Physiologie of which 
Muller was the author. The Handbuch was not merely a 
compilation by a senior editor. Muller's style was to 
critically examine all the information that he printed. He 
therefore repeated the experiments of others and suggested 
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new types of investigations, thus opening avenues not 
previously studied. Schwann played a major role in this 
textbook which demonstrates evidence of numerous 
contributions both of previously resolved ideas and a number 
of exciting new postulates (5). The book also contains 
details of studies which clearly show Schwann's innovative 
skills. His first experiments can be dated on the basis of 
his laboratory notebook, which begins 16 April 1835. In 
these, Schwann envisioned experiments in which it would be 
possible to subject the physiological properties of an organ 
or of a tissue to physical measurement. 
One such method involved the measurement of the secretion of 
a gland; another a design to study muscle function. In the 
latter he measured the length of muscle contracted by the 
action of the same stimulus for different loads to further 
compare the intensity of the contraction with that of the 
stimulus. In order to accomplish this he developed a 
muscular balance and essentially established the basics of 
the first tension-length diagram. 
His ability to undertake these complex kinds of experimental 
work was probably influenced to a large extent by his 
religious background. Throughout his life, Schwann's serious 
involvement with religion and mysticism proved to be a major 
factor in his work ( 6). Although he remained a practicing 
Catholic, Schwann developed an extreme mechanistic tendency. 
It is thought that this change in focus was influenced by the 
death of his mother in 1835. This mechanistic tendency was 
particularly helpful to him in the impressive work which he 
accomplished in Muller's laboratory in Berlin between 1834 
and 1839. 
Muller remained a convinced vitalist and recourse to 
experimentation for him was simply a means of studying the 
effects of a vital force peculiar to a specific organ. He 
had limited chemical or physical background and subsequently 
detached himself from physiology and devoted his time almost 
entirely to comparative morphology. Schwann, however, with 
his extreme rationalistic and mechanistic tendencies, was 
able to almost single-handedly inaugurate the quantitative 
period of physiology in Muller's laboratory. His subsequent 
work bears clear evidence of this skill. In a milieu where 
idealistic philosophy was still dominant, the examination of 
vital forces as physical phenomena and the expression of 
their action as a quantitative entity came almost as a 
revelation to the scientific community. A group which 
included Emil Dubois-Reymond and Hermann Von Helmholtz 
dissociated themselves from the notion of vital force and 
moved towards the study of molecular mechanisms. 
Almost at the same time as he undertook his superb studies of 
muscle physiology, Schwann's research led him to the 
discovery of pepsin (7). This relatively minor observation 
however was almost completely lost in the spate of subsequent 
major investigative work that he embarked upon. He 
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demonstrated the need of oxygen for development of 
putrefaction and subsequently proved that alcoholic 
fermentation required oxygen and was dependent upon the work 
of a live organism - yeast (8). His laboratory notebook of 
16 February, 1836 notes the multiplication of yeast cells and 
documents the relationship between alcoholic fermentation and 
the life cycle of yeast. However, the contribution to 
science for which Schwann achieved most fame relates to his 
insistence on the common cellular origin of every living 
thing (9). Prior to Schwann's publication in 1839 of his 
Mikroskopische Untersuchungen there had been a prolonged 
debate regarding the nature of the human organism and the 
search for a common structural principle of live entities. A 
number of famous scientists had variously suggested "fibres, 
molecules, or globules" as the basis of living organisms. 
Schwann however clearly described cells which had a layer 
around a nucleus (10). He furthermore described membranes 
and vacuoles which were interrelated with these cells. A 
major error in his theory, however, was the proposal that 
cells form around a nucleus within a blastema - an amorphous 
substance that can be intracellular or extracellular (11). 
It is well accepted that Schwann was the first to recognize 
the basic cellular composition of organisms with the cell as 
the vital element and the bearer of all the characteristics 
of life (12). His theory regarding the blastema however was 
erroneous. 
Schwann subsequently spent a number of years studying 
cellular formation and development in considerable detail. 
His contributions to this area were highly regarded and 
widely accepted ( 13). In 1841 he received the Sommering 
Medal and in 1847 the Sydenham Society published an English 
version of Mikroskopische Untersuchungen which was translated 
by Henry Smith. In the introduction Smith presented the 
following judgement: "The Treatise has now been seven years 
before the public, has been most acutely investigated by 
those best competent to test its value, and the first 
physiologists of our day judge the discovery which it unfolds 
as worthy to be ranked amongst the most important steps by 
which the science of physiology has ever been advanced." 
Schwann himself however suffered a major disappointment in 
1839 when he failed to be awarded a chair at the University 
of Bonn. His short and brilliant scientific career virtually 
halted at this time. He moved to Louvain and subsequently 
Liege where he, to a large extent, abandoned rationalism and 
became a mystic (14). The scientist gave way to the 
professor, inventor, and subsequently to the theologian. It 
appears that part of the transformation was initiated by the 
disappointments attending the circumstances surrounding his 
failure to be awarded a Professorial Position at Bonn. In 
addition, however, he was badly hurt by a number of papers 
published by Turpin, Wohler and Liebig who fiercely 
criticized his work on the role of yeast in alcohol 
fermentation. Indeed, this cruel treatment of Schwann by the 
scientific leaders of his time made it virtually impossible 
for him to pursue a further scientific career in Germany. 
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Years later, Pasteur clearly demonstrated that Schwann had 
been correct and that criticism of his work had been both 
inappropriate and utterly unjust. 
These setbacks resulted in the cooling of Schwann's ardent 
rationalism and he became preoccupied with religious 
meditation. Much of this state of mind was presumably 
influenced by his brother Peter who was a Theologian. In 
1839 Schwann accepted the Chair of Anatomy at Louvain, but· 
his scientific impetus and enthusiam for investigation had 
been broken. Like Pascal before him, he abandoned 
rationalism to return to the God of his childhood, the "God 
of the Heart, not of reason." He remained a well regarded 
Professor at Louvain and subsequently in 1848 moved to 
Liege. The rest of his life was spent in a solitary 
existence darkened by episodes of major depression and 
anxiety. 
During his stay in Louvain (1839-1848) Schwann developed a 
method to utilize a biliary fistula model for the study of 
the role of bile in digestion. He concluded that a lack of 
bile in the digestive tract was incompatible with survival. 
His papers of 1844 and 1845 on the biliary fistula were his 
last physiological works. When he moved to Liege in 1848 he 
became more of an inventor and developed a number of 
instruments used in mining technology. These included pumps 
for. the aspiration of water in coal mines and respiratory 
apparatus for rescue operations (15). These instruments 
became the forerunners of the apparatus utilized for 
measurement of metabolism in man and of the devices used by 
underwater divers. At Liege, Schwann was mostly preoccupied 
with religious meditation. Although he worked extensively on 
Theoria, a complement to his Mikroskopische Untersuchungen, 
he was to fail in the completion of this last opus. 
During a Christmas visit to a brother and sister living in 
Cologne he suffered a stroke and died on 11 January 1882 
after two weeks of agony, during which he several times 
expressed the regret that he had not been able to publish the 
whole of his Theoria. 
Schwann was a brilliant and complex man. Every subject that 
he addressed led to the identification of entirely new 
concepts and directions of research. His mind however was 
one which questioned constantly the nature of the involvement 
of man with the mysteries of God. It is probable that his 
personal disappointments in dealing with the intellectual 
dwarves and bureaucratic bigots who governed his day to day 
existence and research studies seriously embittered him. 
Certainly his early spiritual retirement into a world of 
religious mysticism can be interpreted as a manifestation of 
his serious disillusionment. His discovery of pepsin, 
observations on the vital necessity of oxygen and his 
recognition of putrefaction and fermentation as properties of 
organic function were masterpieces of intellectual 
endeavour. Yet all of these pale when viewed against the 
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initial observations which delineated the basic concepts of 
the cell. These precepts have withstood the test of time and 
form the basis of modern cell theory. When one contemplates 
the unique intellectual productivity of this man over a brief 
five-year period in Muller's laboratory, one is left to 
ponder to what heights Schwann might have aspired if the 
scientific hierarchy of his age had allowed him to flourish. 
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John Newport Langley was born in Newbury in 1852, the second 
son of John Langley, a private school master. He was 
educated at Exeter Grammar School and entered Saint Johns 
College Cambridge in October 1871. Initially he studied 
mathematics, constitutional history and other literary 
subjects with the intention of competing for a place in the 
civil se,rvice. During the second year of his studies he 
changed his plans and gave up other subjects to read natural 
science. To a large part this decision was influenced by his 
exposure to Dr. Michael Foster, fellow and praelector of 
Physiology, of Trinity College who was at this time 
conducting classes in elementary biology, embryology and 
physiology. In May of 1873, Langley first attended Foster's 
lectures on the subject of physiology. Subsequently he spent 
all his working life at Cambridge studying physiology. In 
1883, Foster became the first Professor of Physiology at the 
University of Cambridge and later on was knighted as Sir 
Michael Foster, became Secretary of the Royal Society and 
first editor of the Journal of Physiology. When Langley 
first met Foster the latter had already demonstrated his 
ability to attract and select the best recruits for 
biological science. He was widely remembered as a man of 
great personal charm, humor and shrewdness. More than twenty 
years later, Foster wrote of his initial meeting with 
Langley: "From the very first time I marked him as a man of 
whom something was to be made" (1). Langley himself, forty 
years after those early days, wrote that: "Foster lead a 
considerable number of his earlier pupils to a scientific 
career. He first aroused an interest in scientific problems 
and then sometimes gradually, sometimes suddenly, suggested 
that there was no better course in life than that of trying 
to solve them." 
In 1873, Langley was elected to a foundation scholarship at 
Saint Johns and in December 1874 was placed in the first 
class of the Natural Science Tripos. At this stage, Langley 
was assisting Dr. Newell Martin, who was Foster's assistant. 
In 1875, having obtained his BA degree, he succeeded Martin 
as demonstrator since the latter had left Cambridge for 
Baltimore to be a Professor at Johns Hopkins University. In 
1877, Langley was elected to a fellowship at Trinity College. 
From 18 7 5 until 1884, Langley was responsible for the 
organization and conduct of Foster's laboratory classwork. 
Initially, Langley had studied Jaborandi (pilocarpine) and 
its effect on the heart. In 1884, Langley was appointed to 
the permanent college staff at Trinity College as a lecturer 
in Natural Sciences and in the same year became a University 
lecturer in Histology. He held these positions until 1903 
when he was elected Professor of Physiology in the 
University, upon Foster's resignation of the chair. The 
obituary of John Newport Langley, as written by W. M. 
Fletcher, in the 1926 Journal of Physiology, attests to the 
magnificent contribution of this man to the study of 
Physiology. "The main achievements of Langley's research 
work are familiar to the readers of the Journal of Physiology 
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and need little here in the way of description or comment. 
They stand permanently in their place, not merely as 
additions here and there to knowledge, but as indispensable 
stepping stones along which at this point, or that, the 
progress of knowledge has actually made its way. Each gain 
he made was a step placed securely and finally and few indeed 
of them as the road has become more firmly and widely trodden 
by others following have been found wrongly placed. All his 
chief works keep, and mu·st always keep, their place in the 
significant history of Animal Physiology. The bare titles of 
his papers and books deployed there along the years give the 
plainest testimony to me to his unwearing, unhalting service 
to science. No single year in all that series, extending well 
nigh for half a century, from youth to age, appears without 
its contribution of effective work." 
Langley's two main contributions to physiology can be 
considered under the headings of those dealing with the 
mechanisms of secretion and those establishing the main 
anatomical and functional lines of the autonomic nervous 
system. It is the former area of study to which this thesis 
is primarily addressed. It essentially covers the first 
fifteen years of his work, whereas the latter study of the 
nervous system encompassed the succeeding thirty years or 
more (Table 1). As in most studies, chance is often the 
starting point. Foster in 18 7 4, had suggested that he 
examine the newly introduced drug, Jaborandi and its effect 
on the heart. He did this in frogs and mammals and his 
results lead him to further study its effect upon secretion 
first in the submaxillary gland of the dog and then 
subsequently into the pure research of the physiology of 
secretion which he followed avidly until almost 1890. As 
Fletcher comments: "A merely competent worker might have 
described the actions of pilocarpine and then have passed 
even usefully to the actions of similar and different drugs. 
Langley, however, opened up at every point the physiology of 
secretion, adapting his technical work not only to the 
convenience of his laboratory but to his intellectual 
needs." He made histological studies of gland structure, in 
activity and rest, and checked the interpretation of the 
appearance of killed and stained cells by simple but most 
effective direct observations of the living gland cells. He 
correlated these findings with experimental unravelling of 
the nervous influence upon the glands and the share in these 
taken by vasomotor phenomena. He further linked both sets of 
results with chemical estimations of the changing qualities 
of secretion under different circumstances. The well known 
steps he took and the variety of the work done are to be 
traced in the titles of his successive papers. 
Before Langley's work was published, the accepted view had 
been that of Heidenhein that gland cells became more granular 
as secretion took place (2). Langley showed that the reverse 
was true: that granules were stored up during rest to be 
passed out in secretion not only in the pancreas, as 
previously been reported by Kuhne and Lea, but over a wide 
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range of glands (3). Langley's further studies indicated the 
beliefs that the secretory nerves might have special or 
trophic functions in the glands which could be explained in 
terms of purely vase-motor changes in the gland circulation. 
Apart from these latter observations the results of his work 
in the secretory glands have stood the test of time. Much of 
this work was incorporated into a major article contributed 
to salivary glands in Schafer's Text Book of Physiology ( 4). 
In a series of publications between 1879 and 1882, Langley 
established the basic morphology and secretory 
characteristics of the pepsin-forming glands of the 
oesophagus and the stomach (Table 1). The articles are 
masterful in their original thinking and lucid writing and 
the powerful interpretation which he was able to make with 
limited means at his disposal. Indeed, little further 
meaningful progress in the study of gastric pepsin secretion 
was made in the subsequent half century after these 
observations. Of considerable interest is his last 
publication on the subject of pepsinogen with Edkins in 
November of 1886 (5). The latter individual subsequently 
went on to make one of the most fundamental contributions to 
the understanding of human gastrointestinal physiology by 
providing evidence of the existence of gastrin. Indeed, for 
other reasons related to the confusion of his peers regarding 
the difference between gastrin and histamine, Edkins, like 
Langley, remained for almost the next half century a 
virtually unknown contributor to the science of the gut. 
On March 24, 1881, Foster communicated to the Royal Society 
Langley's work entitled "On The Histology and Physiology of 
pepsin-forming glands" (6). He reported studies in Rana 
temporaria, Bufo vulgaris, Triton taeniatus, Triton cristatus 
and Coluber natrix. In these different animals he examined 
the structure of the resting stomach, noted the alterations 
which occurred during secretion and also developed a 
methodology for studying the relative amounts of pepsin 
contained by the different portions of the stomach. He 
furthermore was able to characterize the granules of pepsin 
within the chief cells and to delineate the nature of their 
secretion during secretory activity of the stomach. Of 
particular interest in this paper, Langley became the first 
individual to propose the use of the term oxyntic glands. 
Previously, glands of the stomach had variously been called 
fundus glands, peptic glands or rennet glands. In his own 
words: "It is only after great hesitation that I venture to 
employ a new term, but without a new term I find myself 
reduced to circumlocution or inaccuracy". 
Langley and Sewall reported that the most striking event of 
secretory activity was the using up of cell granules. They 
noted that after about six hours the granules again began to 
increase and re-accumulated steadily until the cells were 
granular throughout (7). 
It was also observed that during the winter months the 
- 28 -
granules decreased in the oesophageal and gastric mucosa of 
the frogs that were being studied. This problem still causes 
difficulties to investigators of this particular area of 
physiology. In the course of his experiments, Langley 
concluded that the oxyntic glands formed pepsin and that the 
granules farmed by the cells in the oxyntic glands were the 
same kind of granules as those secreted by the oesophageal 
glands. Using a simple but ingenious colorimetric test which 
embodied the principle of the digestion of fibrin, stained 
with carmine, Langley was able to differentiate between the 
pepsin content of different areas of mucosa. Almost fifty 
years later, Anson and Mirsky using a similar colorimetric 
method for the digestion of hemoglobin were able to measure 
pepsinogen activity. Similarly, Langley reported on the use 
of osmic acid as a morphological method for determining the 
amount and the nature of the granular content of these 
secretory cells. By use of the now well established 
technique of placing a sponge in the stomach and recovering 
it as a test of digestive function, Langley was able to 
ob serve that in newts stimulation of secretion resulted in 
emptying of the granules from the chief cells. He 
subsequently compared the nature of the gastric glands and 
their secretory function in frogs, newts and snakes, 
commenting that "the osmic acid specimens of the gastric 
mucus membrane of a hungry animal showed no great difference 
in the characters of the cells throughout the oxytic gland 
region." 
His further studies delineated the different amounts of the 
pepsin content of the successive regions of the stomach of 
the various animal species that he studied. The conclusions 
which he derived from the studies were salient, specific and 
of considerable importance. He came to a number of important 
conclusions. Firstly, that pepsin is formed from the 
granules seen in the gland cells in the living states. In 
defence of this statement he cited a number of points: 
(a) In each part of the animals studied the amount of 
pepsin contained in any part of the stomach was 
directly proportional to the amount of granules 
contained by cells of that part. 
(b) In each of the animals studied he noted that the 
cell granules diminished in number and size during 
digestion. 
(c) Thirdly that when a definite weight of gastric 
mucous membrane was taken at a stage of digestion 
when the granules were markedly diminished it 
contained a marked diminished amount of pepsin. 
The second main conclusion was that the gland cells did not 
store pepsin as such but stored zymogen "out of which pepsin 
arises when the cell secretes". This latter observation was 
not dissimilar from the studies of Heidenhein. The latter 
had reported that "Cells of the pancreas do not store up 
trypsin but store up a substance which under certain 
conditions can give rise to trypsin" (8). Heidenhein, in 
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fact, introduced the word zymogen to include the antecedent 
of the ferment recognized in cases. Similarly, it had been 
reported by Ebstein and Grutzner that the gastric glands of 
mammals contained a certain quantity of a substance capable 
of giving rise to pepsin when acted on by sodium chloride or 
by dilute hydrochloric acid. Langley commented that in the 
gastric glands and the oesophageal glands of the frog and the 
newt, that the granules showed a general similarity (9,10). 
It seemed to him, the ref ore, that the microscopic appearance 
rendered it far more probable that the stored granules 
"should consist of a zymogen rather than that they should 
consist of a ferment or other ready formed secretory 
product". In a subsequent paper he discussed the entire 
question of the formation of pre-products by gland cells. He 
also stated "that since the pepsin of different animals 
probably differs somewhat in its properties, it is probable 
that both pepsin and its antecedents differ in different 
animals somewhat in chemical constitution". This remarkable 
observation has, in recent years, been considerably expanded 
with the analysis and chemical configurations being 
determined for a number of pepsin moieties from different 
species. 
The third main conclusion was that during secretion, three 
chief phenomena could be recognized in gland cells, viz: 
(a) a using up of granules 
. ~) a fresh formation of granules 
(c) a growth of protoplasm - occur simultaneously. 
Langley explained that the different morphological aspects of 
the gland cells depended upon the relative activity of these 
three processes. In support of this view he quoted exerpts 
from Heidenhein in which the latter reported that to account 
for the changes which he observed in the pancreas: "In the 
cells a continuous change takes place; a using up of a 
substance in the inner portion, an addition of substance to 
the outer portion. In the inner portion change to the 
granules into secretory constituents, in the outer portion 
employment of the nutritative material for the formation of a 
homogeneous substance which, on its part, is changed into 
granule material." As the reader will recognize these 
changes preceded by almost 75 years the clear understanding 
of the subcellular compartmentalization of cell function. 
They are indeed remarkable intellectual guesses and 
observations, of the site and function of the endoplasmic 
reticulum and Golgi apparatus of the cell. Both Langley and 
Heidenhein had understood in 19th century terms the formation 
of zymogens and their intracellular transfer prior to 
exocytosis. In fact, a careful reading of Heidenhein's 
interpretation of the morphological changes occurring during 
pancreatic secretion provides a startling understanding of 
the perspicuity of these individuals using the relatively 
crude investigative tools available at that time. 
Heidenhein had reported that in the mammal the presence of 
digestible food caused a more rapid flow of gastric juice 
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than the presence of non-digestible food. He interpreted 
this to be a chemical stimulation caused by the absorbed 
products of digestion. Langley felt that the same principle 
could be used to explain the stimulatory mechanisms by which 
gastric glands are activated when the animal is fed with 
digestible or non- digestible food. His numerous experiments 
with newts and frogs brought him to the conclusion that 
peptone farmed by the zymogens might be the particular 
product which caused increased gastric secretion. However, 
in experiments performed by the injection of peptone into 
either the lymph sac or stomach of frogs he was unable to 
arrive at a clear view as to whether peptone itself caused 
gastric secretion. He finally concluded that the absorbed 
products might cause "an increase in use-up of the granules" 
so that during the later parts of digestion there might be 
some additional factor responsible for the formation of 
granules. He postulated that this process involved an 
additional factor present in some of the digestive products 
which was "converted into a fit state to be assimilated by 
the gland cells". In a series of experiments which he 
performed to evaluate the nature of this digestive product, 
he arrived at the conclusion that when the stimulus is 
removed, the gland cells form granules although no digestive 
products have been absorbed. The observation "that the more 
rapid formation of granules which takes place when digestible 
substances are given", he attributed to an increased supply 
of those substances which serve as a food to the cells. 
Langley was obviously addressing the question of synthesis 
and his observations, though carefully directed, did not 
allow him to quantify the process. Subsequent studies of the 
synthesis of pepsinogen have required the development of 
complex radio-isotopic labelling procedures for amino acids 
and have only been available in the last 25 years. Indeed 
the subject is still poorly understood. 
In his last conclusion, Langley addressed the question of 
exocytosis, a process as yet unknown to scientists of his 
day. "The difference in the changes produced by secretion in 
different gland cells is due partly to variations in the 
relative rates with which the using up of granules, the 
growth of protoplasm, and the formation of granules go on, 
both in each cell as a whole and in various parts of it; 
partly also to variations in the power of the gland cells to 
move the granules towards the lumen." In studies in the newt 
and Triton cristasis, using a gastric sponge as the 
stimulatory agent, Langley was able to determine that in 
both cases acid secretion of a good digestive power was 
obtained but the observable diminution in the number of 
granules in the cells was very small compared to the amount 
of acid secreted. These observations allude to two issues. 
Firstly, the recognition of a process by which granules are 
moved outside of the cell and secondly, an early indication 
of the recognition of the fact that acid and pepsin 
secretion, though related, might occur at somewhat different 
rates. 
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INTRODUCTION 
Pepsinogen is a potent digestive enzyme secreted by the chief 
cell into the gastroduodenal lumen. Such a powerful and 
abundant agent must affect the mucosa it bathes, and in fact 
pepsin is an active barrier breaker likely to play a 
significant role in the pathogenesis of peptic ulcer 
disease. Abnormalities in pepsinogen have also been linked 
epidemiologically to gastric carcinoma and its precursors. 
Thus, in addition to elucidating mammalian secretory 
physiology, an understanding of the biology of pepsin and the 
control of its secretion may prove crucial for the treatment 
of these diseases. Furthermore, pepsinogen secretion is 
closely analogous to other exocrine functions, so that data 
on pepsinogen-related disorders may illuminate the role of 
exocrine dysfunction in diseases such as pancreatitis. 
HISTORICAL NOTES 
In 1836, the German physiologist Theodor Schwann described a 
water-soluble factor in gastric juice which digested egg 
white. He called it "pepsin," after the Greek word for 
digestion [110]. Crude gastric pepsin extracts were used by 
18 69 to treat dyspepsia, vomiting, and diarrhea on the 
supposition that undigested food caused disease [43]. (Such 
use continues among health faddists [51].) In 1878, 
Heidenhein demonstrated that canine pyloric pouches secreted 
an acid-dependent digestive factor which was probably pepsin 
[44]. Langley [71] described the histology of pepsin 
secretion in 1881, demonstrating the depletion of secretory 
granules simultaneous with the loss of peptic activity from 
frog gastric and esophageal homogenates. 
Northrop crystallized pepsin in 1930, the first demonstration 
that enzymes were proteins [83]. The newly purified pepsin 
was soon implicated in ulcerogenesis. Howes [55] showed in 
1936 that although acid alone did not prevent the healing of 
feline gastric ulcers, pepsin and acid together did. In 
1942, Schiffrin found that cat intestinal segments filled 
with acid did not ulcerate until luminal pepsin was added 
[109]. Subsequent research would analyse the biochemistry of 
pepsin, the control of its secretion, and its role in 
disease. 
BASIC BIOLOGY 
The Chemistry of Pepsinogen and Pepsin 
Pepsin is stored as inactive pepsinogen, a forty kilodalton, 
375 amino acid polypeptide. After exocytosis, gastric acid 
hydrolyzes forty to fifty amino acids from pepsinogen, 
exposing its active site to create bioactive pepsin 
[34,128]. Once formed, pepsin catalyzes the generation of 
more pepsin [47]. 
Active pepsin is a single polypeptide chain of approximately 
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320 amino acids folded by three disulfide bonds (47]. A 
paucity of basic amino acids (47] renders pepsin most active 
and stable in acid. Pepsin digests protein, preferentially 
cleaving peptide bonds in which the carboxyl group comes from 
tyrosine, tryptophan or phenylalanine (143]. 
Much can be deduced about human pepsin by analogy to related 
acid proteases in other species [2,59,121]. All are of 
similar molecular weight and structure. In each, two 
essential aspartyl residues are juxtaposed by a dominant 
central fold and hydrogen bonded together (143]. Human 
pepsin is most active from pH 1.8 to pH 3 (138], suggesting 
that one aspartate is acidic (pKa 4.5) and one in basic form 
(pKa 1.1) (Fig. 1). 
Isozymes of Pepsinogen and Pepsin 
The pepsinogen molecule differs significantly between species 
(36,127] and each species exhibits several isozymogens 
[41,149]. Human pepsinogen is separable by gel 
electrophoresis into seven isozymogens with different pH 
optima and isoelectric points (86,140,141] (Fig. 2). 
Homologous pepsinogens with similar electrophoretic 
mobilities in different species are often closer in structure 
than the isozymogens of one species [34]. 
Each pepsinogen yields one or more pepsins with different 
properties [68,147]. Conversely, some pepsins are derived 
from more than one pepsinogen (34,68,147]. At least twelve 
classifications of human isozymogens exist [107]. The 
nomenclature used here is based on the work of Samloff (107]. 
Samloff numbered pepsinogens according to their migration 
toward the anode on an electrophoretic gel. Pepsinogen 1 is 
the fastest (most electronegative) and pepsinogen 7 the 
slowest. Pepsin 1, originating from pepsinogen 1, is unlike 
other human pepsins in being stable and active above pH 5 
[8 6]. Pep sinog ens 1 through 5 are collectively named 
pepsinogen I. The less electronegative pepsinogens 6 and 7 
are called pepsinogen II. A "slow moving protease" dominates 
gels of fetal mucosa and occurs frequently in gastric cancers 
(51], but is structurally unrelated and not unique to 
gastrointestinal mucosa (107]. 
Diversity in isozyme activity may facilitate digestion of 
different proteins (138]. The hyperactive pepsin 1 may be 
significant in ulcerogenesis. In addition, isozymogen ratios 
may prove useful clinical markers for ulcers and gastric 
cancer. 
Histology of Pepsinogen-Producing Cells 
Fortuitously, the classification of pepsinogens by 
electronegativity is biochemically and histologically 
significant. Antibodies to pepsinogen I and pepsinogen II do 





Figure 1. Schematic sequence construct of 
structure of human pepsin, based on homologies 
pepsin [2] and other acid proteases [59,121]. 
molecule is a prolate ellipsoid divided by 
bioactive cleft into two lobes. 
a central 
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Figure 2. Agar gel electrophoresis of human plasma. Human serum acid proteases are separable into seven pepsinogen isozymogens and a "slow moving protease (SMP) . 11 
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differences. Immunofluorescence demonstrates pepsinogen I 
only in the body and fundus of the human stomach [99] while 
antibodies to pepsinogen II also stain antrum, duodenum, 
distal esophagus, and gastric cardia [101]. Although pigs 
[7 4] are similar to humans, cats and dogs [73], amphibians, 
reptiles and fish [58] secrete pepsinogen I and II 
cosynchronously from esophagus through duodenum. 
The human gastric gland is a microscopic invagination of 
fundic mucosa (Fig. 3). Chief cells predominate at the base 
of the gland but are sparse toward its luminal opening [94]. 
It also contains parietal cells, mucus cells, 
undifferentiated cells and endocrine cells. Difficulties in 
the isolation of pure chief cells from these mixed glands 
have impeded pepsinogen research. 
Five cell types produce pepsinogen in humans. These are the 
chief cell and mucus neck cell in the gastric body and 
fundus, the pyloric gland cell in the antrum, the cardiac 
gland cell in the cardia, and the Brunner's gland cell in 
the duodenum [131]. 
The chief cell is a representative exocrine cell (Fig. 4). 
Apical zymogen granules store pepsinogen [38] while a profuse 
basal endoplasmic reticulum synthesizes new pepsinogen. The 
luminal surface has microvilli and joins adjacent cells by 
tight junctions. A basement membrane lies behind the cell 
[58]. Mucus neck cells are less differentiated than surface 
mucus cells and include stem cells from which the gastric 
mucosa regenerates. Like chief cells, mucus neck cells 
contain zymogen granules and a prominent endoplasmic 
reticulum [58,99]. 
The glands of the pylorus, cardia and duodenum lack chief 
cells [58] but produce pepsinogen. Canine pyloric [39] and 
duodenal [24] pouches secrete pepsinogen and antibodies to 
pepsinogen II stain these areas as well as the gastric body 
and fundus [101]. All pepsinogen-secreting cells make 
pepsinogen II but only chief cells and mucus neck cells 
secrete pepsinogen I [99,101]. Unlike chief cells, the 
pepsinogen II-producing cells of pylorus, cardia and duodenum 
have few zymogen granules [131]. 
Ectopic gastric mucosa may contain pepsinogen I and II 
[72, 75]. Pepsinogen II is also secreted by the prostate [20] 
into the semen (113] but its function there is unknown. 
In fish, reptiles and amphibians, the oxynticopeptic cell 
produces both acid and pepsinogen from esophagus through 
duodenum (58]. Although easy to study, amphibian pepsinogen 
secretion may thus differ substantially from mammalian 
processes. 
Measurement of Pepsinogen and Pepsin 
Northrup assayed pepsin by the digestion of casein, gelatin 
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Figure 3. Light photomicrograph ( original magnification 313x) of human gastric glands containing numerous different cell types. The chief cells are predominantly located in the deeper parts of the gland. At an average they constitute 20-25% of the cell population of the gastric glands. (Courtesy of Dr. Jeff Sussman) 
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Figure 4. Transmission electron microscopic photograph (original magnification 4500x) of the human chief cell. A profuse endoplasmic reticulum (E) and numerous zymogen granules (Z) are evident as is the nucleus (N). (Courtesy of Dr. Jeff Sussman) 
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and egg white [83]. In 1932, Anson and Mirsky described the 
now standard measurement of digested hemoglobin with a 
colorimetric tyrosine assay [3]. Isotopic measurement of 
radiolabelled substrate may be faster and more accurate than 
colorimetry [8,62]. The use of digestion (bioactivity) to 
measure pepsinogen requires that other digestive enzymes be 
inactivated by acid, which does not denature pepsin [111]. 
However, the possiblity of another acid-stable enzyme must 
always be considered. 
Pepsinogen isozymogens can be measured directly in humans by 
radioimmunoassay or electrophoresis. Quantitative RIA's 
cannot differentiate similar isozymogens. RIA's for human 
pepsinogen I [102,135] and II (106] have been applied to 
human diseases but poor cross-reactivity with non-human 
pepsinogens renders these assays useless in animals. 
Electrophoresis is specific but requires larger samples and 
cannot be well quantitated [70]. Although used in genetic 
urine studies, electrophoresis is thus also not generally 
applicable experimentally. In vitro research consequently 
does not distinguish the isozymogens. 
Pepsinogen Genetics 
Although all humans with intact stomachs possess pepsinogen 
I, its component isozymogens vary (68,81]. Single (105] and 
multigenic (35,37,68,84] models have attempted to explain 
urine electrophoresis results. However, in addition to its 
imprecision, urinary pepsinogen electrophoresis does not 
correlate with serum pepsinogen I levels or electrophoresis 
in gastric mucosa (81,87]. Variations in renal isozymogen 
handling may also invalidate urine studies (70,126]. 
Serum studies are m·ore reliable. Twin studies attribute one 
third of pepsinogen I variation to heredity and two thirds to 
environment (130]. Despite confounding factors, siblings of 
patients with peptic ulcers and high serum pepsinogen I 
clearly tend to exhibit elevated pepsinogen I. Siblings 
with high pepsinogen I also have more ulcers (94]. Elevated 
pepsinogen I and duodenal ulcers may cosegregate as autosomal 
dominants (95]. 
As well as illuminating an important physiologic process, an 
understanding of the genetic control of pepsinogen synthesis 
should facilitate pharmacolog ic intervention and provide 
disease markers in affected families. A prepepsinogen I gene 
from a human DNA library (118] has not yet been demonstrated 
in vivo. 
THE CONTROL OF PEPSINOGEN SECRETION 
Contrasting in vitro and in vivo Effects 
Early observations on pepsinogen stimulation in humans and 
intact animals were frequently inconsistent and contradicted 
subsequent in vitro work. such discrepancies may stem from 
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neuroendocrine interference in vivo, from defects in in vitro 
models, or from differences in dosages or species response. 
Pentagastrin stimulates pepsin secretion in man (53.132] and 
dogs (85] but has little effect on isolated rabbit glands 
[77]. The difference is probably due to neural action since 
vagotomy weakens pepsigogic stimulation by pentagastrin in 
dogs (40] and humans [33,42]. {Cholinergic replacement 
reverses this [53].) 
Histamine stimulates pepsinogen release and H-2 blockers 
inhibit this response in vivo in humans [30,53,114], dogs 
[32,40,85,145] and cats [32]. However, histamine does not 
release pepsin from isolated rabbit gastric glands [5,66] or 
rabbit mucosal biopsies [61]. Guinea pig chief cell 
suspensions secrete slightly more pepsinogen at high 
histamine doses [122]. 
Denervation is unlikely to explain these differences since 
histamine releases pepsinogen from denervated canine gastric 
pouches [40] and isolated rat stomachs [15]. Damage to chief 
cell receptors during collagenase digestion is not likely 
when parietal cells remain intact. Also, organ cultured 
rabbit gastric mucosa not exposed to collagenase secretes 
pepsinogen in response to histamine only when 
phosphodiesterase inhibitors prevent cAMP degradation and 
thus potentiate histamine (57]. 
An otherwise weak pepsigogic response to histamine may be 
augmented in intact mammals by some other agent, secreted in 
response to histamine, which stimulates more pepsinogen 
secretion. The dilution of such factors in isolated tissues 
would minimize the pepsigogic potency of histamine in vitro. 
Acid may be the missing link. Histamine strongly stimulates 
adjacent parietal cells to secrete acid [142] and acid causes 
pep sinogen secretion in humans [17], denervated canine 
gastric pouches [60] and in organ cultured rabbit gastric 
mucosa [61]. Potentiation of this effect in isolated rabbit 
gastric glands by cAMP-mediated agents suggests that acidity 
may stimulate a cAMP dependent protein kinase [82]. Gland 
and cell suspensions are buffered to a constant pH while in 
intact mucosae the unstirred layer of mucus slows the 
diffusion of acid, perhaps allowing it to exert a mediated 
secretagogue effect. 
Pepsinogen secretion is inhibited by PGE2 in humans [67] and 
C CK in dogs [79] but these agents stimulate secretion in 
vitro (11,48,62]. These differences may represent species 
variations or pharmacologic rather than physiologic 
responses. 
Serotonin augments pepsinogen secretion in intact dogs [145] 
and in cod [54], probably via sympathetic neurons releasing 
adrenergic agonists [9]. It has not been studied in vitro. 
Unlike other agents, secretin acts similarly in vivo and in 
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vitro. It stimulates pepsinogen secretion and potentiates 
the actions of histamine and gastrin in man [14,137] and in 
dogs [79]. Secretin has proven a potent pepsigogue in vitro 
only at pharmacologic doses far above physiologic levels 
[14, 19]. 
Models for Study 
whole animal studies are methodologically simple and have 
obvious clinical relevance. However, unrecognized 
neuroendocrine feedback loops may contaminate such 
experiments. In particular, vagal stimulation and a "wash 
out phenomenon II related to acid hypersecretion may obfuscate 
human and intact animal studies [135]. Furthermore, acid in 
the duodenum releases pepsinogen in man by neurohumoral 
reflexes not yet elucidated [14]. 
Isolated gastric mucosa is a simpler model. Gastric biopsies 
can be maintained in organ baths [61]. Alternatively, a 
mucosal sheet may be mounted in an Ussing chamber for short 
term culture. This is technically difficult for mammalian 
tissue [8,98]. However, frog esophageal mucosa secretes 
pepsinogen copiously, is physically stronger than mammalian 
gastric mucosa, and survives in less controlled conditions 
[116]. Such techniques are useful but yield nonuniform 
preparations. Furthermore, amphibian secretion may not 
reflect mammalian physiology. Berglindh has isolated rabbit 
gastric glands by type I collagenase digestion of minced 
gastric mucosa [11]. Isolated glands may be further digested 
to cells, using chelators and additional collagenase to break 
intercellular linkages [119]. Cell suspensions may be 
enriched for chief cells by culture [108] or by elutriation 
according to volume and weight [119,148]. 
Gland and cell suspensions yield reproducible results 
uninfluenced by neuroendocrine factors. Enriched chief cell 
preparations may also avoid local paracrine effects from 
parietal or endocrine cells. Unfortunately, digestion 
eliminates tissue polarity [ 4] and may damage receptors 
[119]. Cell culture may select abnormal cells [46]. 
Fin ally, these models rarely distinguish pharmacologic from 
physiologic effects. Thus, in vitro observations require 
confirmation in intact mucosa or whole animals before 
physiologic mechanisms can be reliably deduced. 
The Categorization of Pepsinogen Secretagogues 
Many hormones, nucleotide derivatives and neurotransmitters 
stimulate pepsinogen secretion. Pairs of stimulants with 
less than additive effects are presumed to act through the 
same pathway while those with additive effects are assumed 
independent. Potentiating agents probably activate different 
receptors but have interacting second messengers within the 
cell. Blockers like propranolol and atropine confirm such 
groupings. 
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Two sets of pepsigogues have been defined which are additive 
if not synergistic with respect to one another [5,6,91,115]. 
The first includes beta adrenergic agonists like 
isoproterenol [66,116] as well as prostaglandins [10], 
secretin and VIP [6,91,108]. Cholinergic stimulants 
[66,108,116,150] and bombesin [116], CCK, cerulein and 
gastrin [48] form the second group. Figure 5 summarizes this 
schema for pepsinogen secretion. 
Group I: The cAHP-mediated Secretagogues 
Isoproterenol and epinephrine are classic cAMP-mediated beta 
adrenergic agonists which in other cell systems stimulate 
membrane-bound adenylate cyclase via membrane receptors to 
form cAMP. The cAMP activates an intracellular protein 
kinase which initiates a cascade of enzymatic 
phosphorylations [69]. 
Two lines of research suggest that adrenergic agonists 
stimulate pepsinogen secretion via cAMP. First, 
isoproterenol increases the cAMP content of rabbit gastric 
glands and stimulates adenylate cyclase activity in rabbit 
[66) and frog [116) gland homogenates and rabbit chief cell 
suspensions [66). Second, cAMP and its analogs release 
pepsinogen from rat [91,150], guinea pig [10) and rabbit [66] 
gland suspensions as well as frog esophageal mucosa [116,117] 
and canine chief cell monolayers [108]. Forskolin, a potent 
adenylate cyclase activator derived from coleus roots [112], 
stimulates rabbit glands to secrete pepsinogen [50] while 
cholera toxin, another adenylate cyclase agonist, releases 
pepsin from guinea pig chief cells [90). 
Secretin and VIP may also stimulate pepsinogen secretion 
through cAMP. Both pure secretin and VIP cause pepsinogen 
secretion in canine chief cell monolayers [108], rat glands 
[91], and guinea pig chief cells [135]. These agents also 
increase cAMP levels [122] and stimulate adenylate cyclase 
[91). Secretin and VIP potentiate carbachol and CCK which do 
not act through cAMP [6,90). Isobutylmethylxanthine, which 
inhibits cAMP degradation, increases the potency but not the 
efficacy of secretin [91]. These findings strongly suggest 
that cAMP mediates the pepsigogic effects of secretin and 
VIP. 
Although PGE2 was reported ineffective in rabbit glands [66], 
Berger and Raufman [11) found several prostaglandins to 
stimulate pepsinogen secretion in guinea pig glands. PGE2 
was not potentiated by the cAMP-related agents secretin or 
8-bromo-cAMP but was potentiated by carbachol and by the 
calcium ionophore A23187. PGE2 also stimulates cAMP 
production in enriched canine chief cell suspensions [148]. 
Like isoproterenol, secretin and VIP, the prostaglandins 
probably act through cAMP in chief cells. 
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Group II: The Calcium-mediated Secretagogues 
Cholinergic agonists and peptides of the CCK family stimulate 
pepsinogen release independently of cAMP [49]. The effect is 
probably mediated by changes in intracellular calcium. 
Carbachol stimulates pepsinogen secretion in vivo [132] and 
in vitro. Atropine blockade suggests a muscarinic receptor. 
Carbachol and isoproterenol are additive pepsigogic stimuli 
in rabbit glands [48]. Although bethanechol increases the 
cAMP content of frog esophageal glands in the presence of 
agents which block cAMP degradation [116], it is generally 
accepted that cholinergic agents do not increase cAMP or 
activate adenylate cyclase [49]. CCK, cerulein and gastrin 
similarly have no effect on adenylate cyclase or cytoplasmic 
cAMP [49] despite their pepsigogic potency [62]. It is, 
therefore, probable that cholinergic and some peptidergic 
influences are independent of cAMP. Since atropine does not 
antagonize CCK, at least two different receptors (muscarinic 
vs peptidergic) must influence this secretory control system. 
Bombesin may also stimulate pepsinogen secretion through this 
second control system via its own receptor which is blocked 
by a substance P analog {115,116]. 
Calcium is a potent intracellular signal for secretion in many 
other tissues [ 22, 89] . Many calcium-mediated agents stimulate 
cleavage of membrane associated phosphatidylinositol into 
inositol trisphosphate and diacylglycerol. Inositol 
trisphosphate mobilizes calcium into the cytosol from 
endoplasmic reticular organelles. This increase in 
intracellular free calcium initiates secretory activity by 
binding to calmodulin which allosterically interacts with 
intracellular enzymes. The calcium ionophores A23187 and 
ionomycin mimic this response [116]. Diacylglycerol produces 
a less marked but sustained effect activating 
calcium/phospholipid-dependent protein kinase (C kinase) [ 63]. 
The phorbol esters have been used experimentally to activate 
C kinase and study this phase of calcium-mediated function 
[ 137]. Phenothiazines and related compounds block calmodulin-
dependent processes [146]. 
The application of such probes and blocking agents to chief 
cells suggests that muscarinic and peptidergic stimulation of 
pepsinogen secretion involves both phases of calcium response. 
Incubation of frog esophageal mucosa [116] or isolated rate 
[91,150] or guinea pig [11] glands with the calcium ionophore 
A23187 stimulates secretion. Phorbol esters potentiate this 
effect [76]. Furthermore, the intracellular calcium 
antagonist nicorandil [78) and the calmodulin inhibitor 
chlorpromazine [108) inhibit calcium-mediated pepsigogic 
stimulation. 
Whether the calcium for the first phase of the calcium-
- 48 -
mediated response originates outside or inside the chief cell 
is unknown. Verapamil (a calcium channel blocker) does not 
block carbachol, histamine or pentagastrin stimulated 
pepsinogen secretion in humans or rabbits [1,78]. 
Experiments in calcium-free media have been inconclusive 
[62,66,108], possibly because of calcium from dying cells or 
glassware [22]. 
Intracellular Control Systems 
Agents related to cAMP have been reported to potentiate 
calcium-mediated agonists, even though these messenger 
systems were originally believed distinct [91]. The calcium 
and cAMP pathways interact extensively in other cells 
[8 8, 8 9 J, and may intertwine in the chief cell as well. 
Forskolin increases rabbit gastric gland cAMP, but also 
increases cytoplasmic calcium, just as carbachol and CCK do 
[18 J. S omatostatin blocks both cAMP and calcium-mediated 
agents in frog isolated peptic cells [45] and intact dogs 
[10], perhaps at a final common pathway [45] (Fig. 5). 
Pepsinogen Synthesis 
Little is known about the control of pepsinogen synthesis. 
Carbon-14 incorporation into suspensions of rabbit and human 
glands demonstrates the synthesis of protein, believed mostly 
pepsinogen [2 9]. Cimetidine seems to inhibit pepsinogen 
synthesis although no stimulation by histamine has been 
observed. Dibutyryl cAMP also stimulates pepsinogen 
synthesis, probably through the cAMP messenger system [29]. 
Pentagastrin, secretin and CCK cannot stimulate pepsinogen 
synthesis on their own, but each stimulates pepsinogen 
synthesis in rabbit gastric mucosa cultured with 
acetylcholine [12 3]. Pepsinogen synthesis in canine chief 
cell monolayers lags about thirty minutes behind secretion 
after stimulation by carbachol, VIP and CCK. Synthesis may 
be stimulated by the depletion of intracellular stores [28]. 
Pepsinogen synthesis in the frog esophagus exhibits marked 
seasonal variation [116]. The agents controlling this 
variation, when found, may prove pharmacologically useful. 
In addition, peptic ulcer disease in humans may also 
fluctuate with the seasons [144] and it is tempting to 
speculate on whether similar mechanisms might underlie both 
sets of variations. 
PEPSINOGEN IN DISEASE 
Although abnormalities in pepsinogen have not yet been shown 
to cause disease, it seems unlikely that such a potent 
digestive enzyme has no effect on the gastroduodenal 
mucosa. Clinical research has related pepsinogen isozymogen 
levels to preneoplastic and neoplastic diseases and peptic 
ulcers. Unfortunately, our understanding of pepsinogen 
secretion remains insufficient to explain the complexities of 
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Figure 5. Pepsinogen secretion is stimulated in the chief 
cell by agents acting through cyclic AMP or through flux of 
calcium into the cytosol from intracellular organelles or 
extracellular fluid. Zymogen exocytosis may also be 
stimulated by luminal acid. Once secreted, pepsinogen is 





we can only 
The correlations between pepsinogen and disease 
represent causes, effects, epiphenomena 
associations; lacking a theoretical framework, 
collect observations and hypothesize. 
The loss of peptic activity in frozen samples may obscure 
retrospective studies [16,27]. Serum studies are most likely 
to be valid since pepsinogen is stored more stably at a 
neutral pH. Glycerol or ·titration to neutrality may preserve 
samples [25]. 
Cancer and Preneoplastic States 
The search for a relationship between pepsinogen and gastric 
cancer has been energetic. Six percent of gastric cancers 
stain histochemically for pepsinogen while no other neoplasm 
does [92]. Pepsinogen fractionation may yield more valuable 
clinical markers. Pepsin 5 dominates apparently normal 
gastric mucosa distant from the site of pathology in two 
thirds of gastrectomy specimens for cancer but in only 20% of 
specimens from ulcer patients [147]. Similar work 
demonstrated immunofluorescent staining of all gastric 
cancer specimens with "pepsinogen IV" [51], analogous to the 
isozymogen producing pepsin 5 [100]. 
More common are blood studies. Nomura [81] identified forty-
eight patients who had blood frozen for another study before 
developing evidence of gastric cancer. Nearly a third, and 
40% of those with "intestinal" carcinoma, had low serum 
pepsinogen I while only 6% of controls demonstrated low 
levels. 
Patients with premalignant gastric lesions also may exhibit 
pepsinogen isozymogen abnormalities. One study found low 
serum pepsinogen I in 25% of subjects with intestinal 
metaplasia but in less than 3% of subjects without metaplasia 
[120]. Low serum pepsinogen I was four times as frequent in 
ethnic Japanese as in caucasians (who are less likely to 
develop gastric cancer). 
Atrophic gastritis, which precedes intestinal metaplasia, 
also lowers serum pepsinogen, perhaps by reducing chief cell 
mass [13,26]. Pepsinogen fractionation is even more 
significant. Serum pepsinogen I is 97% specific and 91% 
sensitive in screening relatives of patients with pernicious 
anemia [129]. In fact, low serum pepsinogen I is a better 
test for atrophic gastritis than high gastrin because an 
atrophic antrum may secrete less gastrin. Atrophic gastritis 
and low pepsinogen I correlate similarly in other populations 
[124,136]. In fact, atrophic gastritis can be staged 
according to the pepsinogen I/II ratio [106]. 
The associations between low pepsinogen I and high pepsin 5 
levels and preneoplastic and neoplastic conditions seem so 
impressive that patients with low serum pepsinogen I may 
require periodic gastroscopy [80,81]. However, how pepsin 
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abnormalities actually relate to gastric cancer remains 
unclear. Gastric tumors probably do not make large amounts 
of pepsin 5 [92). If the low pepsinogen I seen with these 
diseases stems from a decrease in chief cell mass, then chief 
cells synthesizing pepsin 5 might survive better and produce 
a relative abundance of pepsin 5. Pepsin 5 could also be a 
cocarcinogen, either directly or through digestion of some 
dietary chemical. However, the correlations may reflect only 
a coincidental linkage between the genes for pepsinogen I or 
pepsinogen 5 and some sequence predisposing to gastric 
cancer. 
Peptic Ulcer Disease and Pepsinogen 
The second focus for clinical pepsinogen research has been on 
ulcerogenesis. current ulcer therapy emphasizes acid 
control, but acid alone does not cause ulcers [23,109,134). 
Pepsin permits the acid access to the mucosa [134,142]. 
Hypoxic and hyperacidic gastric mucosa requires pepsin to 
ulcerate [64,65). 
High concentrations of hyperactive pepsins may breach the 
mucosal barrier in ulcer patients. Patients with duodenal 
ulcers have high plasma pepsinogen levels [77) and high 
intragastric peptic activity [97). Conversely, low or normal 
pepsinogen levels may predict subsequent freedom from ulcers 
[21). Furthermore, patients whose duodenal ulcers recur 
after vagotomy secrete more pepsinogen than those who are 
cured [52). Carbenoxolone and bismuth do not block acid 
secretion but inhibit the secretion of pepsin and its 
activity and treat ulcers [7 ,23). 
Serum studies are difficult to interpret since mucosal 
ulceration and necrosis may release pepsinogen. Furthermore, 
age, renal failure, smoking, gender, and ICU stress alter 
pepsinogen and pepsinogen I levels [81,93,139,141). 
Nevertheless, pepsinogen I seems linked to peptic ulcer 
disease. Elevated serum pepsinogen I and duodenal ulcer 
disease are often inherited together [95). Gastric ulcer 
patients have normal serum pepsinogen I while duodenal ulcer 
patients have high levels and patients with Zollinger-Ellison 
syndrome exhibit massive elevations of serum pepsinogen I 
[102,103]. Pepsinogen I levels may be bimodally distributed 
in duodenal ulcer patients, with one group having 
significantly higher levels [102). This could represent 
disease more directly related to pepsinogen. The pepsinogen 
I/II ratio may also be important. Duodenal ulcers are 
associated with high serum pepsinogen I and gastric ulcers 
with high pepsinogen II and a low I/II ratio [104). 
Isozyme fractionation of gastric juice refines these 
observations. Pepsin 1, derived from a pepsinogen I 
pepsinogen, is more stable and better able to digest mucus 
than other pepsins [8 6). Patients with ulcers secrete 
increased amounts of pepsin 1 [133). Pepsin 1 becomes more 
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prominent during the hypersecretory state characteristic of 
many ulcer patients. In healthy cats (149] and patients with 
peptic ulcers ( 141], insulin hypoglycemia and gastrin 
significantly increase the proportion of pepsin 1 secreted. 
It is unclear whether pepsin 1 secretion differs between 
duodenal and gastric ulcer disease (125,141]. 
CONCLUSIONS 
Pepsin is an essential gastric enzyme, synthesized as 
pepsinogen and secreted into the lumen by chief cells and 
mucus neck cells in the gastric fund us as well as by the 
glands of the duodenum, pylorus and gastric cardia. Its 
secretion is modulated by two distinct yet interacting 
pathways. The first involves cAMP and is activated by 
adrenergic stimulation, prostaglandins, and such hormones as 
secretin and VIP. The second control mechanism responds to 
vagal and cholinergic stimuli, to bombesin and to CCK, 
cerulein and gastrin. It appears to be mediated by calcium 
entering the cytosol from interstitial fluid or intracellular 
organelles and acting through both calmodulin and 
calcium-dependent kinase pathways. The relative importance 
of the various calcium pools is unknown. Secretory 
modulation by interactions of the cAMP and calcium systems at 






synthesis remains largely unexplored. Secretin, 
and cholinerg ic agonists stimulate pep sinogen 
but the path ways through which they act are 
Pepsin isozymes may be clinically significant. Pepsin 5 
seems linked to the intestinal type of gastric carcinoma and 
pepsin 1 to ulcers. Whether these correlations are causal is 
unknown. Detailed epidemiologic studies may better define 
subgroups of neoplastic and peptic disease which are 
primarily pepsinogen-related. Refinement of currently 
speculative models of pepsinogen genetics (35,68] may 
determine whether these associations stem from genetic 
cosegregation or peptic actions. 
Pepsin is a powerful digestive enzyme plentiful in the 
stomach. Its further study promises to illuminate not only 
the biology of secretion but also the genesis of "peptic" 
ulcer disease and gastric malignancy. 
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History and Review of 
Pepsinogen Measurement 
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A) HISTORICAL CONSIDERATIONS 
Initially the issue of accurately measuring pepsin revolved 
around the rate at which pepsinogen was transformed into 
pepsin and whether this was a standard reproducible 
percentage. Gottlieb, in 1924, reported that pepsinogen was 
rapidly converted at pH's of 1-3 but slow at pH's 3-4 and 
very slow above that [1]. His methodology was somewhat 
inaccurate since he used fibrin as a substrate. Subsequently 
Ege and Menck-Thygesen reported that a conversion began at 
pH 5.1 and was 10 times more rapid at a pH of 4.1 [2]. This 
observation was confirmed by Sumner and Somers who reported 
that at pH 2 conversion of pepsinogen to pepsin was 
instantaneous [3]. Herriot in 1938 had stated that the 
conversion of crystalline pepsinogen commenced at pH 6 and 
became increasingly rapid at a lower pH [4]. Hirschowitz and 
others reported that pepsinogen was rapidly, 
autocatalytically and irreversibly transformed into pepsin at 
a pH of 2. O and that assay should take place as shortly as 
possible thereafter [5]. 
In the measurement of pepsin using its acid protease 
activity, a number of techniques were utilized. The first 
technique involved the activity measurement in substrate 
concentration high enough to give maximal rate. The theory 
was that the amount of substrate split would be proportional 
to the amount of enzyme present. Indeed this was the 
principle of the technique employed in the original 
hemoglobin-based assay [6]. 
An alternative technique related to the activity measurement 
in substrate solutions so dilute that the monomolecular law 
was simulated. This technique was of no particular advantage 
in the measurement of pepsin since it was only of use where 
the substrate was relatively insoluble. 
The third possibility was the use of the principle that for a 
given substrate the time required to decompose a given 
fraction would vary in inverse proportion to the amount of 
enzyme present. This theoretical consideration was never of 
particular use in the measurement of pepsin since the 
kinetics of the equation were not well characterized for the 
pepsin digestive reaction, and it was not initially possible 
to express the activity of the enzyme as a velocity 
constant. For practical use, therefore, the first principle 
of activity measurement in substrate concentrations high 
enough to give maximal rates has always been used as the 
primary methodology for the measurement of pepsin. 
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The various methods that have been historically utilized in 
peptic assay are listed below. (Reproduced with kind 









1907 Fuld & Levison 






1922 Loeper & Debray 
1922 Euler 
to W illstatter 
1932 Northrop 
1932 Anson & Mirsky 
Method 
Meat liquefied by gastric juice. 
Discovery of pepsin-digestion of 
meat and egg-white. 
Fibrin flakes, egg-white. 
Solid fibrin. 
carmine stained fibrin. 
Egg-white tubes. 







Globin (of HB) with 
precipitation. 
Edestin modified with titration 
method. 
Blood proteins, for blood 
enzymes. 
Rennet 
Gelatin viscosity changes 
Formation of soluble nitrogen 
Increase in formol titration. 
Hemoglobin 
In essence, the earlier methodologies reported prior to 1922 
could be divided into 2 groups: 
1. those depending on the digestion of solid protein 
2. those depending on the precipitation of proteins 
in solution. 
1. Methods Depending On The Digestion Of Solid Proteins 
a) 1861 Brucke used the clearing of suspensions of egg 
albumJn at room temperature or fibrin flakes at 
36-40 C to first detect activity in the urine which 
he initially acidified on collection of the phosphoric 
acid [7]. The egg white method was subsequently 
utilized by Liebmann [8]. 
b) Grutzner (1874) digested solid fibrin [9] and 
subsequently 
c) with Sahli [10] and Gehrig [11] (1895 & 1886) modified 
this methodology by combining fibrin with carmine and 
measuring the amount of dye released after peptic 
digestion. The method was not entirely sensitive since 
fibrin staining by carmine was not always equal and the 
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sensitivity was somewhat lacking. 
d) In 1902 Nierensteiner and Schiff [12] modified the 
original method of Mett (1894) [13] in which glass 
tubes were filled with coagulated egg white and 
suspended in the acidified test solution. This method 
was initially used for clinical observation but its 
vague endpoint and crude results precluded its use in 
accurate studies. 
e) Jacoby and Solms (1907) utilized the principle of the 
clearing of a fine suspension of ricin and egg white 
[14]. The difficulty with this methodology was the 
preparation of a reproducible substance and the 
problems involved in measuring a loss of translucency 
in a suspension of particles which was not entirely 
uniform. 
f) Subsequently in 1920 Michaelis used suspensions of 
diluted human or sheep serum precipitated with 10% 
sulpho-salicylic acid to produce a milky suspension 
[15]. This methodology suffered from the same problems 
as that experienced in measuring the loss of 
translucency in the ricin egg white mixture of Jacoby 
and Solms. 
The methodologies reported above were inaccurate and tedious 
to the extent that they were not able to be used for 
scientific investigation of an accurate nature. One of the 
main problems was the difficulty in preparing reproducible 
substrates and the inability to accurately measure 
endpoints. Of particular concern was the failure to 
accurately pH the digest and the result that a digestion 
methodology might thus be occurring at a non-optimal pH. 
2. Methods Depending on Change in Precipitation of 
Dissolved Proteins 
a) Hammerschlag (1894) used the principle that egg white 
in solution is precipitated by Esbach's reagent and 
that this property is lost on digestion by pepsin [16]. 
Unfortunately the measurement took a considerable time, 
the endpoint was vague and a large amount of gastric 
juice was required. 
b) Fuld and Levison (1907) utilized the precipitation 
method in which edestin in hydrochloric acid was 
digested and the undigested portion precipitated with 
NaCl [17]. The undigested proportion was then titrated 
with alkaline (NaOH) and the amount of NaOH required 
to dissolve the precipitated edestin was taken as a 
measure of the amount that had been digested. Again, 
the difficulties in substrate preparation, inequality 
of samples and the indeterminate endpoint of solution 
of undigested edestin rendered this methodology 
inadequate. 
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c) In 1908 Gross, utilizing a similar technique to Fuld 
and Levison, employed casein in hydrochloric acid as a 
substrate [18]. He utilized sodium acetate to 
precipitate the undigested casein and the amount 
remaining was used as an index of the peptic activity 
by subtraction. Again, the difficulty with the 
methodoloy related to the fact that pure casein was not 
easy to store and that impure casein did not give a 
clear solution with a sharp endpoint. Gross made an 
important contribution in stating that peptic activity 
was mathematically proportional to the amount 
digested. This conclusion had been derived by an 
extrapolation of the Schutz-Borrisow law which stated 
that pepsin activity was proportional to the square of 
the protein digested [19]. 
d) Glaessner in 1922 employed the globin of hemoglobin 
which he precipitated with ammonia and redissolved with 
NH 4 Cl as a measure of the amount left over after 
digestion [2 O]. 
e) Ege in 1923 improved the method of Fuld and was the 
first to utilize the measurement of the pH of each 
digest [21]. He used edestin in acetic acid at a pH of 
1.5-1.6 precipitated with 20% NaCl followed by 70% 
(NH 4 ) 2 so.<\ and compared this to a standard 0.5% 
gum arabic suspension. The endpoint was extremely 
reproducible to within 1-3 drops of the precipitant. 
The method was subsequently further refined by 
comparison of the unknown with standard Armour pepsin. 
In 1924 Gottlieb claimed that he was able to work to 
within an accuracy of 95% with this method and it 
remained the methodology of choice for scientific work 
until the hemoglobin method of Anson and Mirsky 
replaced it [6]. 
INITIAL PRINCIPLES OF PEPTIC ASSAY 
In 19 3 2 Northrop discussed the various principles and 
techniques involved in peptic assay:[22] 
1. the measurement of change in viscosity of protein 
induced by pepsin 
2. the production of non-protein nitrogen by pepsin 
and the determination of activity by the increase 
in formal titration 
3. the production of amino (carboxyl) groups. 
The first effect of pepsin on a protein solution is the rapid 
decrease in viscosity of the solution followed by a second 
and slower decrease in substrate protein nitrogen. The third 
change which is the slowest of all is an increase in the 
number of titratable carboxyl (amino) groups. Although other 
changes which include alterations in optical activity or 
conductivity occur they are less specific. 
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1. Viscosity Changes 
Northrop used a number of different changes for 
estimating viscosity including gelatin and edestin, 
casein and dried milk. He claimed that the viscosity 
changes might be measured accurately and rapidly with 
less than 3% error (Northrop and Hussey 1923). However 
the viscosity changes and their relation to the 
chemical changes induced by acid protease were not 
clear. Arbitrary units were required for the 
measurement of specific viscosity and depended heavily 
on temperature and time measurement. 
2. The Production of Non-protein Nitrogen 
This method utilized casein or edestin and was based 
upon the measurement of increased non-protein nitrogen, 
either after increasing time intervals with a fixed 
concentration of enzyme or after a fixed time using 
different concentrations of enzyme. The exact 
significance of the changes in relation to the chemical 
changes was not clear and the further disadvantage was 
that it was somewhat slower than the viscosity change 
measurements. Furthermore there was no simple relation 
between the amount of non-protein nitrogen produced and 
the amount of active enzyme, except when the latter was 
present in extremely small quantities. Under the 
latter circumstances, however, the determination was 
somewhat inaccurate. The method was complicated overall 
and required interpretation by interpolation of 
different concentrations of an unknown enzyme solution 
with the result that the calculations varied 
considerably with the purity of the solution. As with 
the previous methodology, the development of arbitrary 
units of activity were required which defined the 
liberation of non-protein nitrogen under extremely 
specific conditions. 
3. Production of Amino (Carboxyl) Groups 
The advantage of this methodology was the fact that it 
had a clear chemical relation to enzyme reaction. 
Unfortunately the amount produced was small and not 
directly proportional to the amount of enzyme present. 
The methodology was difficult and the end result 
somewhat inaccurate. Gelatin, casein and edestin were 
used to generate activity curves and arbitrary units of 
activity defined. 
In 193 2 Anson and Mirsky developed the hemoglobin 
digestion method which has remained the basis for most 
subsequent methodologies utilized in the measurement of 
peptic activity [6]. It was accurate since it measured 
end products: was based upon rapid digestion by pepsin 
giving proportionality of results for both the 
concentration of enzyme and time: and utilized a 
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substrate of considerable reproducibility. Furthermore 
the substrate could be stored unchanged over long 
periods of time and small variations in the methodology 
of the measurement did not significantly influence the 
final result. As a result, the methodology of Anson 
and Mirsky has formed the keystone for most of the 
subsequent 50 years of peptic activity measurement. It 
has been variously upgraded by altering certain of the 
test conditions, altering the substrates and labelling 
the protein substrate with radio-active isotopes. In 
the \~~sequent section, I will detail the final form of 
the I-labelled albumin assay that was developed in 
my laboratory to measure the peptic activity of 
secreting guinea pig gastric mucosa! membrane mounted 
in Ussing chambers. In initial studies (isolated 
gastric glands) I utilized the standard Anson Mirsky 
methodology. Subsequently, when further accuracy and 
sensitivity was required I switched to 4 carbon 
labelled hemoglobin as the method of choice. 
Unfortunately the expense of this method necessitated 
the development of a less costly technique. I thus 
spent some time modifying the methodology to a certain 
extent and developing the use of "1 2 5 r-labelled 
albumin as a basic substrate. The exact details of 
this latter methodology will be presented subsequently. 
B) OVERVIEW 
Pepsinogen is the inactive precursor of pepsin and itself 
possesses no catalytic activity and can thus only be measured 
using an immunoassay. Specific radio-immunoassays for PG I 
and PG II have been developed and employed for measurements 
of pepsinogen in tissues, serum and urine [23,24]. This 
methodology has been adequately demonstrated to be highly 
sensitive and extremely specific. It is, however, only of 
clear advantage if the sample size is small or a specific 
distinction between PG I or PG II is necessary for the 
investigation or study under progress. 
In general terms, however, to assay pepsinogen one has to 
express the result in terms of pepsin since pepsinogen must 
be hydrolyzed into pepsin before demonstrating any activity. 
This usually results in a somewhat less sensitive assay but 
is adequate since it allows the new bioactive pepsin to be 
measured using the resulting acid protease activity as an 
indicator. The first formal assay performed using this 
principle was the classical methodology developed by Anson 
and Mirsky who used a hemoglobin substrate at a pH of 2 [6]. 
Subsequently this assay has been considerably modified for 
large scale use in an auto-analyzer [25]. Alternatively, the 
sensitivity of the assay may be enhanced by measurement of 
the proteolytic end products by a protein assay procedure 
[26]. A further refinement of this technique which allowed 
for increased sensitivity was the usage of radiolabelled 
hemoglobin assay substrate [27]. There are a large number of 
different methodologies which have been utilized to measure 
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the proteolytic activity of the activated acid protease. 
Mostly these have employed different pH's, different 
substrates and radiolabelling techniques. In many cases, 
they have been specific to the investigative group which 
first described them and have not attained general usage. In 
the subsequent paragraphs of this chapter I will describe the 
modification which we have utilized to measure the small 
amounts of pepsinogen secreted by mammalian guinea pig 
mucosa. 
A particular concern in the assay of pepsinogen which has 
been pointed out by a number of different authors is the use 
of different units for expressing the result. The original 
definition of one peptic unit (6] is the activity of pepsin 
that releases 0.1 umol of tyrosine f 0om 5.0 ml of 2% hemoglobin at pH 1.7 in 10 minutes at 37 c. Unfortunately, 
most assays suffer from sufficient deviation in standard 
conditions to prohibit direct expression of the values in 
peptic units. As a result most assay values in more recent 
studies have been compared to standards of crystalline 
pepsinogen which have a defined activity in terms of peptic 
units. Until better and more precise methodology is 
available this will probably remain the standard methodology 
for expressing peptic activity (28]. 
C) Contemporary Measurement Of Pepsin 
The measurement of pepsinogen and pepsin in biological fluids 
has suffered from several major deficiencies. These have 
included the absence of an acceptable and available reference 
standard, the potential presence of other proteolytic enzyme 
activity at acid pH and the use of protein substrates of 
differing compositions. In more recent times the estimation 
of proteolytic activity at acid pH have included a 
nephelometric assay using bovine albumin as a substrate (29], 
a colorimetric method using an insoluble substrate covalently 
labelled with Remazolbrilliant Blue (30], a method using 
autologous serum as a substrate (31], a radial diffusion 
assay in which the hemoglobin substrate is incorporated into 
agar gel (32], a microassay based on the detection of amino 
groups liberated from N,N-dimethylhemoglobin (33], a 
titrimetric assay based on the consumption of hydrogen ions 
during the hydrolysis of peptide bonds (34], and a method 
using human hemoglobin as a substrate (35]. In addition, a 
semi-automated procedure for serum pepsinogen has also been 
reported (36]. A number of recent studies have indicated 
that pepsin hydrolyzes ester as well as peptide bonds. 
Pepsin has been shown to hydrolyze selected esters of 
b-phenyl-L-lactic acid (37 ,38,39] and certain sulfite esters 
(40,41]. Robinson and White have reported that p-nitrophenyl 
sulfite is a suitable substrate for the spectro-photometric 
assay of peptic activity in canine gastric juice (42]. The 
relative specificities of the human group I and group II 
pepsins for these substrates is however not known. 
Furthermore, considerable investigation has been undertaken 
regarding the hydrolysis of various synthetic peptides by hog 
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pepsin [43,44,45,46]. Although these studies have been 
concerned with delineating the mechanism of pepsin action and 
determining the active site of the enzyme it is possible that 
this methodology may be,of use in a analytic technique. 
Whilst most methodology for the measurement of peptic 
activity has concentrated on overall measurement, recent 
studies have attempted to develop assays which are capable of 
differentiating group · I from group II pepsinogens and 
pepsins. Chiang et al. [47] have reported that the group I 
pepsins, but not the group II pepsins (gastricsin), hydrolyze 
N-acetyl-L- phenylalanyl-L-diiodotryosine (APDT). The 
activity of the group II pepsins in gastric juice can thus be 
determined by subtracting activity obtained against APDT from 
activity obtained against hemoglobin. Similarly, Huang and 
Tang [48] have recently discovered a series of synthetic 
substrates apparently specific for the group II pepsins. The 
relative insolubility of these substrates and the prolonged 
incubation time required for measurement has limited the 
usefulness of this test. 
A second approach has been based on the differential heat 
!ability of the two groups of pepsins. At pH 7 .25 and 25°c 
for 2 minutes or, at pH 7.1 and 20°c for 90 minutes the 
group II pepsins are stable but the group I pepsins are 
inactivated [49]. 
A third potentially useful approach is based on the fin ding 
that the group I and group II pepsinogens are 
immunochemically distinguishable. This has not been 
definitively shown for the respective pepsins. Preliminary 
results with an electrophoretic immunoprecipitation technique 
using antiserum apparently specific for the group I 
pepsin o gens and pepsins have been reported [ 5 o]. 
Considerably more work must be done in this area since 
proteolytically inactive hydrolysis products of pepsin may 
retain immunological activity [51]. 
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This apparatus was originally developed in the late 1940's to 
measure ion flux in amphibian epithelium [l]. It has since 
been modified to maintain gastric mucosa [2,3,4,5]. Through 
improved tissue handling techniques, refinement of the tissue 
environment, and development of a sensitive pepsin assay, I 
have been able to study mammalian gastric mucosa instead of 
the more commonly utilized amphibian (frog) tissues. Hartley 
guinea pigs from 150-200 grams were anesthetized by Metofane 
inhalant anesthesia in an ether jar and sacrificed by 
cervical decapitation. Their peritoneal cavities were 
entered through a vertical midline incision and their 
antrectomized stomachs removed. The stomachs were opened and 
rinsed of their contents using deionized water. The serosal 
and submucosal layers were dissected from the mucosa. The 
intact mucosal sheets were then mounted between two lucite 
half-chambers. The submucosal solution was bathed in 
mammalian Ringers solution (122 mM NaCl, 25 mM NaHC0 3 , 5 mM 
KCL, 1.3 mM Mgso 4 , 2.0 mM CaCli, 1.0 mM KH 2 Po 4 , and 
20 mM glucose) and gassed with 95 o o 2 and 5% co 2 . The 
osmolality of the solution was 293 mosm/1. The pH of the 
media was adjusted to 7.30-7.40 with 14 N HCL. The luminal 
side of the mucosal sheet was gassed with pure oxygen and 
bathed in 154 mM NaCl (308 mosm/1). Casein hydrolysate 
0.03% w/v (Polypep, sigma, st. Louis) was added to saturate 
protein binding sites in the chamber and improve pepsinogen 
recovery. Luminal solution pH was maintained at 5.0 by 
titration with 5mM NaOH using the pH stat technique with an 
autotitrator (Radiometer Copenhagen). Acid secretion was 
calculated from the amount of alkali added to maintain 
constant pH. The luminal solution was sampled in triplicate 
(100 ul each) at twenty minute intervals for measurement of 
gepsinogen concentrations. All fluids were warmed to 39-40 
C and maintained at this level by a circulating water 
bath. 
The pH of 5 chosen for the luminal solution represents a 
compromise between the instability of pepsin at higher pH [6] 
and the inaccuracies of pH stat technique at lower pH [7]. 
Pepsin is relatively unstable at alkaline or neutral pH 
because of the relatively low number of basic amino acids in 
its structure. The pH stat methodology loses some accuracy 
at increased hydrogen ion concentrations because of added 
hydration of co 2 and dissociation of H2 co 3 . A further 
inaccuracy results from the higher volume of titrant utilized 
to keep the pH relatively low. By convention, for titration 
of H+ with an OH- titrant it is assumed that VT = 
AH/[OH- ]T where VT is the volume of titrant added to 
bring the solution to the desired end point; AH the amount 
of H+ (hydrogen ion concentration of sample multiplied by 
the volume of the sample); and [OH- ]T is the OH-
concentration of the titrant. The equation for pH stat, 
however, is V~ = AH/[H+] + [OH-]T where 
[H+ ]0 is the initial and final HC+ concentration. Thus,
 
the pH of 5 utilized in these experiments causes a difference 
of the calculated from actual hydrogen ion secretion of less 
than 2%. 
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A voltage clamp apparatus (DVC 1000 World Precision 
Instruments, New Haven) connected to the chamber by silver 
chloride electrodes in series with 4 M KCl half cells and 4 M 
KCl 5% agar bridges is used to continually ascertain tissue 
viability by measurement of the potential difference across 
the mucosa. By placing a 25 microamp current across the 
membrane, tissue resistance can be calculated utilizing Ohm's 
law, V=I "R. Increased tissue resistance represents 
decreased cell function and poor tissue viability. 
Attainment of stable baseline acid secretion is another 
indicator of tissue viability. 
After the initial equilibration period of 150 minutes is 
completed, the mean potential difference and the mean 
electrical resistance remain stable. Figure 1 is a 
representative graph of potential difference and tissue 
resistance of a typical mucosa over the final 150 minutes of 
a mounting period. Acid and pepsinogen secretion of this 
same tissue remained constant at 1.44 ueq/hr and 0.024 
units/hr respectively. Figure 2 depicts the total amount of 
acid and pepsin that an unstimulated mucosa! sheet secretes 
into the luminal solution over a 2 .5 hour experimental 
period. 
M ucosal viability is further supported by morphological 
studies. Figure 3 is a light micrograph of a deserosalized 
gastric mucosa! sheet at the time of mounting. It is stained 
with toluidine blue, which is relatively selective for chief 
cells and periodic acid Schiff (PAS), which is selective for 
mucous cells. The secretory product from the mucous cells is 
distributed exclusively at the cell apex. The zymogen 
granules from the chief cells are relatively heterogenous in 
their distribution, although their general orientation is 
apical. Figure 4 is an electron micrograph of a glandular 
unit from a mucosa! sheet that has been maintained in the 
Ussing chamber for 5 hours. There is no disruption of 
glandular or cellular architecture as demonstrated by minimal 
tissue edema, normal nuclear chromatin, abundant microvilli 
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In 193 o Northrup assayed pepsin by the digestion of egg 
white, casein and gelatin [1]. A few years later, Anson and 
Mirsky [2] developed an assay based on the ability of pepsin 
to degrade the hemoglobin protein. This technique, however, 
is not sensitive enough to measure the small quantities of 
pepsinoqen present in mammalian Ussing chamber samples. 
Later, "l 4 c-labelled hemoglobin was used as a protein 
f'ibstrate to automate pepsinogen assaying [3]. Although the 
C-hemoglobin technique is sensitive, it is quite 
expensive and requires amplification of beta particles with 
scintillation fluid. In addition, the trichloracetic 
acid-precipitated hemoglobin is difficult to separate. 
The pepsinogen content of guinea pig gastric mucosa is 700 
+ 50 unitf/gram wet weight (n=6, mean + SEM) or 21.6 + 1.6 
units/ cm (mean + s EM) after stripping the serosa and 
extraction by freeze-thawing in 0.1% Triton X dissolved in 
0.01 M HCl with a pH of 2.0. By comparison, the mucosa of 
the ffog esophagus has been reported to contain 0.52-2.32 
mg/cm of pepsinogen, depending on the season [4]. Thus, 
the guinea pig gastric mucosas used in these experiments have 
less than one hundredth of the pepsinogen present in the frog 
esophagus. Similarly, the basal secretory rate measured for 
guinea pig mucosal s~eets in the Ussing chamber preparation 
was 0.07 units/cf /hr, significantly less than the 
(8.7-43.3 ug/cm /hr reported for frog esophagus 
preparations by Hirschowitz. The pepsinogen assay used for 
these experiments was therefore adapted for the detection of 
the small quantities of pepsin secreted by guinea pig mucosa. 
First, I undertook some modification of the classical 
Anson-Mirsky 1ssay to increase sensitivity. Initially I substituted 4 c-methemoglobin for non-radioactive 
hemoglobin in order to automate the assay counting and to 
increase P\ec?sion. Finally, I changed the substrate for the 
assay to 2 I-labelled albumin. As in the Anson-Mirsky 
methodology, pepsin is allowed to incubate with the protein. 
Non-digested protein is precipitated with trichloracetic 
acid, and the pepsin content calculated from the quantity of 
peptides in the supernatant fluid. The 125-albumin assay 
measures the gamma emission from the labeled peptides and is 
sensitive to a level of five micrograms of pepsinogen. The 
brief description of this assay is fallowed by detailed 
methodology on page 85. 
Radioactive protr~R substrate is prepared by the 
incorporation of I to bovine serum albumin using 
chloramine T as an oxidant. The reaction is terminated by 
addition of sodium metabisulfite. Iodinated albumin is 
separated from free iodine by gel permeation chromatography 
using Sephadex G-50. Figure 5 shows the radioactivity of 0.3 
ml (two minute) aliquots collected off the column. The first 
peak, just after the void volume of the column, represents 
iodinated albumin. The second peak represents unbound iodine 
and small protein fragments. Aliquots from the first peak are 
diluted and used to generate a standard curve of known pepsin 
- 84 -
activity for each assay performed (Figure 6). 
To determine the optimum time of assay incubation, 
albumin-pepsin standards were incubated for 24, 48, and 72 
hours, respectively (Figure 7). These data demonstrate 
stability of albumin in an acid environment and no 
significant advantages between one, two or three day 
incubations. This technique has an inter-assay variation of 
4-9% and an intra-assay variation of 3-7%. 
Specific details of all three assays used follow. 
COLORIMETRIC ASSAY TECHNIQUES: 
The first assay utilized in the laboratory was 
spectrophotometric using a modified version of the classical 
Anson-Mirsky technique. Pepsinogen in the medium was assayed 
by an acid protease method in which a fixed aliquot of medium 
was incubated with hemoglobin solution at pH 2.0 for a fixed 
time interval; the enzyme reaction was terminated by adding 
trichloroacetic acid. The hemoglobin reagent contained 20 
mg/ml hemoglobin titrated with HCl to a final pH of 2.0. 
After a preliminary 10 min activation with 0.3 ml of 0.04 N 
HCl, 100 ul of medium was incubated with 0.8 ml of hemoglobin 
reagent for 2 o min at 3 7 °c. Undigested proteins were 
precipitated with 1.8 ml of 5% trichloracetic acid and 
allowed to react for 10 min. The contents were filtered 
through Whatman No. 4 filter paper. The extent of hemoglobin 
digestion was assessed in 1 ml of filtrate by adding 5.0 ml 
of 0.2 N NaOH and, after 10 min, 0.5 ml of 1 N phenol 
( F olin- Ciocalteu) reagent. Spectrophotometry was performed 
at 760 nm after 30 min. Pepsinogen activity was expressed in 
terms of peptic units (PU) released per 2 ml final sample. 
One PU corresponded to the amount of enzyme yielding an 
absorbance change of o. 001 in one min under the assay 
conditions. 
14c-METHEMOGLOBIN TECHNIQUE: 
The Anson-Mirsk.r, assay was later modified to measure the 
digestion of 1 c-methemoglobin. Io each milliliter of 
assay buffer (pH 2.0), 10 5 cpm of 
4c-methemoglobin (New 
England Nuclear Research Products, Dupont Company, 
Wilmington, DE) was added. All samples were incubated for 
thirty minutes in a shaking water bath at 37 °c until the 
reaction was terminated by the addition of 1.8 ml of 
trichloracetic acid ( 5% w/v) with rapid mixing for an 
additional ten minutes. To separate the intact hemoglobin 
molecules from the digested peptide fragments, each 10 X 75 
mm tube was centrifuged at 1500 g (Beckman J-6M) for 60 
minutes. The supernatant was added to 5.0 ml of 
scintillation fluid (Safety Solve, Research Products 
International Corporation, Mount Prospect IL) in a 20 ml 
scintillation vial. Then, gamma emission was measured in an 
automated counter (Tricarb 1500. Packard Instrument Co., 
Sterling VA). Total gland pepsinogen content was determined 
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by freezing gland suspensions in liquid nitrogen for 5 
minutes, thawing at 23 °c for 30 minutes, centrifuging the 
fluid for 30 minutes at 1500 g and assaying the supernatant 
for pepsinogen as described above. 
125I-ALBUMIN TECHNIQUE: 
To measure pepsinogen in Ussing chamber samples the assay was 
modified to use 125-iodinated albumen as a substrate. 
Because of improved sensitivity and relative simplicity, this 
assay is now also utilized for pepsinogen determination in 
all non-Ussing chamber pepsinogen experiments in my· 
laboratory. One and one-half nmol RIA grade bovine se~"sm 
albumin (Sigma, st. Louis) was added to 4.0 nmol Na
1 I 
(Amersham IMS 30, Amersham Corp. Arlington Heights, IL). 
Chloramine T (70 nmol) was added to the solution and mixed 
for 15 seconds. The reaction was terminated by the addition 
of 200 nmol of sodium metabisulfite. The solution was then 
diluted with 300 ul 0.06 M phosphate buffer (pH 7.4). The 
iodinated albumin was then separated from the free iodine by 
running the solution through a 6 x 0.5 cm column of Sephadex 
G-50 Superfine (Pharmacia, Piscataway NJ) eluted with 0.06 M 
phosphate buffer (ph 7 .4). 
Fractions of 0.3 ml were collected and their radioactivity 
measured (Figure 5). Iodinated albumin was the sample 
I~~lected just after the void volume. Incorporation of 
I with this method was 75%, giving an expected specific 
activity of 0.43 mci/nmol ( 16 Bq/fmol). The first collection 
of labeled albumin was then diluted 1:25 with 0.5 M acetic 
acid and stored frozen in 1.0 ml aliquots for later use. No 
significant autodigestion of the protein was observed for up 
to four weeks of storage. 
For each pepsinogen assay one aliquot of 
125I-labelled 
albumin was thawed and added to 50 ml of a 0.031 M HCl / 0.05 
M KCl buffer, pH 1.8. To each 100 ul sample, 250 ul of the 
acid-albumin solution was added. The pepsinogen in each 
sample was, thus, converted to pepsin. The samples were 
incubated for 18 hours. Nine hundred (900) ul of 5% w/v 
trichloroacetic acid was added to each tube to precipitate 
the undigested albumin. Fifty ul of 1% (w/v) unlabelled 
albumin was then added to each tube to facilitate the 
formation of a visible pellet following the subsequent 
centrifugation at 1500 g for 60 minutes. The digested 
fragments of 125I-albumin remaining in the supernatant were 
quantitated by automated gamma scintigraphy (Packard 
Auto-Gamma 5780, Sterling, VA). 
Each assay was standardized using purified porcine pepsinogen 
(Sigma) of known activity. One unit of peptic activity is 
conventionally defined as the amount needed to produce a 
change in absorbance at 280 nm of 0.001 per minute at pH 2.0 
at 37 °c, measured as trichloroacetic acid-soluble 
products, using hemoglobin as a substrate. 
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MORPHOLOGICAL STUDIES 
Gastric mucosal sheets were examined at both the light and 
electron microscopic levels. Samples for light microscopy 
were placed in buffered formalin, embedded in paraffin and 
stained with hematoxylin and eosin. Additional samples were 
treated with toluidine blue and Biebrich scarlet which have 
stronger affinity for chief cells. 
Samples for electron microscopy were placed in a fixative of 
3% glutaraldehyde, oriented with a dissecting microscope, 
embedded 1n epoxy 812 (E.F. Fullam Inc., Latham NY) and 
sectioned to one micron thickness. Plastic embedded sections 
were stained with basic fuschin and examined under the light 
microscope for orientation and subselection of representative 
areas for ultrathin section. The ultrathin sections were 
placed on copper grids, stained with osmium tetroxide and 
uranyl acetate and examined using a Phillips 300 electron 
microscope. 
Criteria for tissue injury included evidence of edema, 
vacuolization, diminished numbers of microvilli, and 
disruption of tight junctions and cellular membranes. 
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Figure 1. Graph of potential difference expressed in 
-millivolts (open circles) and resistance expressed in ohms 
(filled circles) vs. time (hours) for a typical gastric 
mucosa! preparation after an initial 150 minute equilibration 
period. The relative stability of these electrical 
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Figure 2. Graph of total acid (microequivalents/ml) and 
pepsin (milliunits/ml) vs. time (hours) secreted into the 
luminal solution by an unstimulated gastric mucosal sheet 
after a 2.5 hour equilibration period. Acid and pepsin 
secretion remain stable. 
- 89 -
-
Figure 3. Light micrograph (400 X magnification) of guinea 
pig gastric mucosa stained with toluidine blue and periodic 
acid Schiff. The serosa is removed from the mucosa by blunt 
dissection at the level of the muscularis mucosa. No 
disruption of glandular architecture is observed. Mucus 
cells (M) are located near the glandular neck, parietal cells 
(P) are situated in the middle of the gland, and chief cells 
(C) are found at the base of the gland. 
- 90 -
Figure 4. Electron micrograph (3000 X magnification) of a 
glandular unit from an unstimulated guinea pig gastric 
mucosa! sheet maintained for five hours in an Ussing chamber 
apparatus. A gastric gland has been transected revealing 
chief ( C), parietal (P), and endocrine cells (E). The 
parietal cells are relatively pale and contain numerous 
mitochondria and endoplasmic reticulum. The zymogen granules 
are oriented apically are readily visible in the dark 
staining chief cells. Chief cells can be differentiated from 
mucous cells by their relative heterogeneity of orientation 
of secretory product. The endocrine cells have secretory 
granules located at the base of the cell. The micrograph 
reveals no sign of damage to the gastric gland cells despite 
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Figure 5. Graph of counts per miy~\e (CPM) vs. fraction 
number of 0.3 ml aliquots for I-labelled albumin 
collected from a 6.0 cm gel permeation chromatography column 
of Sephadex G-50. The column rate was 0.15 ml/min. The 
first peak represents intact molecules of labeled albumin. 
Subse'i~~nt peaks represent labelled protein fragments and 
free iodine. Fraction 4 is diluted in 0.5 M acetic 
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Figure 7. standard curves of pepsinogen assay of 24, 48, and 72 hour incubation times. stability of albumin in an acid 
environment is demonstrated. 
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CHAPTER 8 
A Micro-Method for the Assay of 
Cellular Secretory Physiology 
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INTRO DU CTI ON 
Isolated cell systems are critical for investigations of 
cellular physiology and intracellular mechanisms regulating 
stimulus-secretion coupling. These studies require reliable 
methods for rapid processing of large numbers of replicate 
samples in parallel studies investigating both secretory 
product and intracellular messengers. Isolated enriched 
parietal cells have proven to be useful models in the study 
of the mechanisms of gastric secretion [1]. Rabbit parietal 
cells secrete both acid and intrinsic factor. While acid 
secretion can not be assessed directly in isolated cells, the 
accumulation of the weak base aminopyrine into cells has been 
adopted as a semi-quantitative method which reflects the 
general pattern of parietal cell acid secretion [2,3]. 
Intrinsic factor secretion into the media can be determined 
directly by its binding to cyanocobalamin [4]. 
Traditionally, parietal cell secretion has been measured 
through the use of multiple incubation flasks or tubes under 
conditions of intermittent oxygenation. These methods can 
often be cumbersome, especially when large numbers of 
conditions or time course studies are involved. We present 
here an simplified method for carrying out secretory assays 
using an incubation procedure miniaturized into microtiter 
plates and combined with continuous oxygenation and rapid 
separation of cells from media by vacuum filtration. The 
data presented here demonstrate that intracellular 
accumulation, secretory product and intracellular second 
messengers can all be measured in parallel with easier 
handling of replicate specimens. A preliminary report of 
this work has been presented [5]. 
METHODS 
MATERIALS 
New Zealand lf~ite Rabbits (3.5-4.0 kg) were obtained from 
Millbriof.· [ C]-dimethylamine-aminopyrine (4,366 Bq/nmol) 
and [ Co] - cyanocobalamin ( 4 o oo Bq/pmol) were from 
A mersham. Cyclic AMP assay kits were from Diagnostic 
Products. Safety-Solve scintillation fluid was obtained from 
Research Products. Collagenase (type I), Lactate Assay kits 
and all other chemicals were purchased from Sigma. 
ISOLATED PARIETAL CELL PREPARATION 
Parietal cells were isolated from rabbit fundic mucosa using 
collagenase digestion and separation through counterflow 
elutriation, as previously described [6-8]. The resulting 
enriched fraction contained 80+5% cells with a yield of at 
least 108 cells. These cells were then resuspended in 
incubation media (134 mM NaCl, 5.4 mM KCl, 5.0 mM 
Na 2 HP0 4 , 1.0 mM NaH 2 Po 4 , 1.2 mM Mgso 4 , 1.0 mM CaC12 , 10 mg/L phenol red, 2 mg/ml bovine serum albumin 
(Fraction V) and 2 mg/ml glucose, pH 7 .4) for subsequent 
studies. Cells were counted in an improved Neubauer chamber 
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and purity of the elutriated cells was assessed by 
examination of approximately 500 cells stained with 
hematoxylin and eosin in randomly selected fields. Cell 
viability was assessed by trypan blue exclusion and lactate 
concentration in the entire contents (cells plus media) of a 
single well. 
INCUBATION CHAMBER 
A microtiter plate incubation chamber was designed and 
constructed completely from polycarbonate (Yale Medical 
Instrumentation Facility, New Haven, CT). The chamber 
(Figure 1) holds a single 96-well microtiter plate which is 
oxygenated through the continuous flow of humidified gas over 
the plate. The chamber is sealed through . a circumferential 
silicone rubber rim attached to the chamber top. The top is 
held in place with four clamps which can be rapidly released 
and latched for access to the plate during time course 
experiments. The entire chamber is completely immersible in 
a heated shaking water bath for maintenance of an even 
incubation temperature. The rate of gas flow through the 
chamber can be monitored and regulated at the chamber outlet. 
AMINOPYRINE UPTAKE 
Enriched parietal cells from elutriation were suspended in a 
incubation media at 2. 5 x 106 cells/ml and preincubated 
with c14cJ-aminopyrine at 2.12 nmol/ml for 30 min with 
humidified 100% o2 at 37°c in a shaking water bath. The incubation of parietal cells with secretagogues was carried 
out in the incubation chamber utilizing a 96-well millititer 
filter plate (Millipore, Millititer SV) possessing a Durapore 
membrane filter with a 5 um pore size. Incubation media was 
added to each well of the millititer plate (170 ul for a 
single secretagogue). 100 ul of the cell suspension 
containing 250,000 cells preincubated with 
c14 cJ-aminopyrine was then added to each well. 
Concentrations of greater than 250,000 cells per well were 
not utilized because of impaired filtration in subsequent 
steps. Secretagogue was added to each well in a volume of 30 
ul (with 10-fold higher than the desired final concentration) 
making a total incubation volume of 300 ul. In the time 
course studies, the plate was incubated for a two hour period 
and secretagogue was added at O, 30, 60, 70, 80, 90, 100, 
105, 110, 115, and 117 .5 min after beginning of incubation, 
thus giving a time course in the presence of secretagogue 
from between 2 .5 and 12 O min. During incubation, the 
incubation chamber was immersed in a shaking water bath at 
37°c with 100% humidified oxygen at 2 p.s.i. At the end 
of the incubation period the plate was immediately removed 
and placed on a vacuum filtration chamber (Millipore) and 
rapidly filtered under vacuum. The filtrate was collected 
into the respective wells of a standard tissue culture 
m icrotiter plate using a transfer guide (Millipore). These 
supernatants were retained for the measureiint of intrinsic 
factor and scintillation counting for [ c J-aminopyrine 
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when ratios were determined. The filtrate microtiter plates 
could be stored at -20° c for assay of intrinsic factor at 
a later date, usually within 2 weeks. The Durapore membrane 
filters were dried on the vacuum system, a process that took 
approximately 4 min. Dried filters were then punched out 
using a filter punch iMillipore) into scintillation vials, 
for measurement of [ 1 C]-aminopyrine uptake into cells 
retained on the membrane filter. Scintillation fluid (3 ml) 
was added directl[. to the vials for beta counting. The 
accumulation of [ 4c]-aminopyrine within each fraction was 
expressed as pmol aminopyrine uptake per million cells, after 
subtraction of the background radioactivity adherent to the 
membrane filter assessed by measuring the binding of 
[14cJ-aminopyrine in the absence of parietal cells. 
MEASUREMENT OF WHOLE LACTATE CONCENTRATION 
For evaluation of the respiratory status of cells incubated 
in the microtiter plate chamber versus flasks, cells were 
incubated either under standard conditions in the microtiter 
plate chamber with continuous oxygenation or in a 50 ml 
Erlenmeyer flask with intermittent oxygenation for 60 seconds 
every 15 minutes. In both cases, the concentration of cells 
was maintained at 750,000 cells/ml. After 60 minutes of 
incubation, the contents of two wells from the microtiter 
plate or 600 ul of cell suspension from the flask were 
withdrawn and added to an equal volume of 10% trichloracetic 
acid. Duplicate samples were utilized for each condition. 
Lactate was then determined in the deproteinized supernatant 
utilizing a standard enzymatic/ spectrophotometric assay 
[Sigma Lactate Kit; 9]. Results were expressed as mM lactate 
for the entire sample (cells plus media). 
MEASUREMENT OF CELLULAR cAMP CONTENT 
Intracellular cyclic AMP concentrations were measured in 
parallel to the secretion studies described above except that 
parietal cells were preincubated in incubation media without 
[14c]-aminopyrine. Measurements were made in triplicate 
wells incubated on the same plate as the secretory studies 
described above. At the end of the incubation period the 
plate was rapidly dried and filters punched into vials 
containing 0.5 ml of ice cold 3% perchloric acid in an ice 
bath. The samples were extracted by vortex mixing and were 
then neutralized to pH 6.5 by the addition of 30% potassium 
bicarbonate. Cyclic AMP concentrations were then measured on 
these supernatants by the method of Tovey, et al [10], using 
a commercially available kit (Diagnostic Products Corp). 
This method utilizes competitive binding between 
[3H]-cyclic AMP and endogenous cyclic AMP for the specific 
binding protein. Separation of free from bound cAMP is 
accomplished by absorption onto dextran coated charcoal, 
followed by beta counting of the resulting supernatant. This 
assay shows a cross reaction with cyclic GMP of less than 
0.1% The method detects changes between the adjacent samples 
of 40 fmol/tube with 95% confidence (equivalent to 0.64 pmol 
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cAMP/million cells). 
INTRINSIC FACTOR SECRETION 
Intrinsic factor secreted in;9 the media was measured by 
assessing the binding of [ Co)-cyanocobalamin in cell 
supernatants by a modification of the method of Gottlieb, et 
al [11). Fifty ul of filtrate were incubated with 100 ul c57 coJ-cyanocobalamin (300 fmol, specific activity 0.4 
Bq/fmol) in 1 ml of 150 mM NaCl for 40 min at 24°C. Bound 
label was then separated from free by the addition of 0.5 ml 
of a hemoglobin (25 mg/ml) coated, activated charcoal (Norit 
A, 250 mg/ml) suspension. After 20 minutes, the suspension 
was centrifuged at 1700 g for 15 min. The supernate was then 
decanted for gamma counting. Results were expressed as pmol 
intrinsic factor secreted per million cells. All 
cyanocobalamin binding capacity was assumed to be intrinsic 
factor. 
STATISTICAL ANALYSIS 
Between animal precisions for aminopyrine uptake, intrinsic 
factor secretion and intracellular cAMP were calculated as a 
coefficient of variation. Statistical significance was 
assessed using the Student's t-test for paired data using the 
mean data from triplicate wells for each data point in the 
experiments, where n=number of rabbits used in each 
procedure. 
RESULTS 
Cells incubated in the microtiter plate chamber demonstrated 
greater than 9 5% viability for up to six hours after 
preparation as assessed by trypan blue exclusion. Similarly 
whole lactate concentrations (media plus cells) were not 
significantly changed during the first 60 min of incubation 
(0.28 + 0.09 mM at time zero versus 0.35 + 0.11 mM at 60 
min). In contrast, cells incubated in flasks with 
intermittent oxygenation showed a greater than two-fold 
higher lactate level (0.81 + 0.11 mM; p<0.05) in after 60 min 
of incubation. 
Uptake of [ 14 cJ-aminopyrine in unstimulated cells was 
10.2+1.5 pmol/million cells which corresponds to l.25+0.18% 
of the total radioactivity added. Dose-response curves for 
histamine and carbachol stimulation (60 min incubation) of 
both aminopyrine uptake and intrinsic factor secretion are 
shown in Figures 2 and 3, respectively. Aminopyrine uptake 
and in;rinsic factor secretion were significantly stimulated 
by 10- ~ histamine (p<0.05) and the maximal effect was seen 
at 10- M. Hall, maximal effective d~se of histamine 
(ED 50 ) was 10- M. The effect of 10- M histamine was 
completely abol~shed by cimetidine 10- 4M. In comparison 
forskolin (10- M) elicited an almost two-fold higher 
resp~mse than the maximal histamine dose. Carbachol at 3 x 
10- M caused a small, but significant increase in 
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aminopyrine uptake (p<0.05) and intrinsic f~gtor secretion 
(p<0.05) with a maximal effect seen at _3l10 M. The half 
maximal effective dose of carbachol was 10 M. 
The time course for histamine (lo- 5 ) stimulation of 
aminopyrine uptake, intrinsic factor secretion and cellular 
cAMP concentrations are shown in Figure 4. There was a rapid 
three-fold increase in cytosolic cAMP concentrations in the 
first 5 minutes of stimulation with histamine (p<O. 005). 
This increase was sustained throughout the two hour period of 
study. Histamine elicited a continuing increase in 
aminopyrine uptake (p<0.001) and intrinsic factor secretion 
(p<0.002 from 15 min on) throughout the two hour period of 
study. Basal aminopyrine accumulation into unstimulated 
cells incubated for 30, 60 or 120 min in the absence of 
secretagogue did not significantly change. Similarly, 
intrinsic factor secretion from unstimulated cells did not 
significantly change during a two hour incubation period. 
The time course of aminopyrine uptake, intrinsic factor 
secretion and cellular cAMP content in carbachol stimulated 
parietal cells is shown in Figure 5. Aminopyrine uptake 
increased rapidly in response to carbachol within the first 
ten minutes of stimulation (p<0.01). No significant further 
accumulation occurred after 30 minutes. Intrinsic factor 
secretion followed a similar pattern with significant initial 
release (by 10 min, p<0.05) and hardly any secretion after 
the first 3 O min. There was no significant change in 
cellular cAMP content during carbachol stimulation. In 
contrast, however, the forskolin control (10- 6M) caused a 
20-fold increase in intracellular cAMP content from 5.6+1.2 
pmol/million cells to 49.6+5.8 pmol/million cells (p<0.001). 
The goefficients of variation between animals for histamine 
(10- M) and carbachol (10- 5 M) on aminopyrine uptake, 
intrinsic factor secretion and cellular cAMP are shown in 




Between animal coefficient of variation of aminopyrine 
uptake, intrinsic factor secretion and cellular cAMP content 
in unstimulated parietal cells and fallowing incubation with 
histamine, carbachol and forskolin (n=12). 
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Figure 1. Custom built polycarbonate incubation chamber for 
parietal cell incubation. This chamber allows cells 
incubated in a microtiter plate to be sealed (with lid and 
gasket shown), and immersed in a shaking water bath at 37°c. The design of the chamber allows continuous gassing 
with humidified oxygen which flows in one end, over the 
microtiter plate and out of the opposite end of the chamber. 
Clamps on the sides of the chamber ensure a watertight seal 
but can be released rapidly for addition of secretagogues 
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Figure 2. Dose-response effect of histamine on 
[
14
cJ-aminopyrine uptake (an indirect measure of acid 
secretion) and intrinsic factor secretion from isolated 
rabbit parietal cells. Effect of histamine. 10- M with 
cimetidine 10-
4M (Cimet) and forskolin 10- 5M are added 
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Figure 3. Dose-response effect of carbamylcholine 
(carbachol) on [
14 cJ-aminopyrine uptake and intrinsic 
factor secretion from isolated rabbit parietal cells. Bars 
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Figure 4. Time course effect of histamine stimulation of 
rabbit isolated parietal cells on: top panel: 
(
14
cJ-aminopyrine uptake, middle panel: intrinsic factor 
secretion and bottom panel: cellular cAMP content. Graphs 
show mean and SEM from 6 separate experiments. 
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Figure 5. Time course effect of carbamylcholine (carbachol) 
stimulation of isolated rabbit parietal cells on: top panel: 
(
1 
C]-aminopyrine uptake, middle panel: intrinsic factor 
secretion and bottom panel: cellular cAMP content. Graphs 




The micro-method of incubation for rabbit isolated parietal 
cells has proven to be simple, reliable and very flexible. 
Using four incubation chambers and two shaking water baths it 
is possible to process nearly 400 replicates (4 x 96) 
simultaneously from a single rabbit stomach. This enables 
the investigator to undertake very complex experiments with 
several dose response curves or multiple time points. 
s ecretagogue can be added to multiple wells simultaneously 
using a multiple channel micropipette thus making time course 
study particularly fast. The method is not subject to the 
large variability seen with conventional flask incubations. 
This is evidenced by the small coefficients of variation 
within and between groups. Replicates within a study are 
represented by different wells in the microtiter plate and 
are, therefore, "true" replicates as opposed to serial 
samples taken from a single incubation flask. Indeed the 
conditions within each well remain identical, except for dose 
of secretagogue ( dose responses), or time of contact with 
agent (time courses). The cells are always incubated for the 
same total period and the incubation volume does not change, 
as it does with sequential sampling. Above all the method is 
quick and simple. With practice and automatic pipettes, a 
whole plate can be set up in 4-5 minutes. 
Another micro-method for the study of oxyntic cell function 
has previously been described using isolated gastric glands 
from human gastroscopic biopsies [12]. This method utilizes 
microtubes for the incubation of gastric glands and thus 
overcomes the problem of individual replicates [12]. The 
microtube method still has only a limited oxygen supply 
compared with continuous oxygenation in the microtiter plate 
chamber. In addition, if this method were applied to handling 
several hundred replicates, in individual small tubes, it 
would prove to be rather cumbersome. 
The time course of histamine stimulation shows a sharp rise 
in cellular cAM P concentrations which is maintained 
throughout the 2 hour time course. This is accompanied by a 
marked increase in both aminopyrine uptake and intrinsic 
factor secretion which occurs in linear fashion throughout 
the two hour incubation period. In contrast the secretory 
response to carbachol is transient and less pronounced. 
Aminopyrine uptake and intrinsic factor secretion during 
carbachol stimulation. increase rapidly during the first 5 
minutes, and then plateau by 30 minutes. Basal aminopyrine 
uptake measured in cells incubated for 30, 60 and 120 minutes 
showed no significant change (data not shown). As would be 
expected with a secretagogue acting via a calcium-dependent 
mechanism there was no change in cellular cAMP content during 
carbachol stimulation. 
These observations in cells incubated in the microtiter plate 
chamber are similar to the results obtained in previous 
studies with the exception of the time course for both 
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aminopyrine uptake and intrinsic factor secretion stimulated 
by histamine. The histamine time course is rather different 
from that described using previous methods [1,8,13,14]. 
Other studies, including our own employing flask incubation 
methods, have demonstrated aminopyrine uptake in response to 
histamine over a period of only 30 or 40 minutes. 
Nevertheless, a similar linear time course of aminopyrine 
uptake has been seen recently in cultured !abbit parietal 
cells [15]. The only major difference between the present 
work and previous studies lies in the incubation method. 
Previous investigators have demonstrated that aminopyrine 
uptake is independent of the media aminopyrine concentration 
[16]. Similarly, the results are not biased by our 
expression of the data as pmol aminopyrine accumulated rather 
than ratios. The expression of the data as a ratio was based 
on the need to adjust the data to consider the intracellular 
volume in gastric glands [3]. In the case of the data 
presented here, where a fixed number of isolated cells are 
added to each well in each experiment, the correction for 
intracellular volume becomes a constant (1, 7]. Calculated mean aminopyrine ratios at 60 and 120 min of stimulation with 
histamine were 150 and 300, respectively. If the parietal 
cell acid space is assumed to be 10% of the cell volume, this 
would yield an approximate acid space pH of 3 [3]. The 
representation of the data was unchanged when ratios were 
used and so we have represented the data as accumulation into 
a specific number of cells for ease of calculation. In any 
case, the continued release of intrinsic factor into the 
media throughout the two hours of histamine stimulation 
suggests that secretion from parietal cell continued 
throughout the period. Intrinsic factor release was not due 
to dying cells, since no significant release was observed in 
unstimulated cells. Indeed, total intrinsic factor content 
was unchanged throughout the two hour incubation (Adrian, et 
al., Unpublished Results). Finally, the results do not 
represent an artifact encountered through the absence of a 
bicarbonate buffer system, since similar patterns of 
histamine stimulated aminopyrine accumulation and intrinsic 
factor secretion were obtained using a bicarbonate buffer 
system and 95% 0 2/5% co 2 as the chamber gassing medium (Lewis and Golden ring, Unpublished Results). 
The lower lactate concentration in cells incubated in the 
microtiter plate chamber compared to those incubated in 
flasks with intermittent oxygenation suggests that the 
chamber maintains the oxidative respiratory status of the 
cells during long incubations. The linear course of 
aminopyrine accumulation and intrinsic factor release 
stimulated by histamine may therefore reflect an improved 
ability of the cell to continue secretory activity. The 
parietal cell is extremely rich in mitochondria, and on 
stimulation, oxygen consumption is increased in direct 
proportion to the rate of acid secretion (7, 1 7]. The 
absence of sustained secretion seen in other models could 
reflect inadequate oxygen tension resulting in a reduction of 
secretion with time. The increased levels of lactate seen in 
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cells incubated in flasks as opposed to the microtiter plate 
chamber suggest that the chamber may improve the level of 
aerobic respiration in these cells. 
The results demonstrate that the present method easily allows 
accurate simultaneous determination of cellular accumulation, 
secretory products and intracellular messengers. The method 
should also find broader application to other second messe2ger measurements including inositol trisphosphate levels and Ca 
flux. The time course experiments demonstrate the capability of 
this new method of studying secretion from the isolated rabbit 
parietal cell. The versatility and ease of handling large numbers of replicates makes this technique valuable for the 
investigation of a wide range of tissues and cell preparations. 
SUMMARY 
A new micro-method for investigating secretory physiology in 
isolated cells was developed and evaluated. The method utilized 
a specially designed polycarbonate incubation chamber to provide constant oxygenation to cells incubating in a 96 well microtiter 
plate. Cells were rapidly separated from media by vacuum 
filtration. Isolated parietal cells wee utilized to demonstrate 
the versatility ~f the method for assay of intracellular accumulation of ( 1 CJ-aminopyrine, secretion of intrinsic factor 
into the medium as well as assay of Jntracellular cAMP. 
Histamine stimulated the uptake of ( 1 CJ-aminopyrine and 
intrinsic factor secretion in a sustained and linear fashion. 
At the end of the two hour period uptake of aminopyrine and secretion of intrinsic factor were increased 17 and 5-fold, 
respectively. This response to histamine was accompanied by a 
rapid and sustained 3-fold rise in intracellular cyclic AMP. In 
contrast, carbamylcholine caused a transient increase in r14cJ-
aminopyrine accumulation and intrinsic factor secretion which 
was most pronounced during the first 10 minutes and had almost 
ceased by 30 minutes. Carbamylcholine had no effect on 
intracellular cAMP levels. This method, which can handle 400 
replicates using parietal cells from the fundic mucosa of a 
single rabbit, is suitable for studying the time course of 
intracellular events which accompany general secretory processes. 
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CHAPTER 9 
Isolated Gastric Glands in the Study 
of Gastric Secretory Relationships 
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INTRODUCTION 
The physiological and medical importance of gastric secretion 
and its regulation needs no explanation. The subject has long 
occupied a prominent position in surgical research. In the 
past, particular attention was paid to whole-animal models. 
Studies in intact animals have an understandable appeal 
because they seem to approximate "real" situations. At the 
same time, the results of experiments on whole-animal models 
have often been difficult to interpret, since causes and their 
effects may both be obscured in such experiments. For 
example, the actions of stimulatory or inhibitory agents may 
be profoundly altered by interference from vagal or 
sympathetic neural influences, by the release in vivo of 
gastrointestinal hormones, or by paracrine modulatory actions. 
Similarly, quantitative estimation of the products of gastric 
secretion is complicated in some whole-animal preparations by 
such problems as partial retention of luminal contents, 
admixture of extraneous secretions, including mucus, bile, and 
pancreatic juice, and mucosal ulceration and even bleeding. 
There is an important place in gastric secretory research, 
therefore, for an in vitro mucosal preparation that retains 
its normal secretory functions and relationships yet is free 
of many of the complications encountered in whole-animal 
studies. Intact mucosal preparations have been utilized for 
in vitro studies of gastric secretion. Isolated sheets of 
gastric mucosa mounted in Ussing chambers [ 1] have been 
particularly useful for studies over time of transmembrane 
potential differences, ionic currents under both open- and 
short-circuit conditions, and unidirectional transmembrane 
isotopic fluxes. The Ussing chamber requires a separate 
apparatus for each membrane, and a relatively limited number 
of membranes can be obtained from a single animal. Gastric 
mucosal biopsies incubated in organ culture [2,3] are well 
suited for long-term (24-hr) studies of biosynthetic and 
secretory activity. For investigation of net secretion of 
macromolecules on a short time scale, however, intact mucosal 
preparations are unsatisfactory. Adjacent areas of gastric 
mucosa typically display appreciable differences in secretory 
function, and intact mucosal preparations tend to reflect this 
variability. Some responses are considerably slower in intact 
mucosal preparations than in isolated cells and glands. 
Intrinsic mucosal reflexes may play a role in modulating 
responses to some agents. 
Preparations of isolated parietal cells [4,5] and isolated 
chief cells [ 6] appear to retain many of the functional 
characteristics these cells display in vivo. The validity of 
the isolated chief cell technique is currently being 
independently confirmed in my laboratory. The process by 
which the cells are isolated is somewhat more time-consuming, 
complex, and stressful to the cells than the preparation of 
isolated glands, and cumulatively increase the likelihood that 
functional artifacts may occur. Another potential 
disadvantage of cell isolation procedures, whose importanceis 
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difficult to estimate at this time, is the loss of spatial 
relationships between secretory cells, between cells and 
secretory products, and between secretory products in the 
lumen of the gastric gland. 
Some investigators have suggested the use of isolated gastric 
glands for research on gastric secretory function, and have 
shown that such glands can respond to a variety of stimuli 
[ 7, 8, 9] . From my point of view a major advantage of the 
isolated glands is the fact that they may be regarded as the 
secretory unit of the gastric fundus, the minimum structural 
entity for secretory interactions of chief and parietal cells. 
Thus, the preparation is well suited for either comparative 
studies of intrinsic factor and acid secretion by the parietal 
cell or pepsinogen secretion by the chief cell. 
A basic requirement for studies of secretory interactions in 
vitro is that individual cell types in the preparation respond 
appropriately to individual physiological secretagogues. I 
have therefore examined secretory effects in the isolated 
gastric gland preparation of three classic stimuli for gastric 
acid secretion [4], which are a paracrine substance, a 
parasympathetic transmitter, and a peptide hormone, 
respectively: histamine, acting as an H2 agonist; carbachol 
(carbamoylcholine), a long-acting analog of acetylcholine, 
acting as a muscarinic agonist; and pentagastrin (G-5), a 
long-acting gastrin analog. In addition, I have examined the 
effects of an active fragment of cholecystokinin, 
cholecystokinin octapeptide (CCK-8), and the beta-adrenergic 
agonist isoproterenol, both of which have been implicated in 
pepsinogen secretion [10,11,12]. Finally, I have used the 
cAMP-mimetic analog 8-Br cAMP, since the effects of histamine 
on parietal cells and those of isoproterenol on chief cells 
are both believed to be mediated by cAMP [13,14]. 
I have measured effects of these secretagogues on principal 
parameters of parietal cell and chief cell secretion in 
isolated gastric gland suspensions. Parietal cell secretory 
function was tested by measurement of intrinsic factor (IF) 
secretion, with separate and combined studies of 
1"c-aminopyrine accumulation, a measure of acid secretion. 
Changes in overall metabolic activity were tested by 
measurement of oxygen consumption. Chief cell secretory 
function was tested by measurement of pepsinogen (PPG) 
secretion. Chief cell secretion and parietal cell secretion 




Dose-response curves were obtained for the release of 
intrinsic factor (IF) into the medium. For this purpose, IF 
secretion was measured in experiments of 30 min duration as 
a function of secretagogue concentration over a broad range. 
The time course of IF secretion between 5 and 60 min was also 
observed in response to histamine and 8-Br cAMP at appropriate 
concentrations. The time courses of 14C-aminopyrine 
accumulation and oxygen consumption were similarly observed 
under comparable conditions. Dose-response curves for the 
release of pepsinogen (PPG) into the medium were obtained over 
a broad range of secretagogue concentrations in experiments 
of 30 min duration. 
Gland Preparation 
Non-fasted New Zealand white rabbits weighing 3.5-4.0 kg were 
anesthetized with sodium pentobarbital (Abbott), 40-45 mg/kg, 
via a lateral ear vein, and midline laparotomy was performed. 
The abdominal aorta was isolated and ligated distally, and a 
cardiac venous catheter was inserted in retrograde fashion 
infrarenally. Sodium heparin, 500 mg/kg, was administered 
through the catheter and allowed to circulate for 1-3 min. 
The animal was bled, a left thoracotomy was performed, and the 
thoracic aorta was clamped. The superior mesenteric artery 
was ligated, isolating the celiac axis. The portal vein was 
incised for rapid drainage. To expand mucosal connective 
tissue spaces and thus facilitate subsequent enzymatic 
digestion [7], warmed (37°C) and oxygenated colloid-free 









, pH 7.4) was then infused via the aortic 
cannula under 600 mm Hg pressure, with a cardiac roller pump 
(Travenol) . 
Following perfusion, the stomach was removed and opened along 
the lesser curvature. The cardia and antrum were discarded. 
The fundus was rinsed in PBS and the mucosa bluntly stripped 
off with a scalpel handle and minced into small pieces with 
fine dissecting scissors. The wet weight of the edematous 
fundic mucosa was 14-18 gm. The mucosa was placed in a 
balanced salt solution containing 12. o mM NaHCO , 1 mg/ml 
collagenase (Sigma type I), 1 mg/ml rabbit or bo~ine serum 
albumin (Sigma), and 2 mg/ml glucose, and incubated at 37°C 
with 100 percent 0
2 
for 30 min in a shaker bath. 
After incubation, glands were gravity filtered through 
decreasing sizes of Nylon mesh to a final size of 300 um. The 
resulting gland suspension was washed three times with 1 x 
gravity sedimentation and resuspended in fresh incubation 
medium (Nacl
2 , 134 mM; KCl, 5.4 mM; NaHPO, 5.0 mM; NaHPO, 2 4 2 4 1.0 mM; MgS0
4
, 1.2 mM; cac1
2
, 1.0 mM; phenol red, 10 mg/L; 
bovine serum albumin, 2 mg/ml; and glucose, 2 mg/ml, pH 7.4). 
-116-
Trowell's T-8 medium, with 2 mg/ml each bovine serum albumin 
and glucose, was used in some experiments with no difference 
in the results. 
Freshly isolated perfused fundic mucosa, mucosa digested in 
collagenase medium for 15 or 30 min, and washed glands were 
also fixed at 37° and 4°C in phosphate- or cacodylate-
buffered glutaraldehyde, washed, ftnd, after 
appropriatehistological preparation, examined by optical 
microscopy and by scanning and transmission electron 
microscopy. The ability of gland cells to exclude Trypan Blue 
was assessed by mixing equal volumes of gland suspension and 
Trypan Blue, 400 mg/100 ml in PBS [7]. The ability of glands 
to synthesize and retain cAMP was tested by incubation with 
forskolin 10·5 M (15] for 30 min, boiling to terminate the 
incubation, and measurement of cAMP content in the supernatant 
by a commercial radioimmunoassay. 
secretion Studies 
Secretion of IF or PPG was assessed after incubation of gland 
suspensions for various times in incubation medium containing 
the secretagogue. IF or PPG was measured in the medium. In 
a typical experiment 1.8-ml quadruplicate aliquots of gland 
suspension were added to o. 2 ml of medium, or medium with 
added secretagogue, and incubated for 0-60 min at 37°C with 
100% 0
2
• Following this incubation, glands and supernatants 
were separated by filtration (Millipore Type AP40 fiberglass 
filters) or centrifugation in a Sorvall centrifuge (Dupont 
Instruments, Newtown, CT) at 10,000 x g for 1 min. In each 
study initial and final unincubated controls and incubated but 
unstimulated control tubes (medium alone) were routinely 
included. 
Intrinsic Factor Secretion 
IF secretion into the medium was determined by assessing the 
binding of 57Co-labeled cyanocobalamin (57Co-CBL) in the 
filtrate or supernatant, as follows: 500 ul of sample was 
allowed to react for 40 min with 0.5 ml of ~Co-CBL. Bound 
label was then separated from free label by the addition of 
hemoglobin-coated charcoal suspension, which binds free CBL 
but not the IF-CBL complex. The suspension was centrifuged 
for 15 min at 3000 rpm in a Sorvall centrifuge, and samples 
of supernatant were counted in a Packard Instruments gamma 
counter (United Technologies, Downers Grove, IL). IF 
secretion was expressed as the amount of bound 57Co-CBL 
radioactivity (counts per minute) of stimulated samples, ± 
SEM. Net secretion was defined as the difference between the 
means for stimulated and unstimulated samples. The 
significance of the differences between means of replicate 




Secretion of acid by parietal cells was measured by 14C-aminopyrine (1 4C-AP) accumulation under basal conditions 
and in response to stimulation by the appropriate agents. The 
procedure has been described in detail elsewhere [8]. 
Identical aliquots of gland suspension were preincubated in 
two flasks with dimethylamine-
14C-aminopyrine (Amersham or New England Nuclear), O .1 uCi/ml, 
for 30 min with 100 percent 0
2 
at 37°C in ashaker bath. At 
zero time, 4 ml of incubation medium containing an appropriate 
concentration of stimulating agent was added to the labeled 
gland suspension in the experimental flask, and an equal 
volume of medium alone was added to that in the control flask. 
At 5, 15, 30, 45, and 60 min thereafter, 1.5 ml aliquots were 
withdrawn in quadruplicate and centrifuged at 10,000 x g for 
1 min. 
The supernatants were withdrawn, and two 0.5-ml aliquots were 
taken for determination of 14C-AP. The surface of the pellet 
was washed in fresh medium to remove tracer in residual 
supernatant. The pellet was then dissolved in 250 ul 
concentrated nitric acid for 10 min at 50 degrees C and 
diluted to 550 ul with Hp. 500-ul samples of dissolved 
pellet and corresponding supernatant were counted for 1 min 
in a Beckman LS7000 scintillation counter (Beckman 
Instruments, Fullerton, CA) with automatic quench correction. 
The ratio of 14C-AP in the pellet to that in the supernatant 
was calculated. Results are expressed as percent increase, 
± lSEM, in the 14C-AP ratio for stimulated glands above that 
for unstimulated glands. The significance of the difference 
between means of replicate runs was determined by Student's 
unpaired t-test, with p < 0.05. 
oxygen consumption 
The consumption of oxygen by unstimulated and stimulated 
glands was measured over time using a Clark-type polarographic 
electrode system (Model 53 Biological Oxygen Monitor, Yellow 
Springs Instrument Co., Yellow Springs, OH) precalibrated with 
air-saturated water. One ml of either incubation medium or 
incubation medium plus secretagogue was placed in the standard 
sample chamber at 37°C for 3 min. Following this, 3 ml of 
gland suspension which had been oxygenated with 100% o for 2 • 2 min was added to each chamber and excess gas was expelled. 
The percent saturation of 0
2 
was recorded initially and at 5 
min intervals for a period of 1 hr or until no measurable o 
was present, whichever was less. The change in percent 
saturation in each sample was calculated over time, and the 
oxygen consumed in ul/min was calculated, based on 25 ul of 
0 2 in a 100% 0 2-saturated incubation medium. 
PPG in Glands and Medium 
PPG in the medium was assayed by an acid protease method in 
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which a fixed aliquot of medium is incubated with hemoglobin 
solution at pH 2. o for a fixed time interval; the enzyme 
reaction is terminated by adding trichloroacetic acid [16]. 
The hemoglobin reagent contained 20 mg/ml hemoglobin titrated 
with HCl to a final pH of 2.0. After a preliminary 10-min 
activation with 0.3 ml of 0.04 N HCl, 100 ul of medium was 
incubated with o. 8 ml of hemoglobin reagent for 20 min at 
37°C. Undigested proteins were precipitated with 1.8 ml of 5% 
trichloroacetic acid and allowed to react for 10 min. 
Thecontents were filtered through Whatman No. 4 filter paper. 
The extent of hemoglobin digestion was assessed in 1.0 ml of 
filtrate by adding 5.0 ml of 0.2 N NaOH and, after 10 min, 0.5 
ml pf 1 N phenol (Folin-Ciocalteu) reagent. Spectrophotometry 
was performed at 760 nm after 30 min. PPG activity was 
obtained in terms of peptic units (PU) released per 2-ml 
sample, 1 PU corresponding to the amount of enzyme yielding 
an absorbance change of o. 001 in one min under the assay 
conditions. The significance of differences between means of 
replicate runs was determined by student's paired or unpaired 
t-test, as appropriate, with p <0.05. 
Graphical Representation 
The data were depicted graphically by means of an IBM PC/XT 
equipped with Lotus Symphony software and a Hewlett-Packard 
7475A plotter. For uniform representation all IF, 
1•c-aminopyrine, and PPG data were expressed as percent of the 
maximum stimulation observed in the experiment, i.e. , defining 
the (minimum) unstimulated value as o and the maximum 
stimulated value as 100. For clarity, individual standard 
errors< 5% were not displayed. For curves containing points 
with 1 SEM > 5%, the program displayed a complete envelope 
representing± 1 SEM. 
RESULTS 
Characteristics of Isolated Gland Preparation 
A single rabbit stomach typically yielded about 1 g wet weight 
of glands, enough for 200 or more incubations at a dilution 
of 70, 000-90, 000 glands per ml. This dilution was appropriate 
for the experiments described above, on the basis of the 
sensitivity of the assay methods used. 
Examination of perfused fundic mucosa, mucosa digested for 15 
min, and washed glands by scanning electron microscopy (Fig. 
1) showed the glands initially imbedded in the fibrous 
connective-tissue matrix in a uniform parallel array (Fig. 
lA) . After collagenase incubation for 15 min (Fig. lB) , 
collagen digestion was far advanced at the serosal ends of the 
glands, where most of them had become separated. The mucosal 
ends of many glands were still attached to the mucosal 
surface, while other glands had broken loose at the neck. In 
the final suspension, the filtered and washed glands had lost 
their connective-tissue covering but retained their 
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essentially tubular morphology. A portion of a gland is shown 
at high magnification in Fig. lC. Two morphologically 
different outer cell surfaces, one smooth and the other 
covered with microvilli, were distinguishable at this stage. 
On the basis of their ability to exclude Trypan Blue at least 
95% of the gland cells were viable. On stimulation of their 
cellular adenylate cyclase systems for 30 min with 10·5 M 
forskolin, the glands responded with a marked increase in cAMP 
content. The ratio of forskolin-stimulated to unstimulated 
cAMP levels ranged from 6.0 ± 0.3 to 36.9 ± 3.6 in different 
experiments. A useful index of functional cell integrity in 
gland experiments was the ratio of total stimulated release 
of IF or PPG to the unstimulated release of that protein. 
Loss of secretory response or significant cell damage would 
be expected to reduce this ratio toward unity. In 
representative experiments reported below, the maximum 
secretion in 30 min was approximately 26 times the 
unstimulated release in the case of IF, and 11 times the 
unstimulated release in the case of PPG. 
Stimulation of IF Secretion 
Histamine stimulated parietal cells of isolated gastric glands 
to secrete IF, as measured by comparing IF release into the 
medium, during a 30-min period, in the absence of histamine 
and in response to histamine at concentrations from 10~ M to 
10-3 M (Fig. 2) . At 10~ M, histamine caused a small but 
significant increase in IF release over unstimulated levels 
(p < 0.05). The mean IF secretory responses at 10~ Mand 10~ 
M were 62 ± 22% and 84 ± 7%, respectively, of the maximum 
response obtained, at 10-3 M. 
The results in Fig. 2 are expressed as percentages of maximal 
stimulation, as are most of the results in this chapter 
section. To put such percentage figures in perspective, in 
the experiments with histamine cited above the ratio of 
maximal secretion to unstimulated secretion was 26.3 ± 2.5; 
that is, the magnitude of the unstimulated response (not 
shown) was only 3.8% of the total secretion in response to 
histamine, and histamine stimulated secretion by 2,500%. IF 
secretion in response to other secretagogues is described 
below. 
Time Course of Histamine Effect on IF Secretion 
When IF release by isolated gastric glands was sampled 
sequentially, at 5, 15, 30, 45, and 60 min, in the presence 
and absence of 10~ M histamine (Fig. 3), during the course of 
the observations IF levels in unstimulated glands did not 
change significantly (p > 0.05). In the presence of 
histamine, on the other hand, IF secretion into the medium at 
5 min was already 9 ± 1% of the maximum (i.e., 60-min) level. 
This value was significantly different (p < 0.05) from the 
unstimulated level of o.o ± 0.5%. Thereafter, 
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histamine-stimulated IF secretion rose almost linearly by 
significant increments (p < 0.05) over each successive 
interval. The increase between 5 and 15 min was slightly 
greater than for other intervals. The 15-min value was 34 ± 
1% of the 60-min period, yielding a calculated secretion rate 
50% greater than the overall rate for 60 min. 
Effects of Histamine on the Accumulation of 14C-aminopyrine 
In the same experiment (Fig. 3) histamine also stimulated 14C-
aminopyrine accumulation in glands, expressed as the ratio of 
14C in glands to 14C in medium. In unstimulated glands, 
accumulation of 14C-aminopyrine did not change significantly 
during the observation period from 5 min to 60 min (p > 0.05). 
By the time of the initial 5-min measurement, accumulation of 
the label by stimulated glands had attained a value equal to 
47 ± 10% of the 60-min level, significantly greater (p < 0.05) 
than the value of o. O ± o. 6% for unstimulated glands. At this 
point the aminopyrine ratio for stimulated glands was 2. 3 
times the ratio for unstimulated glands. The difference 
continued to increase until 30 min, when the 14C-aminopyrine 
level in stimulated glands became stable, reaching 97 ± 10% 
of the 60-min maximum. This value corresponds to an 
aminopyrine ratio for stimulated glands equal to 3. 6 times the 
ratio for unstimulated glands. 
Concurrent Effects of a-Br cAMP on the Secretion of IF and the 
Accumulation of 14C-aminopyrine 
The cAMP-mimetic analog 8-Br cAMP also stimulated IF 
secretion, with a maximal response at 10-4 M. When glands 
stimulated with 8-Br cAMP at this concentration were sampled 
sequentially from 5 min to 60 min, IF secretion displayed a 
time course (Fig. 4) comparable to that for 10~ M histamine 
stimulation (Fig. 3). At 5 min, IF secretion was 0.8 ± 0.1% 
of maximum for the stimulated glands and o.o ± 0.1% for the 
unstimulated glands, a small but significant difference (p < 
o. 05). At each later time period, IF secretion increased 
almost linearly in response to 8-Br cAMP stimulation,· by 
significant increments (p < 0.05). 
In the same experiment, 8-Br cAMP stimulated 14C-aminopyrine 
accumulation significantly over the basal level (p < 0.05) at 
all times studied, from 5 to 60 min. After 5 min, for 
example, the 14C ratio for stimulated glands was 9. 7 ± O. 2% of 
the 60-min maximum, compared with o.o ± 0.3% for unstimulated 
glands (p < 0.05). After 45 min the stimulated ratio was 83 ± 5% of maximum, and there was no significant further increase 
in 14C-AP accumulation (p > o. 05) . 
Stimulation of oxygen consumption by Histamine 
The time course of the effect of histamine ( 10·5 M) on o 
consumption by isolated gastric glands at 5-min interval~ 
over60 min is shown in Fig. 5. Initially all chambers were 
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consumption rate (slope of the 
curve) decreased slightly with time. The difference between 
stimulated and unstimulated 0
2 
consumption was significant at 
all time points from 5 min on (p < 0.05). 
CCK-8 stimulation of PPG and IF Secretion 
The peptiqe CCK-8 stimulated the secretion of both IF and PPG. 
Parallel dose-response curves were obtained for the 
simultaneous secretion of IF and PPG by isolated ~lands in 
response to CCK-8 at concentrations from 10·11 to 10· M (Fig. 
6). At 10·11 M and 10·10 M, CCK-8 did not significantly 
stimulate secretion of IF or PPG over the basal levels of O 
± 5% and o ± 4%, respectively (p > 0.05). At 10·9 M and 
higher concentrations, CCK-8 significantly stimulated 
secretion of both macromolecules (p < o. 05) • At 10·9 M CCK-8, 
for example, the release of IF was 55 ± 10% of maximal, while 
PPG release was 31 ± 1% of maximal. A further significant 
increase was observed between 10·9 M and 10-a M CCK-8 (p < 
0.05). The results of experiments with CCK-8 stimulation of 
aminopyrine accumulation are given below (Discussion). 
Effects of carbachol and Isoproterenol on PPG secretion 
Stimulation of PPG secretion by isoproterenol, 10-a M, by 
carbachol at concentrations ranging from 3 x 10·1 M to 10·4 M, 
and by combinations of these is shown in Fig. 7, where the 
results are expressed as percentages of the maximum 
stimulation obtained with carbachol alone. PPG secretion was 
significantly increased at all concentrations of carbachol 
from 10-a M to 10-4 M (p < o. 05) • The maximum secretion 
obtained with carbachol alone was 6.3 + 2.0 times the 
unstimulated secretion. At 10-a M, carbachol increased 
secretion from the basal level of o ± 1% of maximal to 25 ± 
2% (p < 0.05). Isoproterenol alone at the submaximal 
concentration of 10-a M caused a net PPG release of 81 ± 3% of 
the maximum obtained with carbachol (100 ± 11%), significantly 
less than the latter (p < 0.05). The combination of 
isoproterenol, 10-a M, with carbachol significantly increased 
PPG secretion at every concentration of carbachol (p < 0.05). 
The combined action of 10-4 M carbachol and 10-a M isoproterenol 
stimulated PPG secretion equal to 169 ± 6% of the maximum 
obtained with 10-4 M carbachol alone. The combined response 
was 10. 8 ± 1. 2 times the unstimulated secretion. PPG 
secretion with other secretagogues is described below 
(Discussion). 
DISCUSSION 
The results of these studies demonstrate several features of 
the isolated gastric gland preparation that bear important 
implications for the study of gastric secretory function. The 
experiments show that isolated rabbit gastric glands display 
appropriate gastric secretory responses, delineated below, 
when stimulated by a variety of secretagogues. The parietal 
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cells in these glands respond appropriately, secreting IF into 
the medium. They appropriately accumulate 14C-aminopyrine, an 
indirect indication that hydrogen ions are being secreted by 
these cells. Oxygen consumption by the glands increases 
appropriately in response to stimulation. In addition, 
thechief cells in these glands respond appropriately by 
secreting PPG into the medium. 
It must further be emphasized that the use of isolated gastric 
glands allows different parietal cell and chief cell secretory 
functions to be activated or inhibited simultaneously, and to 
be measured in the same experiment. No less significant is 
the fact that the essential tubular structure of the glands 
is preserved, as scanning electron microscopy reveals. Thus 
the isolated gastric gland, as the multicellular structural 
unit of gastric secretory function, provides a unique model 
for in vitro study of the structural and functional 
interrelations of gastric secretory cells and their secretory 
products. 
IF secretion by isolated rabbit gastric glands was markedly 
stimulated by histamine (Figs. 2 and 3). In the rabbit IF is 
secreted exclusively by the parietal cells [17]. Histamine 
stimulation of IF secretion by rabbit gastric mucosa has been 
documented for mucosal biopsies in organ culture [ 3] and 
dispersed mucosal cells [5]. Thus IF secretion by isolated 
rabbit gastric glands represents an appropriate response by 
the parietal cells in these glands to histamine stimulation. 
Besides 8-Br cAMP, discussed below, four other secretagogues 
were tested, of which three stimulated IF release to varying 
degrees. The muscarinic agonist carbachol and the peptide 
hormones CCK-8 and G-5 also stimulated IF release, but less 
effectively than histamine and 8-Br cAMP. Carbachol at its 
maximally effective concentration, 3 x 10·5 M, elicited a 
response that was 7.0 ± 0.6 times the unstimulated level (in 
other words, 600% over unstimulated) , or 27 ± 5% of the 
maximum obtained with 10"3 M histamine in the same experiments. 
The IF secretory responses to maximally effective 
concentrations of CCK-8 and pentagastrin (G-5) in separate 
experiments were smaller still. The maximal responses to 
CCK-8, at 10-a M, and pentagastrin (G-5), at 10~ M, were only 
50 ± 19% and 24 ± 6%, respectively, over the unstimulated 
level. These increases, while small, were nevertheless 
significant (p < 0.05). Of secretagogues tested, only the 
beta-adrenergic agonist isoproterenol failed to stimulate IF 
release at any concentration from 10-a to 10·4 M--al though 
isoproterenol proved to be an effective stimulus for PPG 
release in this concentration range (below). 
With sequential sampling, IF secretion in response to 
histamine after 5 min and 15 min was 9% and 34%, respectively, 
of the 60-min total. Thus the onset of IF secretion by 
isolated glands in response to histamine was virtually 
immediate, apparently within the first minute. The rate of 
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secretion diminished only slightly in subsequent intervals, 
since the maximum secretion rate, between 5 min and 15 min, 
was only 50% greater than the overall rate for 60 min. A 
qualitatively similar time course of IF secretion in response 
to histamine has been reported for dispersed mucosal cells 
[ 5 J • 
Histamine, 10·5 M, also vigorously stimulated 14C-aminopyrine 
accumulation by isolated gastric glands, confirming that the 
parietal cells of these glands secrete acid in vitro in 
response to this classic stimulus. The onset of aminopyrine 
accumulation occurred rapidly. After only 5 min inthe 
presence of histamine, the glands contained 2.3 times as much 
aminopyrine as unstimulated glands. 
Aminopyrine accumulation in response to histamine reached a 
plateau at 30 min. This steady state does not necessarily 
imply that proton secretion had slowed. Aminopyrine builds 
up in the parietal cell vesicles and gland lumen as it is 
trapped by secreted protons. Since the glands are an open 
(secreting) system, the aminopyrine level in the glands 
increases only until the rate of aminopyrine entrapment by 
secreted protons is equalled by the flow of protonated 
aminopyrine from the glands. The rate of aminopyrine 
accumulation in glands is thus a qualitative or 
semiquantitative reflection of the rate of proton secretion, 
but is not proportional to it. We have previously noted this 
plateau effect with CCK-8 stimulation [19]. 
Histamine stimulated oxygen consumption by isolated gastric 
glands (Fig. 5). In parallel experiments (not shown) 8-Br 
cAMP caused a highly significant increase in the rate of 0
2 consumption, from 51 ± 6 percent per hour to 131 ± 10 percent 
per hour (p < O. 05). Since histamine stimulated parietal 
cells but failed to stimulate PPG secretion by chief cells, 
stimulation of oxygen consumption by histamine suggests that 
stimulation of IF and acid secretion by isolated gastric 
glands is accompanied by an immediate increase in aerobic 
metabolic activity and thus in oxygen demand. This result is 
consistent with the behavior of isolated gastric glands in 
previous studies [8,18] and parietal cells in other 
preparations [ 4 J. The parietal cells are rich in 
mitochondria, and the minimum energy cost of the osmotic work 
required to concentrate protons 106-fold is quite large [4]. 
Less is known about the metabolic requirements for the 
biosynthesis, storage, and secretion of PPG and IF. Since 
8-Br cAMP stimulated secretion by both parietal and chief 
cells, it is likely that a portion of the stimulation of 
oxygen secretion by 8-Br cAMP reflects its action on chief 
cells, but further studies will be required to estimate the 
magnitude of this contribution precisely. 
The cAMP-mimetic analog 8-Br cAMP stimulated IF secretion and 14C-aminopyrine accumulation (Fig. 3) as well as oxygen 
consumption by the glands. These results are consistent with 
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the interpretation that cAMP is an intracellular mediator in 
the pathways by which histamine, as an H2 agonist, stimulates 
parietal cells in gastric glands to secrete both IF and acid 
[ 13, 19] . It has previouly been observed that 8-Br cAMP 
stimulates aminopyrine accumulation and oxygen consumption in 
isolated rabbit gastric glands [8] and IF secretion in 
isolated rabbit mucosal cells [5]. 
While histamine was a very effective stimulus for IF 
secretion, aminopyrine accumulation, and oxygen consumption, 
it failed to stimulate PPG secretion at any concentration 
tested. By contrast, the peptide hormone CCK-8 stimulated 
secretion of both IF and PPG by isolated gastric glands at 
concentrations from 10·9 M to 10·1 M (Fig. 6). Moreover, in 
separate experiments CCK-8, 10~ M, also caused a significant 
increase in 14C-aminopyrine accumulation over time (not shown). 
The 14C ratio for stimulated glands was 1. 6 times that for 
unstimulated glands, a statistically significant difference 
(p < o. 05) , and this proportion increased gradually to a 
maximum of2.0 at 60 min, a significant increase (p < 0.05). 
Further details concerning CCK-8 stimulation of IF secretion 
and aminopyrine accumulation in isolated glands have been 
discussed in a separate chapter [20]. 
In addition to CCK-8, three other secretagogues stimulated PPG 
secretion. Isoproterenol and carbachol, when tested alone and 
in combination, were found to have marked stimulatory effects 
which were also additive (Fig. 7). The most effective 
stimulus for PPG secretion, in terms of the maximum response 
obtainable at any concentration, was the cAMP analog 8-Br 
cAMP. At the maximally effective concentration, 10·3 M, 8-Br 
cAMP elicited 2.7 times as much PPG secretion in 30 min as 
carbachol at 10·5 M, its maximally effective concentration. In 
contrast to CCK-8, another peptide of the gastrin family, G-5, 
failed to stimulate PPG secretion. 
In addition to histamine, 8-Br cAMP, and CCK-8, IF secretion 
was stimulated by the muscarinic agent carbachol and the 
peptide hormone fragment G-5. PPG secretion was stimulated 
by isoproterenol, 8-Br cAMP, CCK-8, and carbachol. Whereas 
histamine and isoproterenol probably work through 
cAMP-mediated mechanisms, CCK-8, carbachol, and G-5 are not 
known to stimulate adenylate cyclase in parietal or chief 
cells, nor is there any other evidence to suggest that they 
act on these cells through the mediation of cAMP. The 
prevalent view is that these three secretagogues probably act 
in most cases by a calcium-dependent mechanism; I have 
discussed this concept elsewhere as it pertains to chief cells 
(Chapter IV). This idea has yet to be confirmed, but if it 
proves correct, then the stimulation of IF secretion and 
aminopyrine accumulation in isolated gastric glands can occur 
by two different pathways, one cAMP-dependent and the other 
calcium-dependent. In the former class, 8-Br cAMP and 
forskolin [14] stimulate both chief cells and parietal cells. 
In the latter class, carbachol and CCK-8 are found to 
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stimulate both types of cells. 
Differences between parietal cell and chief cell sensitivities 
to various stimuli have also been observed. Histamine was an 
effective stimulus for parietal cells but not for chief cells. 
Isoproterenol showed the reverse pattern of responses, 
stimulating PPG secretion but not IF secretion or 
1•c-aminopyrine accumulation. These observations support the 
presence of specific intact and functional receptors in the 
membranes of each of the different cell types within the 
isolated gastric gland complex. It is thus likely that 
parietal cells, but not chief cells, carry H2 receptors linked 
to adenylate cyclase, and that chief cells have 
beta-adrenergic receptors coupled to adenylate cyclase while 
parietal cells do not. 
The results described above demonstrate that isolated gastric 
glands respond to a variety of physiological stimuli in a 
physiologically relevant manner. The effects may be observed 
under well controlled and highly reproducible conditions, in 
the absence of various extrinsic neural, hormonal, paracrine, 
and circulatory influences. Agents may be administered at 
concentrations varying over several orders of magnitude, up 
to high levels which, while physiologically relevant at the 
cellular level, may be difficult or impossible to achieve 
bysystemic administration in the intact animal. Secretory 
responses can be measured without the complications that 
sometimes arise in vivo, such as contamination with extraneous 
gastrointestinal secretions, like bile or pancreatic juice, 
or mucosal ulceration. In addition, multiple secretory 
parameters may be investigated under identical conditions or 
even in the same experiment, permitting the study of secretory 
interactions between parietal and chief cells, or between 
different parietal cell secretions, in the physiologically 
relevant structural context of the gastric secretory unit. 
Of particular interest is the opportunity to study in vitro 
the mechanisms of secretion in a cell system which generates 
both macromolecules and protons. 
Thus, the isolated gastric gland preparation has clear 
benefits over whole-animal preparations for the study of 
gastric secretion, and also has specific advantages over 
isolated cells. I conclude that for many gastric secretion 
studies, especially those concerned with secretory 
interactions at the level of the gastric secretory unit, the 
isolated gastric gland preparation offers a significant 
practical alternative to both intact animal and isolated cell 
preparation. The ability to isolate a specific functional 
unit of the stomach composed of a number of different cells 
which are interrelated structurally and functionally provides 
a major tool in the study of gastric physiology. The clear 
morphological and functional interrelationship has led me to 
propose the term gastron for this uniquely organized 
arrangement of cells. 
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SUMMARY 
In order to investigate gastric secretory processes, their 
interrelations, and the factors which modulate them, I have 
modified and developed a preparation of isolated glands of 
rabbit gastric fundus. The isolated gland preparation permits 
the separate or simultaneous estimation of multiple gastric 
secretory functions under highly controlled conditions in the 
absence of interference by extrinsic neural, hormonal, and 
circulatory influences. Histamine, 10·5 M, stimulated a 
four-fold increase in intrinsic factor release by parietal 
cells into the medium, more than doubled the accumulation of 
14C-aminopyrine in the glands ( a measure of acid secretion) , 
and nearly tripled overall oxygen consumption by the glands, 
but had no effect on pepsinogen secretion. Conversely 
isoproterenol, 10-6 M, stimulated pepsinogen secretion, but 
failed to show any effect on intrinsic factor secretion. An 
active cAMP analog, 8-Br cAMP, at 10·3 M, strongly stimulated 
all four secretory parameters tested, a result supporting the 
view that cAMP mediates gastric secretory stimulation by both 
histamine (H2) and isoproterenol (beta-adrenergic). The 
muscarinic agonist carbachol, 10~ M, was slightly more 
effective in stimulating pepsinogen release than 
isoproterenol, 10-6 M, and combinations of carbachol and 
isoproterenol produced additive effects on pepsinogen 
secretion. As the multicellular structural unit of gastric 
secretory function ( "gastron") , the isolated gastric gland 
retains potentially important relationships between distinct 
parietal and chief cell secretory processes. Thus, the 
isolated gastric gland preparation offers unique advantages 
for efforts to elucidate the physiology and pathology of 
gastric secretory processes. 
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Figure 1. Scanning electron micrographs of rabbit gastric 
mucosa and isolated gastric glands. A--Perfused mucosa prior 
to collagenase digestion; view of cut edge, mucosal surface 
at top, showing parallel alignment of glands. ~--mucosa after 
digestion with collagenase for 15 min; as in A, the mucosal 
surface is at the top, and most of the glands remain attached 
to the mucosal surface, but the orderly parallel arrangement 
of the glands is nearly lost, and in some regions separation 
of the glands is essentially complete. g--Portion of an 
isolated gland at higher magnification after digestion, 
filtration, and washing. Smooth and rough cell surfaces are 
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Figure 2. Concentration-response curve for histamine 
stimulation of IF secretion by parietal cells of isolated 
gastric glands. Release of IF into the medium over 30 min in 
the absence of histamine and in the presence of histamine at 
concentrations from 10~ to 10·3M. Results are expressed as 
mean % of the maximum response obtained (response to 10·3M = 
100%), ± 1 SEM. Representation of standard errors in this and 






































Figure 3. Time course of IF secretion and 14C-aminopyrine 
accumulation by isolated gastric glands in the presence and 
absence of 10-5M histamine. IF secretion, O (unstimulated) , 
+(stimulated); aminopyrine accumulation, O(unstimulated), 
6(stimulated). Results are expressed as% of the difference 
between the stimulated level at 60 min and the unstimulated 
level at 5 min. 
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Figure 4. Time course of stimulation by 8-Br cAMP of IF 
secretion and 14C-AP accumulation by parietal cells of isolated 
gastric glands, in the presence and absence of 10~ M 8-Br 
cAMP. IF secretion, D (unstimulated) , + ( stimulated) ; 
aminopyrine accumulation, O(unstimulated), ~(stimulated). 
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45 50 55 60 
Figure 5. Time course of histamine stimulation of 0
2 consumption by isolated gastric glands. Disappearance of 0
2 from the metabolic chamber in the absence of histamine(-+-) 
and in the presence of histamine, 10·5 M ( C ) . Results are 
expressed as the mean decrease in% 0
2 
saturation (from an 
initial level of 42% saturation). Each point represents the 
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Figure 6. Concurrent stimulation of PPG and IF secretion by 
CCK-8. Concentration-response curves for release of PPG (+ 
) and IF ( O) in response to CCK-8 at concentrations from 
10·11 M to 10·1 M. Values are expressed as % of maximum 
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Figure 7. Stimulation of PPG secretion by carbachol and 
isoproterenol. Dose-response curves for carbachol-stimulated 
PPG release in the absence ( O ) and presence ( + ) of 
isoproterenol, 10.a M, at carbachol concentrations from 3 x 10"7 
M to 10-4 M. Results are expressed as % of the maximum 
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A general model of pepsin secretion was postulated by 
J. N. Langley in 1881. Morphologic microscopic findings led him 
to propose that pepsin was stored in granules within the chief 
cell and released upon appropriate stimulation of the cell 
[l]. Subsequent research has supported this model with the 
stipulation that pepsin is stored in the form of an inactive 
precursor, pepsinogen (2]. 
The release of acid and pepsinogen following administration 
of certain gastric secretagogues (first messengers) such as 
gastrin has been frequently studied in intact animals (3]. 
Intervening neural, hormonal, and paracrine influences 
complicate the interpretation of in vivo results. An 
important effect in this category is the stimulation of 
pesinogen release by acid on the mucosal surface of the 
stomach through a local ref lex [ 4] . Moreover, because of 
these complexities, in vivo studies cannot clarify the role 
of intracellular mechanisms (e.g., second messengers) in 
modulating pepsinogen secretion. Thus, there has been 
considerable interest in the development of in vitro models 
in which chief cell function may be studied in relative 
isolation with minimisation of extracellular influences. 
In an early in vitro model - organ culture of gastric mucosal 
biopsies acetylcholine, in the presence of the 
cholinesterase inhibitor physostigrnine, stimulated pepsinogen 
secretion (5]. 
Similarly, isobutylmethylxanthine, which inhibits the 
degradation of cAMP to adenosine monophosphate (AMP) by 
phosphodiesterase, also stimulated pepsinogen secretion in 
both organ cultures of mucosal biopsies as well as in intact 
gastric mucosal strips in vitro [ 6] . These experimental 
systems suffered from several technical problems, including 
regional variations of secretory patterns within gastric 
mucosa. 
Techniques that were initially developed for the isolation of 
pancreatic exocrine cells [7] could not be directly applied 
to isolating chief cells from rabbit mucosa. The extremely 
dense lamina propria of rabbit gastric mucosa does not permit 
efficient digestion by collagenase. Consequently, in initial 
studies I therefore examined pepsinogen secretion from 
isolated intact gastric fundic glands of the rabbit, adapting 
a method originally used for parietal cell studies [2]. In 
preliminary investigations by my colleague D. Shaefer, the 
glands remained rapidly responsive to acetylcholine [8]. 
Other laboratories have confirmed and extended these findings 
[ 2] . The present study utilizes isolated gastric glands ( IGG) 
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to investigate intracellular mechanisms of pepsinogen {PPG) 
secretion in an environment largely free of neural, hormonal, 
and paracrine influences. PPG secretion from IGG was measured 
in response to a variety of test probes. The purpose of this 
study was to examine whether second-messenger mechanisms 
mediated by 3 1 :5'-cyclic adenosine monophosphate {cAMP) or 
calcium-calmodulin {C-C), or both, govern PPG secretion from 
chief cells. First messenger probes were therefore used whose 
membrane receptors activate either cAMP mechanisms (histamine 
and isoproterenol) or c-c systems (carbachol and 
cholecystokinin-8, CCK-8). In addition, several probes that 
bypass membrane receptors were tested. In this group, I used 
forskolin {F), a direct stimulator of adenylate cyclase; 
8-bromo cAMP (SB), a direct activator of cAMP-dependent 
protein kinases; and A23187 {A), a calcium ionophore, which 




Four test probes were chosen {Table 1) that act via membrane 
receptors and three that bypass receptor mechanisms. In each 
group, some act via cAMP-dependent mechanisms, and others are 
presumed to act by C-C-dependent mechanisms. Thus, four 
possible pathways for stimulation of PPG secretion were 
tested; [l] through membrane receptors acting via the cAMP 
system; [2] through direct activation of the cAMP system; [3] 
through membrane receptors acting through the c-c system; and 
[4] through direct activation of the c-c system. 
Dose-response curves were predetermined for each probe {Figs. 
1,2,3). Maximal or just submaximal doses were used in the 
experiments. IGG were incubated for 30 minutes in the 
presence and absence of the test agents and then separated 
from the medium by filtration. PPG was measured in the 
medium. 
Statistical Analysis 
In each experiment all incubations were performed in 
quadruplicate. Experiments were repeated in four or more 
rabbi ts for each agent. Thus, each cited value represents the 
mean of 16 or more PPG determinations. Mean values of 
stimulated PPG secretion (expressed as per cent) of total were 
compared to unstimulated values in the same rabbit using 




Receptor-activated Adenylate Cyclase Agents 
(a) Isoproterenol increased PPG secretion significantly above 
baseline levels over the concentration range from 10-
7 to 10-4M 
(p<0.05). The results of a representative dose-response 
experiment giving PPG release as a function of isoproterenol 
concentration are shown in Figure 1. The stimulatory effect 
of 10-4M isoproterenol was not significantly ~reater than the 
effect of 10-6M (p>O. 05). Isoproterenol 10- M significantly 
increased PPG release (Fig. 4), by 3.5 ± 0.9% of total gland 
PPG above the baseline value (p<0.05). 
(b) Histamine, tested repeatedly in concentrations from 10-
8 
to 10-2M, failed in every experiment to stimulate PPG 
secretions significantly above unstimulated levels (p>0.05). 
A net PPG release of -0.02 + 0.30% of total gland PPG (not 
shown) was produced by 10-0 M histamine. The ability to 
dissociate the action of histamine on acid and pepsinogen 
secretion is dealt with in detail in a subsequent series of 
studies. 
Direct Activation of Adenylate Cyclase 
Forskolin caused a marked stimulation of PPG secretion over 
the concentration range from 10-
7M to 10-4M. In a 
representative experiment ~Fig. 3), net PPG release in 
response to forskolin at 10-M and higher concentrations was 
significantly greater than unstimulated release (p<O. 05) . 
There was no significant increase in PPG secretion between 10-
6 
and 10-4M (p>0.05). In another series of experiments (Fig. 5), 
forskolin 10-6M stimulated net PPG secretion significantly, by 
10.6 ± 3.8% of total gland PPG (p<0.05). 
Effects of a cAMP Analog 
8-bromo cAMP was a highly effective stimulus for PPG release. 
At doses from 10-7 to 10-3M a clear dose response curve was 
evident. Thus, 8-bromo cAMP (10-3M) evoked a net increase of 
13.8 ± 4.5% in PPG secretion (p<0.05) (Fig. 
5).Receptor-activated Calcium-Calmodulin Systems 
Carbachol ( 10-6M) significantly stimulated PPG release (Fig. 
4) , by 5. 1 ± 2. 2% of total gland PPG over basal levels 
(p<O. 05) . In preliminary dose-response experiments, CCK-8 was 
tested at concentrations from 10-11M to 10-
7M (Fig. 2) . PPG 
secretion was significantly stimulated (p<0.05) over baseline 
levels by CCK-8 at concentration from 10-
10M to 10-7M. There 
was no significant difference in CCK-8 stimulation between 
10-8M and 10-7M (p>O. 05) . In a separate series of experiments 
(Fig. 4) , CCK-8 ( 10-7M) significantly raised PPG secretion with 
respect to baseline, by 5. 3 ± 1. 5% of total gland PPG 
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(p<0.05). 
Effects of a Calcium Ionophore 
A23187 at a dose of 10-6M (Fig. 5) significantly increased 
secretion over baseline levels by 2.1 ± 1.1% of total gland 
PPG (p<0.05). 
Comparative Effects of the Probes 
Forskolin and 8-bromo cAMP were overall the most effective of 
the seven agents tested. Stimulation of pesinogen secretion 
was significantly greater (p<0.05) for these two agents than 
for any of the others except carbachol (p>0.05). Carbachol, 
CCK-8, and isoproterenol stimulated about one third to one 
half as much pepsinogen release as forskolin and 8-bromo cAMP. 
There was no significant difference (p>O. 05) between the 
levels of stimulation for carbachol, CCK-8, isoproterenol, and 
A23187. 
Table 1. Agents Tested for Stimulation of Pepsinogen 
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Figure 1. Dose-response relationship for isoproterenol 
stimulated pepsinogen secretion from isolated gastric glands 
(IGG). Pepsinogen secretion is expressed as per cent of the 
total pepsinogen secretion. A dose of 10-
7M isoproterenol 
(I) resulted in a significant secretion of pepsinogen over 
unstimulated levels (p<O.O~). Maximal stimulation was 
obtained with doses of 10- M. PPG secretion stimulated gY 
10-4M I was not significantly different from 10- M 
(p>0.05). 
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Figu~e 2. Dose-response relationship for CCK-8 stimulated 
peps1nogen secretion from IGG. Pepsinogen secretion is 
expressed as per cent of the total pepsinogen. CCK-8 at 10-11M 
resulted in a significant stimulation of PPG secretion over 
unstimulated levels (p<O. 05) . Maximal stimulation was obtained 
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FORSKOLIN CONCENTRATION (LOG Ml 
Figure 3. Dose-response relationship of forskolin stimulated 
pepsinogen secretion for IGG. Pepsinogen secretion is 
expressed as per cent of the total pepsinogen secreted. 
Forskolin 10-7M resulted in a significant stimulation of PPG 
over unstimulated levels (p<0.05). Maximal stimulation was 
obtained at a dose of 10-6M. There was significant difference 











Figure 4. Stimulation of pepsinogen secretion from IGG by 
maximal doses of secretagogues that activate cAMP or 
calcium-calmodulin (Ca++ -CaM) second messenger system via 
membrane bound receptors. Results are shown as Mean± SEM and 
are expressed as net pepsinogen secreted. i.e., per cent of 
the total pepsinogen secreted above baseline levels. Probes 
acting through either cAMP or c-c systems significantly 
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Figure 5. Stimulation of pepsinogen secretion from IGG by 
maximal doses of secretagogues that bypass membrane receptors 
directly activating cAMP or calcium-calmodulin (Ca++_CaM) 
second messenger systems. Results are shown as Mean ± SEM and 
are expressed as net pepsinogen secreted i.e. , per cent of the 
total pepsinogen secreted above baseline levels. Forskolin 
and 8-bromo cAMP, which directly activate cAMP mechanisms, 




The use of isolated gastric gland preparations permits the 
study of chief cell function in a simple, controlled 
environment. In the intact animal, chief cell function can 
be affected by alteration in blood pressure, shunting of blood 
past capillary beds, parasympathetic and sympathetic input, 
circulating hormones, and unrecognized regulatory systems. 
With IGG such extrinsic influences can be eliminated. The 
composition of the medium can be precisely controlled. 
Identical aliquots of cells from one animal can be 
simultaneously observed under different conditions. Thus, the 
direct effects of secretagogues on chief cells are more 
readily and unambiguously interpreted in this experimental 
system. 
Unfortunately IGG are not a homogeneous population of chief 
cells. This functional gastric unit, the gastrone, consists 
of a mixture of parietal cells, chief cells, and small round 
cells. This last group consists mostly of endocrine cells. 
The exact functional relationships of these endocrine cells 
is not completely understood. Although IGG experimentation 
allows the study of chief cells in a simplified environment, 
these endocrine cells may be imparting an unrecognized 
paracrine influence on chief cell functions. 
In some respects, isolated chief cell preparations represent 
an even simpler system than IGG [ 10] . However, at least atthe 
present time IGG have certain advantages over the isolated 
cell system. The calcium-free chelating media required for 
breaking tight junctions between cells may affect the function 
of calcium-dependent systems. 
The density-gradient centrifugation required for separating 
enriched cell fractions may alter or injure exposed membrane 
receptors. With disruption of the fundic glands, chief cells 
lose their polarity and become leaky. Until these potential 
limitations of the isolated chief cell preparation can be 
evaluated, the IGG preparation may offer the best available 
means of studying chief cell function in a controlled 
physiological environment. 
Of the seven agents tested as potential secretagogues in this 
study, only histamine failed to stimulate the secretion of PPG 
over unstimulated levels at any of the concentrations used 
(p>0.05). All the remaining agents caused significant 
stimulation of PPG release (p<0.05). The results of these 
experiments suggest that PPG secretion by IGG can be 
stimulated by at least five distinct classes of agents falling 
into two main categories: (1) agents that activate cAMP 
systems and (2) agents that "probably" activate c-c systems. 
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The observation that forskolin and 8-bromo cAMP were the two 
most effective stimulators of PPG secretion supports the 
proposal that cAMP may play a physiological role in the 
control of PPG secretion. It is probable that cAMP is an 
important intracellular regulator of this process. In this 
study, I have examined the effects of seven contrasting 
functional probes on PPG secretion. Each probe stimulates 
cellular function by a distinctive mechanism. Histamine binds 
to specific membrane H2 receptors, activating adenylate 
cyclase in rabbit gastric mucosa [9], resulting in an increase 
in intracellular cAMP [10]. In rabbit IGG, histamine 
stimulation results in acid secretion and intrinsic factor 
secretion from the parietal cells in a dose-dependent manner 
[ 13, 14]. In the present study, however, histamine ( 10-
6M) 
failed to stimulate PPG secretion significantly above baseline 
values. One may thus conclude that histamine mechanisms are 
not primary modulators of PPG secretion in rabbit chief cells. 
A possible explanation of PPG release in response to histamine 
in some intact-animal experiments is that histamine stimulates 
acid secretion, which can then reflexly stimulate the release 
of PPG [ 4]. Alternatively, histamine may release other 
bioactive agents that are capable of stimulating PPG 
secretion. Al though it is well documented that parietal cells 
in various species such as rabbits have H2 receptors, the 
present data suggests that chief cells in the rabbit have 
none. 
Isoproterenol ( 10-6M) significantly increased PPG secretion 
above baseline levels (Fig. 4). Whereas isoproterenol 
stimulates adenylate cyclase and increases cAMP content in 
rabbit IGG, it does not stimulate acid or intrinsic factor 
secretion [11,14]. Thus, beta-adrenergiccatecholamines acting 
through membrane adenylate cyclase and intracellular cAMP 
contribute to the regulation of PPG secretion in the rabbit. 
Although isoproterenol was an effective stimulus for PPG 
secretion, its maximum effect was approximately half that of 
either forskolin or 8-bromno cAMP (Figs. 4 and 5). This 
observation suggests that it is not possible to stimulate 
chief cell adenylate cyclase fully by stimulating 
beta-adrenergic receptors. There are at least two possible 
explanations for this observation. Such a limitation might 
occur if other receptors are preferentially coupled to a 
portion of the chief cell adenylate cyclase. Alternatively, 
in a mobile receptor-cyclase system, there may be an excess 
of adenylate cyclase catalytic subunit over receptor 
molecules, perhaps to ensure optimum response with a limited 
number of receptors. 
The diterpene forskolin is isolated from the roots of Coleus 
forskohlii and has been reported to activate adenylate cyclase 
by direct effect on its catalytic subunit [ 12]. In the 
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present study, forskolin significantly increased PPG secretion 
(Fig. 5). Forskolin has been reported to cause accumulation 
of cAMP in all tissues tested [15]. In particular, forskolin 
stimulates cAMP accumulation and activates cAMP-dependent 
protein kinases in isolated rabbit IGG [ 13]. It does not 
increase cAMP accumulation by inhibition of phosphodiesterase. 
Activationof adenylate cyclase by forskolin is reversible and 
independent of guanyl nucleotides, and it does not appear to 
depend on membrane receptors. Phentolamine (alpha-adrenergic 
blocker), propranolol (beta-adrenergic blocker), and 
cimetidine (H2 blocker) are ineffective in inhibiting 
forskolin-stimulated cAMP accumulation in brain slides [15]. 
It is believed that forskolin acts directly at the adenylate 
cyclase enzyme complex consisting of the guanyl nucleotide 
binding sub-unit and the catalytic subunit [ 15]. Thus, 
forskolin can stimulate pepsinogen secretion in IGG by 
bypassing membrane receptors and directly activating adenylate 
cyclase. 
My observation with the cAMP analog 8 bromo-cAMP (SB) supports 
the hypothesis that cAMP is an important modulator of PPG 
secretion. SB was the most effective stimulator of PPG 
secretion tested in this study (Fig. 5) although the dose used 
was somewhat excessive. The results are consistent with those 
found in rats [14] and guinea pigs, where cAMP analogs are 
potent stimulators of PPG secretion in vitro [10]. 
Carbachol, an acetylcholine analog that binds to muscarinic 
receptors, does not alter the cAMP content of gastric glands 
[2]. The mechanism of action of muscarinic agents on gastric 
glands is not known in detail; however, it appears that they 
function via the c-c system. In isolated pancreatic acini, 
carbachol elevates the cytoplasmic calciumconcentration [15] 
and increases phosphorylation of intracellular proteins in a 
pattern suggesting stimulation of a calmodulin-dependent 
protein kinase [16]. Studies with acetylcholine in rabbit IGG 
by Berglindh and colleagues [17] have shown that cholinergic 
stimulation of acid secretion, as measured by 14C-aminopyrine 
accumulation, requires the presence of extracellular ca++ 
exceeding at least 10-6M. This suggests that some part of the 
cholinergic mechanism involves an influx of extracellular 
ca++. In contrast, histamine-stimulated acid secretion did 
not require the presence of such high calcium levels within 
the medium. In the present study, carbachol ( 10-6M) 
significantly increased PPG secretion (Fig. 4). These results 
are consistent with the possibility that carbachol stimulates 
PPG secretion from chief cells by activating systems mediated 
by c-c. 
The hormone (neurotransmitter) cholecystokinin (CCK) is a 
33-amino acid peptide. CCK-8, the cholecystokinin octapeptide 
used in this experiment, is identical to the c-terminal 
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octapeptide of CCK, and the c-terminal pentapeptides of CCK, 
CCK-8, and gastrin are identical to each other. CCK-8 occurs 
naturally and has bioactivity similar to that of CCK in many 
systems. CCK-8 has been found in pig brain [18], and CCK-8 
immunoreactivity has been identified in the small intestine 
[19]. In the present study, CCK-8 increased PPG secretion 
above unstimulated levels by 5.3 ± 1.5% of total gland PPG. 
CCK-8 reportedlystimulates PPG secretion sixfold in dispersed 
guinea-pig chief cells [ 10] and fourfold in dispersed rat 
gastric glands [17]. CCK-8 does not appear to act through 
cAMP mechanism in rabbit IGG, since adenylate cyclase activity 
in rabbit IGG does not increase following CCK-8 stimulation 
[20]. Absence of calcium from the medium inhibits CCK-8 
stimulated chief cell function [23]. Furthermore, 
phosphorylation studies are consistent with the interpretation 
that CCK-8 acts through c-c dependent protein kinases [19]. 
Thus the evidence suggests that CCK-8 stimulates PPG secretion 
through c-c dependent mechanisms. 
The cytosolic concentration of free calcium ions in most cells 
is normally in the submicromolar range. The ionophore A23187 
selectively promotes the transport of calcium across 
biological membranes, thus transiently elevating the cytosolic 
concentration of free calcium ions [ 21] . In this study, 
A23187 modestly increased PPG secretions above basal levels. 
A moderate increase in PPG secretion has been observed with 
this agent in dispersed glands from rats [24]. The limited 
magnitude of this response may reflect the observation that 
A23187 may cofunction as a protonophore. It is possible that 
the resultant alteration of intracellular pH might alter the 
PPG secretary capacity. These observations further support a 
role for C-C systems in PPG secretion. 
In summary, these experiments clearly support a dual 
modulation of pepsinogen secretion. Thus, isoproterenol and 
forskolin (adenylate cyclase activators), as well as the cAMP 
analogue 8-bromo-cAMP, significantly stimulate pepsinogen 
secretion in IGG. In addition, carbachol, CCK-8, and A23187, 
which all act via c-c systems, stimulate pepsinogen secretion. 
It is, therefore, possible that both cAMP and c-c systems 
participate in the modulation of pepsinogen secretion from 
rabbit chief cells. 
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CHAPTER 11 
Vasoactive Intestinal Peptide 
Augmentation of Cholecystokinin 
Stimulated Pepsinogen Secretion 
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INTRODUCTION 
Vasoactive intestinal peptide (VIP) was isolated from the 
small intestines of hogs by Said and Mutt in 1970 [1]. The 
porcine octacosapeptide was sequenced and synthesized by 
Bodanzky et al. in 1973 [2]. VIP, secretin, glucagon, and 
gastric inhibitory peptide (GIP) are structurally related 
forming a family of gut hormones. Polak and colleagues, using 
immunohistochemical techniques, revealed a wide distribution 
of VIP containing cells throughout the mammalian and avian gut 
[3]. The highest concentration of VIP cells was in the colon. 
A dual role of VIP as a gastrointestinal hormone and as a 
neurotransmitter substance was proposed by Bryant et al [4] 
when they measured high concentrations of VIP within the 
central nervous system. Infusion studies have demonstrated 
that VIP is a more effective inhibitor of histamine-stimulated 
acid secretion and pentagastrin-stimulated pepsin secretion 
than secretin [5]. The clinical relevance of this hormone 
was confirmed when Said and Faloona [ 6] measured elevated 
levels of VIP in 28 patients with Watery-Diarrhea Hypokalaemia 
and Achlorhydria (WDHA) Syndrome. 
VIP' s mechanism of action has been well established in several 
in vitro systems. Acting through adenylate cyclase (AC), VIP 
causes accumulation of cyclic adenosine 3': 5 '-monophospate 
(cAMP) within jejunal mucosa cells [7,8]. Similarly, VIP has 
been reported to elevate levels of cAMP within isolated 
pancreatic acinar cells by activating AC [ 9, 10, 11] . The 
ability of VIP to activate AC in isolated gastric glands from 
the guinea pig fundus has recently been identified [12]. VIP 
affects cellular function of its end organs through the second 
messenger, cAMP. 
It has been reported that the regulation of pepsinogen 
secretion from chief cells is dually mediated by two second 
messenger systems [13]. Isoproterenol, forskolin, and 
8-bromo-cAMP stimulate PPG secretion by acting through 
cAMP-dependent systems. In contrast, carbamychol ine and 
cholecystokinin-octapeptide (CCK-8) cause chief cell secretion 
by altering intracellular calcium levels and possibly 
activating the calcium-calmodulin second messenger system 
[13). The stimulation of chief cells by compounds from these 
two groups produces at least an additive effect. 
The purpose of this experiment was twofold: first, to 
establish the effect of VIP on chief cell secretion and 
second, to examine the interaction of cAMP (VIP) and 
calcium-mediated (CCK-8) secretagogues on pepsinogen 
secretion. Isolated rabbit gastric glands were prepared by 
the technique of Berglindh and Obrink [14). This preparation 
provided an environment free of classical neural and hormonal 
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influences enabling a relatively direct interpretation of 
receptor-mediated cellular events. The effect of VIP on chief 
cells stimulated by a subthreshold dose of CCK-8 were 
examined. Since VIP acts through the cAMP second messenger 
system and CCK-8 through the calcium-dependent second 
messenger system, the augmentation of CCK-8-stimulated 
pepsinogen secretion by VIP would support the hypothesis that 
regulation of chief function is dually mediated by both the 
cAMP and calcium messenger systems. 
METHODS 
Gland preparation 
Isolated gastric glands were prepared from 3-4kg New Zealand 
white rabbits using the techniques previously described in 
detail [13]. 
Peptides 
Synthetic vasoactive intestinal peptide 
Laboratories) and cholecystokinin-octapeptide 




Three series of experiments were performed. In the first set, 
a dose-response curve for VIP was generated. In these 
experiments concentrations of VIP from 10-7 to l0- 11M were added 
to the incubation medium. The level of pesinogen secretion 
at each concentration was determined in quadruplicate samples 
from four different rabbits (n=4) . In the second set a 
subthreshold dose of CCK-8 was found by establishing a 
dose-response curve. Concentrations of CCK-8 from 10-11 to 10-7M 
were used. In the third set of experiments, this subthreshold 
concentration of CCK-8 (l0-9M) was added to IGG with varying 
concentrations of VIP ( 10-7 to 10-11M) . Pepsinogen secretion at 
each combination was determined in quadruplicate samples 
[ 15, 16 J and the study repeated in four different animals 
(n=4) . 
statistical analysis 
At each test dose of VIP alone ( 10-7 to 10-11M) or in 
combination with CCK-8 ( 10-9M) , 16 data points from 4 different 
animals were available for analysis. Comparison was done by 
Student's t test for unmatched samples. Statistical 
significance was defined as P<0.05. 
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RESULTS 
VIP dose response 
Unstimulated levels of pepsinogen secretion (Fig. 1) averaged 10 
± 2% of total pepsinogen. Total pep~inogen in th7se experime~i~ 
averageq 4963 ± 622 ng/ml. VIP in concentrations from 10 
to 10- M failed to stimulate the secretion of pepsinogen above 
unstimulated levels (P>0.05). 
CCK-8 dose response 
Unstimulated levels of pepsinogen secretion (Fig. 2) in these 
studies were 2.8 ± 0.2% of total pepsinogen. Total pepsinogen 
averaged 5756 ± 745 ng/ml. Maximal stimu7ation of pepsinogen secret!~n was achieved with a dose of 10- M. CCK-8 at a dose 
of 10 M did not significantly increase pepsinogen secretion 
above baseline levels (P>0.05). This dose of CCK-8 was used as 
a subthreshold dose in subsequent experiments. 
CCK-8 in combination with VIP 
Unstimulated levels of pepsinogen secretion (Fig. 3) in these 
experiments averaged 8 ± 3% total pepsinogen. Total pepsino~en 
in these experiments averaged 5156 ± 519 ng/ml. CCK-8 (10- M) 
alone. did not significantly stimulate p7psi~ogen secretion a~~ve 
baseline levels <P>0.05). The combination of CCK-8 (10 M) 
with VIP (lo-11 through 10-9M) failed to significantly 
increase pepsinogen secretion above ~aseline values (P>O.O~). 
The combination of CCK-8 (10- M) and VIP (10- M) 
significantly increased pepsinogen secretion abov~ baseline 
lev~ls (P<0.05). This combination (CCK-8 10- and VIP 
10- M) did not significantly (P=0.06) sti~ulate more 
pep~iyogen than the combination of CCK-8 (10- M) and VIP 





















-8 -7 us -11 -10 -9 
VIP CONCENTRATION (Log Molar) 
Figure 1. Vasoacti ve intestinal peptide (VIP) in 
concentration from 10-11 to 10-1 ~ when added to rabbit isolated 
gastric glands failed to significantly increase pepsinogen 
secretion above unstimulated (US) levels (P>0.05). Results 










































-11 -10 -9 us 
CCK-8 CONCENTRATION (Log Molar) 
Figure 2. Pepsinogen secretion stimulated by 
cholecystokinin-8 (CCK-8) in rabbit isolated gastric glands. 
Maximal stimulation was achieved at a dose of 10·1M. CCK-8 
(10~) did not significantly stimulate pepsinogen secretion 
(P>0.05). Results are expressed as percentage total 
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CCK-8 (10-9 M) + VIP (Log M) 
Figure 3. Pepsinogen secretion stimulated by CCK-8 ( 10·9M) 
alone or in combination with varying doses of VIP ( 10·11 to 
10~). CCK-8 (10·9M) alone failed to significantly stimulate 
pepsinogen secretion. The combination of CCK-8 ( 10·9M) and VIP 
( 10~) significantly stimulated pepsinogen secretion above 
unstimulated (US) levels (P<0.05). 
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DISCUSSION 
These studies demonstrated that vasoactive intestinal peptide 
alone in concentration from 10-11 to 10-7M does not stimulate 
pepsinogen secretion from isolated gastric glands (IGG). 
Cholecystokinin-octapeptide at a concentration of l0-
9M also 
failed to significantly elevate levels of pepsino~en secretion 
above basal values. The combination of VIP (10-M) and CCK-8 
( 10-9M) , however, significantly increased pepsinogen secretion 
above basal values. Thus the combination of two peptides at 
concentrations which alone fail to stimulate secretion 
resulted in chief cell secretion. 
VIP stimulation of pepsinogen secretion has not been 
previously demonstrated in rabbit IGG. In rat IGG, however, 
VIP ( 3 x 10-7M) alone significantly increased pepsinogen 
secretion above unstimulated levels [ 17, 18] . In similar 
studies with dispersed chief cells, Raufman and colleagues 
[19] doubled pepsinogen secretion with VIP. Maximum levels 
of secretion with VIP were achieved at a 10-9M concentration. 
Chief cells in our rabbit preparation may be less sensitive 
to stimulation by VIP than rat or guinea pig chief cells. 
CCK-K-8's ability to cause pepsinogen secretion by chief cells 
is well established. Ballantyne and co-workers [13] 
demonstrated that CCK-8 (10-7M) increased levels of pepsinogen 
secretion by 5. 3% ( of total pepsinogen) ± 1. 5% over basal 
levels. Studies in dispersed rat fundic glands found a 
fourfold elevation of pepsinogen secretioncaused by 10-8M dose 
of CCK-8 [20]. Maximal stimulation of guinea pig dispersed 
chief cells was achieved at a 5 x 10-8 M CCK-8 [17]. CCK-8 at 
concentration greater than 10-8M reliably produces pepsinogen 
secretion from rat, guinea pig, and rabbit chief cells. 
Pepsinogen secretion in rabbit IGG can be evoked by two 
classes of agents; ones that activate adenylate cyclase and 
ones that alter cytosolic calcium. I have previously 
demonstrated that isoproterenol and forskolin (agents which 
increase AC activity) and 8-bromo-cAMP (a cAMP analog) 
significantly stimulate pepsinogen secretion from IGG [13]. 
Furthermore, I have shown that CCK-8, carbachol, and the 
calcium ionophore A23187 (drugs acting through calcium 
mechanisms) increase pepsinogen secretion. These observations 
have been supported by a number of different investigators 
[ 21, 2 2, 2 3] . It is therefore probable that regulation of chief 
cell pepsinogen secretion is dually modulated by both cAMP and 
calcium second messenger systems. 
Binding of membrane receptors by secretagogues activates one 
of the second messenger systems (Fig. 4). Binding of 
receptors by agents which act through cAMP systems activates 
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membrane bound AC. This enzyme converts adenosine 
triphosphate (ATP) to cyclic adenosine 3': 5 '-monophosphate 
which acts as the intracellular (second messenger). cAMP is 
converted to adenosine monophosphate (AMP) when it 
phosphorylates a protein kinase. Phosphorylation activates 
the protein kinase allowing it to act on its protein 
substrate. Thus, binding of the membrane receptor by VIP 
leads to phosphorylation of intracellular protein kinases and 
protein substrates. In the gastricchief cell, this mechanism 
presumably results in secretion of pepsinogen. 
Binding of membrane receptors by secretagogues acting through 
Ca2+ mechanisms opens calcium channels precipitating a rapid 
rise in cytosolic calcium concentration [20). One result of 
this is the binding of ca2+ by calmodulin. This 
calcium-calmodulin complex (C-C) can accomplish 
phosphorylation of protein substrates through several 
mechanisms including elevating cellular levels of cAMP of 
activating c-c dependent protein kinase [20). These two 
second messenger systems probably communicate at several 
levels within the cell (Fig. 4). c-c can activate AC 
resulting in higher cellular levels of cAMP. It can also 
increase the activity of phosphodiesterase, an enzyme which 
degrades cAMP to AMP. This causes a decrease in cellular 
levels of cAMP. In addition, cAMP and c-c together may 
activate the same or similar protein kinases and thus trigger 
protein phosphorylation. It seems likely that these pathways 
allow for the two messenger systems to either amplify or mute 
each other [20). 
VIP and CCK-8 promote pepsinogen secretion by different 
mechanisms. Thus, VIP is proposed to utilize the cAMP system 
as an intracellular second messenger while CCK-8 has been 
postulated to act via the c-c system. The effect of VIP on 
adenylate cyclase and intracellular cAMP has been studied in 
several cell types. VIP showed a dose-dependent increase in 
adenylate cyclase activity in human gastric and duodenal 
mucosa [24). Maximal stimulation with a dose of 10 uM/ml 
produced a threefold increase in AC activity. Similarresults 
were found in dispersed guinea pig acinar cells [11,25) as 
wel 1 as human j ej unal mucosa [ 7 ) . Other experiments have 
measured cAMP levels in cells stimulated by VIP. 
Gardner and colleagues [10) examined the impact of VIP in the 
presence of theophylline, a phosphodiesterase inhibitor, on 
acinar cells isolated from guinea pig pancreas. VIP (10-6M) 
caused a fourfold increase of cAMP as measured by 
radioimmunoassay. More recently Sutliff et al reported that 
vasoactive intestinal peptide and secretin increased cellular 
cAMP and pepsinogen secretion in dispersed chief cells from 
guinea pig gastric mucosa. With each peptide there was a 
-161-
close correlation between the dose-response curve for changes 
in cellular cAMP and that for changes in pepsinogen 
secretion. Vasoactive intestinal peptide and secretin had no 
agonist activity and antagonized the actions of vasoactive 
intestinal peptide and secretin on cellular cAMP and 
pepsinogen secretion Studies of binding of 12 5I-vasoactive 
intestinal peptide and of 12sI-secretin indicate that gastric 
chief cells possess four classes of binding sites for 
vasoactive intestinal peptide and secretin. Occupation of 
two of these classes of binding sites correlate with the 
abilities of vasoactive intestinal peptide and secretin to 
increase cellular cAMP and pepsinogen secretion [5]. VIP 
also increased cellular levels of cAMP in human j ejunal 
mucosa [13]. Similarly, VIP (5 x 10-BM) prompted a twofold 
increase in cAMP levels in rat colon sacs [3]. These studies 
indicate that VIP stimulates cells within the mammalian 
gastrointestinal tract by activating membrane bound AC 
which then generates increased levels of intracellular cAMP. 
CCK-8 does not appear to stimulate cellular secretion via 
cAMP but rather by acting through calcium-mediated 
mechanisms. Hersey and colleagues [22] demonstrated that AC 
activity in rabbit IGG was not increased by CCK-8. This 
study also revealed that absence of calcium in the culture 
medium prevented CCK-8 stimulation of chief cell secretion. 
Additional evidence suggests that CCK-8 is dependent upon 
calcium-mediated mechanisms as a second messenger system. 
Recent phosphorylation studies [27] are consistent with CCK-8 
acting through calcium-calmodulin-dependent protein kinases. 
It is , therefore, probable that CCK-8 stimulates chief cell 
function through calcium-dependent second messenger systems. 
In the study reported here, peptides acting through two 
different second messenger systems were tested. This study 
does not address the level at which the summation of th two 
second messenger signals occurs. Previous studies with CCK-8 
have failed to reveal· alterations in cAMP levels. It is 
therefore unlikely that activated calcium-calmodulin 
functions by augmenting cAMP levels either by activation of 
AC or inhibition of phosphodiesterase. As mentioned above, 
studies with CCK-8 have not shown alterations in cAMP levels. 
Alternatively, both systems may cause phosphorylation of the 
same protein kinases. The role of peptide hormone 
interaction or of membrane bound phosphatidyl inositol 
remains to be elucidated. 
I have shown in this study that VIP or CCK-8 alone(in the 
concentrations used)failed to stimulate pepsinogen secretion. 
However, the combination of VIP acting through AC and cAMP 
together with CCK-8 acting through calcium systems succeeded 
in significantly stimulating pepsinogen secretion from rabbit 
IGG. These findings are consistent with the hypothesis that 
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pepsinogen secretion is dually modulated via interactions of 
the cAMP and calcium-calmodulin second messenger systems. 
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CCK-8 Pl Protein 
Ca++/ Substrate 
Colmodul In ~ 
I r 
r!~a m. E·P 
VIP P2 
Figure 4. Stimulation of two classes of peptidergic membrane 
receptors (Pl and P2) can stimulate pepsinogen (PPG) secretion 
from gastric chief cells. Binding of Pl receptors by a 
secretagogue causes an influx of calcium (Ca2+i into the 
cytosol. Calmodulin (C) binds this Ca+ forming 
calcium-calmodulin (C-C). Binding of P2 by secretagogues 
activates adenylate cyclase (AC) which converts ATP to cAMP. 
The second messengers, cAMP and c-c, then cause secretion of 
PPG by the chief cell. 
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CHAPTER 12 
Effect of Trifluoperazine, 
A Calmodulin Antagonist, 
on Pepsinogen Secretion 
-168-
INTRODUCTION 
The therapy of peptic ulcer disease (PUD) has focused mainly 
on acid secretion. The role of the powerful gastric 
proteolytic enzyme pepsin in the pathogenesis of PUD is, 
however, much less well understood. This role may be 
deserving of investigation, since inhibition of either the 
proteolytic activity of pepsin or the release of its 
precursor, pepsinogen, may be among practical therapeutic 
options. 
As the principal gastric protease, pepsin attracted the 
attention of some of the earliest physiologists and 
biochemists. Over a century ago Langley suggested, on the 
basis of microscopic investigations, that pepsin is stored in 
granules in the gastric chief cell and released on stimulation 
[1]. Pepsin and pepsinogen were among the first enzymes to 
be crystallized and extensively characterized [2]. It is only 
within the past decade, however, that a consistent picture of 
the physiological stimulation of pepsinogen release by chief 
cells has began to unfold [3]. 
I have previously reported that pepsinogen secretion is 
modulated at the intracellular level by both cAMP and calcium 
[4,5]. For example, pepsinogen secretion is stimulated by 
cholera toxin [6] and by isobutyl methylxanthine [7], both of 
which increase intracellular cAMP levels. It is also 
stimulated by acetylcholine [7-9], which is believed to act 
on the pancreatic acinar cell by raising levels of 
cytosolic-free calcium [10,11]. Cholecystokinin octapeptide 
(CCK-8), a potent stimulus for pepsinogen secretion, is also 
believed to raise cytosolic-free calcium concentrations 
comparable to those known to activate pancreatic acinar 
secretion. Evidence for dual modulation of pepsinogen 
secretion has also been obtained by other investigators 
[3,12]. 
While calcium ions may potentially influence biological 
processes in many different ways, only two general mechanisms 
have well-documented roles in the calcium messenger system 
that mediates physiological regulatory stimuli [13]. One of 
these mechanisms, the stimulation by calcium of 
phospholipid-dependent protein kinases (C kinases), is still 
in the early stages of investigation, and has not yet been 
unambiguously implicated in gastrointestinal secretory 
processes [ 14] . The second mechanism, which involves the 
binding of calcium ions to calmodulins, forming active 
calcium/calmodulin complexes, has been extensively studied 
since its discovery in 1970 [15]. Calmodulin may play a role 
in some calcium-mediated responses of the pancreatic exocrine 
cell to secretagogues [16]. 
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In an effort to identify inhibitors o~ pepsinogen release with 
potential therapeutic application in PUD, and to obtain 
information about the possibility that calcium may stimulate 
pepsinogen secretion through the calmodulin mechanism, I have 
examined the effect of calmodulin antagonists on pepsinogen 
secretion. the phenothiazine antipsychotic drugs have long been 
known to block the stimulation of phosphodiesterase by 
calmodulin [ 17]. Over the past decade they have come to be 
among the most extensively investigated of the calmodulin 
blockers [17]. One of the most potent of the phenotl'!._~zines is 
trifluoperazine (TFP, Stelazine), with an Ic50 of 10 M [17]. 
It is probable that there are calmodulins in rabbit chief cells, 
as in all other eukaryotic cells. Moreover, it is highly 
probable, on the basis of available data, that there exists a 
pepsinogen secretory pathway responsive to one or more chief 
cell calmodulins, which are sensitive to phenothiazines, 
including TFP; and that TFP can gain access to these calmodulins 
and thus inhibit the calmodulin-sensitive pepsinogen secretory 
pathway. We have therefore studied the effect of TFP on 
pepsinogen secretion in vitro, using the isolated gastric gland 
(gastron) system. The advantage of this preparation is that 
modulatory processes may be scrutinized apart from the 
interference of extrinsic neural, paracrine, or endocrine 
influences [5]. There is, however, a likelihood that several 
cell types present in the isolated gastric gland preparation may 
interact in a paracrine fashion. CCK-8 stimulates pepsinogen 
secretion by isolated rabbit and rat gastric glands [3,4,12], 
The purpose of this study was therefore to evaluate the effect 
of a calcium-calmodulin antagonist (TFP) on pepsinogen secretion 
stimulated by CCK-8. 
METHODS 
Isolated gastric glands were prepared from rabbit stomachs 
perfused in situ at high pressure with colloid-free buffered 
saline, as described by Berglindh and Obrink [ 8]. Stripped 
fundic mucosa was finely chopped and incubated in collagenase-
containing medium for 45 minutes at 37°c. The digest was washed 
repeatedly with serial filtration through successively finer 
nylon mesh, and the resulting washed glands were resuspended and 
incubated in buffered medium containing glucose and albumin, as 
previously described [4,5]. In the present study, glands were 
incubated for 30 minutes in the presence and absence of CCK-8 
and TFP. 
The effect of CCK-8 and TFP, separately and combined, on 
pepsinogen secretion were evaluated quantitatively from 
dose-response curves obtained under three experimental 
conditions. In the first set of experiments, pepsinogen 
secretion was determine~ as a ~nction of concentration 
of CCK-8 alone ( 10- 1M-10- M. These dosages reflect 
concentrations recognized to be within the physiological 
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range. The second set of experiments determined the effects 
of TFP (10~-10~) on pepsinogen secretion in the r.resence of 
a maximally effective concentration of CCK-8 (10.M). In the 
third set, the effects of TFP alone (2 x 10·5M - 5 x 10"'11) on 
pepsinogen secretion were measured. 
Pepsinogen secretion was assayed by measuring net pepsinogen 
release into the medium. We used a modification of the 
proteolytic method of Anson and Mirsky [19], as previously 
described [ 4, 5] . ( 4C] Methemoglobin (New England Nuclear, 
Boston, Mass.), 10 cpm, was added per millimiter of assay 
buffer before proteolysis, and 14C remaining in the digest 
supernatant after trichloroacetic acid precipitation was 
measured in a beta counter (Beckman Instruments, 
Fullerton, Calif). Total gland pepsinogen content was measured 
by freezing gland suspensions in liquid nitrogen, thawing, and 
assaying the supernatant for pepsinogen. 
In another series of experiments, the release into the medium 
of lactate dehydrogenase (LDH) was measured to assess the 
possibility of nonspecific effects of TFP. LDH was measured 
by the method of Wacker et al [20], in which L-lactate is 
oxidized to pyruvate with simultaneous reduction of NAD to 
NADH, and NADH production is measured at 340nm. Assay 
reagents were obtained from Gilford Diagnostic, Cleveland, 
Ohio. 
The effects of TFP on cellular cAMP levels were measured in 
parallel 30-min incubations terminated by boiling for 3 min 
and centrifugation. supernatant cAMP concentrations were 
measured by 125 I-radioimmunoassay (Becton-Dickinson 
Immunodiagnostics, Orangeburg, N.Y.). 
At each concentration of TFP or CCK-8, mean values of each of 
the measured variables were compared with each other and with 
unstimulated values of Student's t-test, and judged to be 
statistically significant at P<0.05. 
RESULTS 
CCK-8 stimulated pepsinogen secretion in a dose-related 
fashion (Fig. 1) . At 10·11M and l0'1°M, no effect of CCK-8 on 
pepsinogen release was seen. At 10·9M, CCK-8 significantly 
stimulated the secretion of pepsinogen over basal levels 
(P<O. 05). A further significant increase was seen at 10·8M 
(P<0.05). There was no significant difference between 10~ 
and 10·1M (P>.0.05). 
When isolated gastric glands were stimulated with CCK-8, 10·1M, 
in the presence and absence of TFP, 1 o~ to 1 o·3M (Fig. 2) , 
CCK-8 alone gave a three-fold stimulation over basal levels 
(Fig. 2) , and this response was unaffected by 10~ and 10·5M 
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TFP (P>0.05). At 10·4M and 10·3M TFP, pepsinogen secretion was 
5. 6 and 6. 5 times the basal level, respectively. This 
response was significantly greater (P<0.05) than that obtained 
with CCK-8 alone (Fig. 2) . Thus CCK-8 stimulation of 
pepsinogen secretion was not inhibited at any TFP 
concentration (Fig. 2). 
When TFP was tested alone, it had no significant effect on 
release of pepsinogen at concentrations up to 2 x 10·5M (Fig. 
3) • At 5 x 10·5M and above, TFP significantly stimulated 
pepsinogen secretion (P<0.05). The mean response increased in 
dose-related fashion. At 2 x 10°4M and 5 x 10°4M, the response 
was significantly greater than 5 x 10·5M (P<O. 05). 
In experiments designed to assess the possibility that TFP 
might nonspecifically promote the release of cell protein, LOH 
release into the medium was not significantly greater in the 
presence of TFP, up to 2 x 10"4M, than in the absence of 
stimulation (Fig. 4). 
Likewise, in experiments to determine whether TFP might affect 
pepsinogen secretion by altering cAMP levels (Fig. 5), TFP at 
10~ - 10~ had no significant effects on glandular cAMPlevels 
(P>O. 05). In the same experiments the adenylate cyclase 
activator forskolin, 10·5M, stimulated an increase of 
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Figure 1. Dose-response curve for pepsinogen secretion as a 
function of CCK-8 concentration ( 10-11M-10-7M) • Pepsinogen 
release is expressed as the mean percentage of the maximum 
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Figure 2. Effects of TFP ( 10~-10·3M) on pepsinogen secretion 
in the presence of 10·1M CCK-8, a maximally effective 
concentration. The results are expressed relative to 
pepsinogen release by glands incubated in the absence of both 
TFP and CCK-8 (UNSTIM). Release by glands stimulated with 
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Figure 3. Dose-response curve for net pepsinogen secretion, 
in excess of basal (unstimulatedO levels, as a function of TFP 
concentration (2 x 10~ - 5 x 10·4M), in the absence of CCK-8. 
Pepsinogen release is expressed as a fraction of total gland 


















TFP COHCEHTRATION (LOC M) 
Figure 4. Effect of TFP ( 2 x 10~ - 5 x 10·4M) on LOH release 
from isolated gastric glands in 3 o min. LOH release from 
glands incubated for the same interval in the absence of TFP 

































UNST1M -6 -5 -4 -J 
TFP CONCENTRATION (LOG M) 
Dose-response curve for the effect of TFP 
on cAMP levels in isolated gastric glands. cAMP 
glands incubated without TFP are also shown 































Figure 6. Effect of 30-min incubation with forskolin, 10·5M, 
on cAMP levels in isolated gastric glands. The cAMP content 
of glands incubated in the absence of forskolin is also shown 
(UNSTIM). The values are means+ 1 SEM. 
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DISCUSSION 
The present results show not only that TFP does not inhibit 
the stimulatory effects of CCK-8 on pepsinogen secretion at 
the low concentrations where it might be predicted to do so, 
but also that at somewhat higher concentrations TFP alone 
actually stimulates pepsinogen secretion. In an attempt to 
explain this unexpected and paradoxical result I investigated 
two possibilities. The first of these was that TFP might 
cause the release by a nonspecific mechanism that would 
liberate other cell proteins such as LOH (12]. The second was 
that TFP might stimulate by the other known mechanism for the 
modulation of pepsinogen secretion, namely, the cAMP-dependent 
mechanism. 
Our results with LOH show that up to 10-"M, TFP has no effect 
on the release of this marker protein. This concentration 
enhanced pepsinogen secretion in both the presence and absence 
of CCK-8. Thus up to this concentration, at least, the 
stimulatory effect of TFP is specific for pepsinogen 
secretion. Presumably in these experiments LOH was released 
by other gland cell types in addition to chief cells. 
The results of the measurements of cellular cAMP show that 
cellular adenylate cyclase is exquisitely responsive to 
forskolin, 10·5M, under the experimental conditions employed. 
Thus adenylate cyclase systems in these glands are functional 
and the assay is capable of detecting much smaller changes in 
cAMP levels than those produced by forskolin. Yet TFP 
produced no discernible effect on cell cAMP levels. Thus it 
is unlikely that TFP alters pepsinogen secretion by increasing 
cAMP levels. 
The foregoing observations raise three very different 
questions, which must be considered separately: First, why 
does TFP not inhibit the stimulatory action of CCK-8 on 
pepsinogen secretion? Secondly, how does TFP itself stimulate 
the release of pepsinogen? And third, what implications do 
these observations have for our understanding of the 
physiological modulation of pepsinogen secretion and for its 
control? 
TFP permeates cell membranes readily, and the IC for 
inhibition of calmodulin by TFP in a great variety of in~vitro 
test systems is 10·5M [ 17 J • Thus, where TFP is observed to 
block calmodulin, it usually does so at concentrations below 
5 x 10·5M [ 17]. The present experiments encompassed the range 
10~ to 10·3M. Thus the absence of an inhibitory effect of TFP 
in these experiments probably cannot be attributed to the use 
of too high or too low a concentration of TFP. 
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Sanders et al. have reported that in monolayers of canine 
chief cells carbachol-stimulated PS is inhibited by the 
calmodulin antagonist chlorpromazine, a phenothiazine 
derivative analogous to trifluperazine (21]. Similarly, 
N,N-(diethylaminO)octyl-3,4,5-trimethoxybenzoate (TMB-8), 
which is believed to inhibit the mobilization of intracellular 
calcium, inhibits carbachol-stimulated PS (21]. The 
explanation of the apparent discrepancy between these results 
and mine is not yet clear, though several possibilities must 
be considered. While chlorpromazine and trifluoperazine 
commonly have qualitatively similar effects on the same 
tissues, the former istypically the less active of the two as 
a calmodulin antagonist. Thus, it is not probable that the 
difference is due to the agents used. Likewise it is possible 
that species differences in calcium-mediated pepsinogen 
secretion account for the difference. No major qualitative 
differences in this regard between the dog and the rabbit have 
received attention, however. 
The calmodulin-sensitive pathway may not be sufficiently 
active under the experimental conditions used here, including 
CCK-8 stimulation, for its inhibition to have been detected. 
Possibly these discrepancies may even reflect fundamental 
differences between the mechanism of carbachol and CCK-8 
stimulation. Neither mechanism has been unambiguously 
established for any cell system, and no direct evidence is 
available for the chief cell. A priori it would be simplistic 
to assume that a cholinomimetic neurotransmitter and a peptide 
hormone act in completely identical ways. In chief cells, 
CCK-8 may work primarily by a pathway that is not 
calmodulin-dependent. This concept is supported by the fact 
that N-(6-aminohexyl)-1-naphthalenesulfonamide (W-5), a 
calmodulin inhibitor belonging to a different class (22], also 
failed to inhibit CCK-8 stimulation of pepsinogen secretion 
in my system. 
The explanation may also rest on pharmacokinetic differences 
between isolated glands and chief cell monolayers, or in the 
actual experimental design. The failure of TFP to inhibit 
pepsinogen secretion in these experiments may mean that TFP 
does not reach the calmodulin-sensitive pepsinogen secretory 
pathway at the proper time in sufficient amounts. such 
failure could suggest that transport of TFP to the calmodulin 
site regulating the pathway is impeded. This interpretation 
leads to the second question. How does TFP at high 
concentrations stimulate pepsinogen secretion? Clearly TFP 
reaches some region of the chief cells. Thus it is unlikely 
that TFP failed at all concentrations in our experiments to 
reach chief cell calmodulin sensitive to TFP. It must not be 
assumed, however, that the inhibitory and stimulatory sites 
of TFP action are the same. 
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The precise nature of the stimulatory process cannot be 
deduced from the present studies. The phenothiazines have 
been reported to interact with numerous other cellular 
constituents, including several types of receptors for 
neurotransmitters, phospholipids and other calcium-binding 
proteins, such as trophin C [17]. The possibilities are 
especially numerous at the high TFP concentrations where the 
stimulation of pepsinogen secretion occurs. In principle it 
is impossible to absolutely rule out nonspecific effects. 
Thus, although LOH has been used as a marker for clear-cut 
nonspecific effects of other agents that stimulate pepsinogen 
secretion [23], it may not be sufficiently sensitive to reveal 
more subtle nonspecific actions. Even the demonstration that 
TFP does not appreciably alter cAMP levels in the isolated 
glands does not entirely exclude the possibility of 
significant cAMP accumulations at sensitive local sites within 
the chief cells. 
In spite of these reservations, however, the stimulation of 
pepsinogen secretion by TFP cannot be ignored, especially in 
the light of the third question: What implications do these 
observations have for the understanding of the physiological 
modulation of pepsinogen secretion and for its control? 
Thefact is that the intracellular mechanisms controlling the 
release of pepsinogen are still largely obscure. The detailed 
events by which cAMP and calmodulin ultimately bring about the 
release of the pepsinogen molecule are mainly subjects of 
speculation. Thus the intriguing possibility remains that TFP 
stimulates pepsinogen secretion through a hitherto undescribed 
mechanism, which may point to a final pathway common to all 
regulatory mechanisms for pepsinogen secretion. The reported 
interactions of TFP with neurotransmitters and phospholipids, 
mentioned above [17], underscore the need for further 
investigation of this possibility. 
These results indicate that TFP is unlikely to be of use as 
a secretory blocker for pepsinogen, at least to the extent 
that pepsinogen secretion is under the control of CCK-8. Its 
potential usefulness as an antagonist to pepsinogen secretion 
in response to other secretagogues such as acetylcholine is 
still to be determined. The identification of an 
intracellular inhibitor of pepsinogen secretion akin to a 
parietal cell proton pump blocker may be the next logical step 
in management of PUD. 
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CHAPTER 13 
Pepsin Release by a 
Prostaglandin E1 Analogue 
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INTRODUCTION 
Prostaglandins are potent inhibitors of gastric acid secretion 
(1-3]. Furthermore, they appear to be capable of protecting 
the gastric mucosa against a wide variety of noxious agents. 
This "cytoprotective" property appears to be independent of 
acid inhibition since it is apparent at much lower 
concentrations and is observed to occur even with 
prostaglandins that do not inhibit acid secretion [4,5]. 
The effects of prostaglandins on gastric pepsinogen secretion 
are less clear. Since pepsin is a potent mucosa! barrier 
breaker strongly implicated in ulcerogenesis, (6] changes in 
pepsinogen secretion due to prostaglandin therapy may be of 
consequence in determining the therapeutic potential of 
prostaglandins in the treatment of peptic ulcer disease. The 
effects of prostaglandins on gastric secretion in human and 
intact animal studies have been difficult to interpret because 
of complex endocrine, paracrine, and neural influences. In 
addition, changes in acid and fluid secretion create artifacts 
in the measurement of pepsinogen secretion. 
Therefore, the purpose of this study was to delineate the 
effect of a prostaglandin E
1 
(PGE,) analogue (misoprostol) [7] 
on acid and pepsinogen secretion in an experimental model 
exempt from endocrine and neural influence. The actions of 
misoprostol on the secretion of pepsinogen and acid were 
accordingly studied in isolated gastric glands and parietal 
cells of the rabbit. 
METHODS 
Isolated gastric glands and parietal cells for pepsinogen and 
acid studies were prepared from gastric mucosa of 3 - 4 kg 
male New Zealand white rabbits. 
Isolated gastric glands were prepared by methodology 
previously described in detail. Isolated parietal cells were 
prepared as per methodology detailed earlier in this thesis. 
Acid secretion of the parietal cells was assessed by the 
uptake of diphenylamine carbon 14-labelled aminopyrine. This 
is a weak base that is nonionized at neutral pH and freely 
diffuses across the cell membrane. Within the acidic 
secretory canaliculi of a stimulated parietal cell, 
aminopyrine becomes ionized and is trapped within the cell. 
Accumulation of labeled aminopyrine in the parietal cell is 
therefore an indirect measure of acid secretion. Parietal 
cell suspensions were incubated with 14C-aminopyrine for one 
hour at 37° C in oxygenated respiratory medium containing the 
agents under study. After incubation, the cells were filtered 
and the percentage of aminopyrine taken up by the cells was 
counted using a beta counter. 
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EXPERIMENTAL DESIGN 
The gastric glands were incubated for 40 minutes with 
misoprostol in concentrations ranging from 10·11 to 10-smol/L at 
37°C with continuous oxygenation. Misoprostolwas initially 
dissolved in ethyl alcohol and then serially diluted using a 
buffered incubation medium. Pepsinogen secretion of the 
treated glands was expressed as a multiple of the rate of 
secretion by untreated glands. No histamine was used. 
Using these techniques, studies of acid secretion were 
performed in isolated parietal cells and studies of pepsinogen 
secretion in isolated gastric glands. Enriched parietal cell 
suspensions were initially incubated with identical 
concentrations of misoprostol and vehicle for one hour at 37°C 
during oxygenation. 
In a second series of experiments, enriched parietal cell 
suspensions were incubated with the same concentrations of the 
misoprostol and the vehicle in the presence of 10-smol/L of 
histamine. After each experiment, the aminopyrine uptake of 
the misoprostol-treated cells was measured and compared with 
control cells (unstimulated for the first series of 
experiments and histamine-stimulated for the second.) 
Data presented represent the mean of six experiments. Data 
were analyzed by Student's paired t-test; P<. 05 was considered 
statistically significant. 
RESULTS 
Misoprostol stimulated pepsinogen secretion in isolated 
gastric glands in a dose-dependent manner. This effect was 
statistically significant at concentrations as low as 
10~0mol/L (P<.05). Half-maximal stimulation occurred at 
10-smol/L whereas treatment of the glands with misoprostol at 
10·1mol/L concentrations resulted in a doubling of pepsinogen 
secretion over the unstimulated state (Fig. 1). The alcohol 
vehicle had no effect on pepsinoien secretion at the 
concentrations required to deliver 10 mol/L misoprostol. 
Misoprostol alone had no effect on acid secretion from 
unstimulated isolated parietal cells, even at 10-smol/L (1.1 ± 
0.2 times unstimulated). However, misoprostol significantly 
blocked histamine stimulation of acid secretion at doses as 
low as 10·10mol/L (P<. 05; Fig. 2) . Half-maximal blockade was 
seen at 10·9mol/L and 78% inhibition of acid secretion occurred 
with 10·1mol/L misoprostol. The alcohol vehicle used to 
dissolve the misoprostol had no effect on basal or histamine 
stimulated acid secretion at similar concentrations. Histamine 
at 10-smol/L alone stimulated acid secretion in isolated 
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Figure 1. Misoprostol stimulates pepsinogen secretion (given 
as multiple of unstimulated values) in isolated rabbit gastric 
glands. Data are normalized to unstimulated state and 
represent mean of six experiments. Values differ 
si~nificantly from unstimulated state (P<.05) except for 
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Figure 2. Misoprostol inhibits acid secretion in histamine-
stimulated isolated rabbit parietal cells. Data are 
normalized to rate of acid secretion in parietal cells exposed 
to 10-emol/L of histamine without misoprostol and represent 
mean of six experiments. All values differ significantly from 
unstimulated state (P<. 05) except 10·11 and 10·10mol/L. 14C-AP 
indicates carbon 14-labeled aminopyrine. 
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Figure 3. Scanning electron micrograph of rabbit gastric 
glands isolated from rabbit fundic mucosa by collagenase 
digestion (x 1000). 
-190-
Figure 4. Scanning electron micrograph of fractured parietal 
cell isolated by collagenase digestion, chelation, and 
elutriation (x 2000). 
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DISCUSSION 
Misoprostol proved a potent inhibitor of histamine-stimulated 
acid secretion by isolated rabbit parietal cells. This is 
consistent with results of other in vitro [1,3,11] and in vivo 
(13] studies. 
Although misoprostol inhibited acid secretion, this PGE, 
analogue significantly increased pepsinogen secretion in 
isolated rabbit gastric glands. Previous studies by Berger 
and Raufman ( 13 J have demonstrated a similar stimulatory 
effect in isolated guinea pig gastric glands. In vivo studies 
with the PGE
3 
analogue enprostil and with prostaglandin E
3 
in 
dogs with gastric fistulas (14,15] suggest that prostaglandins 
inhibit pepsinogen secretion. These studies, however, need 
to be interpreted with caution since the measurement of pepsin 
under these experimental conditions may considerably 
underestimate actual secretory rates. Pepsin may be 
inactivated by the less acidic pH of gastric juice samples 
taken from patients whose acid secretion is potently inhibited 
(16]. Furthermore, acid itself may stimulate pepsinogen 
secretion, (17] and the loss of this stimulation in 
acid-suppressed patients might also conceal prostaglandin 
stimulation of pepsin secretion. Reported findings of 
decreased peptic activity in the gastric lumen of 
acid-suppressed patients may therefore be clinically 
misleading. 
It is unclear whether the stimulation of pepsinogen secretion 
reported herein represents a physiologic or only a 
pharmacologic response, since the actual levels of 
prostaglandins in the target tissue are unknown. However, 
local concentrations of prostaglandins in the stomach are 
known to be high (18]. Serum levels would be meaningful only 
if the prostaglandins were exclusively circulating hormones. 
In fact, prostaglandins probably act as autocrine or paracrine 
messengers, and their effective concentration at the cellular 
membrane is undoubtedly orders of magnitude higher than in the 
peripheral circulation. 
Prostaglandin stimulation of pepsinogen secretion is probably 
mediated by cyclic adenosine monophosphate (cAMP) (19]. The 
calcium-mediated pepsigogue carbachol potentiates PGE 
stimulation of pepsinogen secretion in isolated rabbit gastri~ 
glands (13]. This suggests that prostaglandins act through 
a pathway independent of calcium. The other major 
intracellular pathway resolves around cAMP. In fact, 
prostaglandins also increase the cAMP content of enriched 
canine chief cell suspensions (19]. Furthermore, 
protaglandins have previously been shown to inhibit acid 
secretion by decreasing cAMP in parietal cells (1]. Thus, 
both the stimulation of acid secretion and the inhibition of 
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pepsinogen secretion are likely to occur through 
differential effects of the prostaglandins on cAMP content 
in adjacent gastric fundic cell types. 
Methylated prostaglandin analogues such as misoprotol were 
expected to be valuable in the treatment of peptic ulcer 
disease. However, clinical trials with several 
pros tag land in compounds have generally failed to 
demonstrate a significant advantage over conventional 
antacid therapy or histamine blockade [20,21]. 
The explanation may partially lie in the effects of the 
prostaglandins on pepsin secretion. It has been 
postulated since the first half of this century that 
luminal pepsin may be a significant ulcerogenic agent 
[22]. More recent studies continue to support the concept 
of pepsin as a potent mucosal barrier breaker that permits 
luminal acid to injure the mucosa [16,23]. 
Prostaglandin analogues with diminished or absent 
pepsigogic potency might be more efficacious against peptic 
ulcer disease. Alternatively, pepsinogen-blocking agents 
might be useful adjuncts to prostaglandin therapy. 
Pepstatin is a direct pepsin inhibitor derived from the 
polypeptides in inactive pepsinogen that block the active 
site of the enzyme [24]. Colloidal bismuth is also 
believed to inhibit pepsin whereas carbenoxolone and 
several other drugs inhibit pepsinogen secretion [25]. It 
is possible that a therapeutic trial combining 
prostaglandins with such agents might yield better results 
than prostaglandin therapy alone. It may also be useful in 
future clinical trials of the prostaglandins to monitor 







in pepsinogen secretion should be considered in the 
and development of new regimens for the treatment of 
ulcer disease. As these results show, it cannot be 
that because an agent inhibits acid secretion, it 
same effect on the secretion of pepsinogen. 
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CHAPTER 14 
Dissociation of Pepsinogen and Acid 
Secretion in the Guinea Pig 
-197-
INTRODUCTION 
Pepsin is a potent proteolytic enzyme strongly implicated as a 
cofactor in the genesis of experimental gastric ulcers [1-3] and 
by epidemiologic data in human ulcers [4,5]. Yet, prophylaxis and 
therapy for ulcers and gastritis have emphasized acid almost to the 
exclusion of the contribution of pepsin to breaking the mucosa! 
barrier. This disregard has been partly rooted in the clinical 
intuition (based on older in vivo experiments) that pepsin release 
always parallels the secretion of acid. Indeed, pepsinogen 
secretion generally increases in vivo and in isolated stomach 
preparations in response to agents which stimulate acid secretion 
[6,7] and decreases in vivo with H
2 
blockers [8,9,10] and 
substituted benzimidazoles [11,12]. It has, therefore, been 
hypothesized that chief cell pepsinogen secretion may require a 
flow of water and acid from adjacent parietal cells [ 12] . Al though 
pepsin and acid secretion have been reported to vary independently 
in dispersed gland suspensions [13,14], pepsin secretion may be 
different in isolated gastric glands than from within intact 
mucosa. Furthermore, acid secretion continued at a basal (although 
not increased) rate in these studies with gastric glands. Such 
observations do not therefore preclude a requirement for a moderate 
level of parietal cell secretion to activate pepsinogen secretion 
or to wash pepsinogen from the gastric pits into the gastric lumen. 
Alternatively, stimulated parietal cells might exert local 
influences on adjacent chief cells not evident in isolated gastric 
gland preparations because of dilution by the suspending medium. 
To investigate these possibilities, I studied the effects of 
cholecystokinin, histamine and carbamylcholine on the secretion of 
pepsinogen and acid. I utilized isolated intact sheets of guinea 
pig fundic mucosa, a new model which I have developed for the study 
of mammalian pepsinogen secretion [15]. In a second phase of this 
study, I investigated the effects of proton pump inhibition by the 
potent H+ /K+ ATPase inhibitor omeprazole on the basal, 
carbamylcholine-stimulatedandcholecystokinin-stimulatedsecretion 
of acid and pepsinogen in this model. 
METHODS 
Fundic mucosae from 200 gram female Hartley guinea pigs were 
stripped of their serosal layers and mounted in Ussing chambers as 
previously described [15,16]. Pepsinogen secretion was measured 
using 1~I-albumin as a substrate as previously described, using 15 
hour incubation times [ 14] . All samples were assayed in triplicate 
and each assay was controlled by simultaneous assay of a series of 
known standard pepsinogen concentrations (Sigma). 
EXPERIMENTAL DESIGN 
In the first phase of the study, preparations were treated with 
10~ cholecystokinin-octapeptide (Kinevac, Squibb Diagnostics, New 
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Brunswick, NJ), 10~ cholecystokinin, 10~ histamine (Sigma, St. 
Louis, MO), or 3x10"7M carbamylcholine (Sigma). All secretagogues 
were dissolved inmammalian Ringer's solution. Dithiothreitol (OTT 
0.001%) was added to submucosal solutions in all cholecystokinin 
experiments to prevent inactivating oxidation of the 
cholecystokinin and was also studied separately as a control. 
Eight experiments were done for each agent. 
In the second part of this study, 16 preparations were treated with 
10~ omeprazole (Astra, Hasle) after 40 minutes of basal secretion. 
Twenty minutes later, half of these were stimulated with 3x10·1M 
carbachol while the other eight received 10·9M cholecystokinin. The 
omeprazole was initially dissolved in methanol, but was then 
diluted in Ringer's solution so that the final methanol 
concentration in the submucosal solution was only 0.05%. Measured 
pepsinogen and acid secretory rates were normalized to the basal 
rates of each preparation as recorded during the initial forty o 
sixty minutes after equilibration. Since data were not normally 
distributed, statistical analysis was performed by Wilcoxon signed 
rank and Wilcoxon rank sum tests. Ninety-five percent confidence 
intervals were also determined nonparametrically. 
RESULTS 
The mean basal rate of pepsinogen secretion of these preparations 
was O. 07±0. 01 uni ts hr·1cm·2 while the unstimulated acid secretory 
rate was O. 43±0 .18 ueq H+ hr·1cm·2 • The equilibrium transmucosal 
potential difference ranged from -20 to -40 mv with tissue 
resistances of 40 to 100 Ohm x cm2 • In none of the studies 
conducted was there any significant difference between the 
electrical characteristics of control and experimental tissues. 
Ninety-five percent confidence intervals for acid and pepsin 
secretion in these experiments are shown in Table 1. 
Histamine at 10~ concentrations increased acid secretion by a 
factor of 5.1 (p<0.01) but had no significant effect on pepsinogen 
secretion (p>0.4). Dithiothreitol increased neither the secretion 
of pepsinogen nor the secretion of acid (p>0.4 for both). 
Cholecystokinin at 10·9M stimulated pepsinogen secretion by a factor 
of 9.1 (p<0.01) without altering acid secretion. Similarly, 
cholecystokinin at 10~ had no effect on acid secretion in this 
system but increased pepsinogen release to 23.1 times the basal 
rate (p<O. 01) . Carbamylcholine at 3 x 10·1M raised acid secretion 
by a factor of 4.0 (p<0.01) and pepsinogen secretion by a factor 
of 10. 9 (p<O. 01) (Fig. 1) . None of these agents significantly 
altered transmucosal potential difference or tissue resistance. 
Omeprazole decreased acid secretion to below measurable levels 
within ten minutes of administration in all preparations. 
Pepsinogen secretion in omeprazole-treated tissues was 1.8 times 
control levels but this was not statistically significant (p>0.05) 
(Table 1). Omeprazole-treated tissues secreted no measurable acid 
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even after exposure to 3xl0"7M carbachol. However, these tissues 
did secrete pepsinogen in response to carbachol, increasing 
pepsinogen secretion by a factor of 10.0, which was unchanged from 
stimulation in mucosal sheets treated with carbachol alone (Fig. 
2) . The omeprazole-treated tissues exposed to 10·9M cholecystokinin 
also secreted no acid but increased pepsinogen secretion by a 
factor of 9 .1 afterstimulation with cholecystokinin (Fig. 3). 
Thus, omeprazole had no statistically significant effect on the 
stimulation of pepsinogen secretion by these doses of carbachol and 
cholecystokinin. There was also no significant alteration in 
potential difference or electrical resistance in these tissues 
during omeprazole pretreatment and subsequent carbachol and 
cholecystokinin treatment. 
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Figure 2. Carbachol (CARB) Jx10·1M stimulates both pepsinogen (mean over 20 min normalized to basal) and acid (peak secretory rates normalized to basal) secretion. omeprazole 104M (OM) abolishes measurable acid secretion without altering basal pepsinogen secretion. Tissues treated with omeprazole and then exposed to carbachol (Omep + CARB) still secrete no measurable acid but increase pepsinogen secretion indistinguishably from control tissues treated with carbachol. Values represent means and standard errors from eight preparations each. 
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Figure 3. Cholecystokinin-8 ( CCK) 10·9M releases pepsinogen (mean 
over 20 min normalized to basal) without affecting acid secretion 
(peak secretory rates normalized to basal). omeprazole (Omep; 
10~) had no effect on basal pepsinogen secretion despite complete 
abolition of acid secretion. Tissues treated with omeprazole and 
then with 10·9M cholecystokinin (Omep + CCK) responded to 
cholecystokinin as did control preparations. Values represent 



























Figure 4. Tissues treated with cholecystokinin (CCK; 10·9M) 
together with 10~ histamine demonstrate an acid secretory response 
equivalent to tissues treated with lO°"'M histamine alone and a 
pe~sinogen secretory response equivalent to tissues treated with 
lO""M cholecystokinin-octapeptide alone. Values represent means and 
standard errors for eight preparations each. 
DISCUSSION 
The guinea pig intact mucosal sheet is an in vitro model which is 
more isolated and better controlled than intact animal preparations 
and yet preserves normal tissue morphology and polarity (15]. It 
is thus ideally suited to illuminate reported contrasts between in 
vitro and in vivo results. The transmucosal potential differences 
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and electrical resistances of the preparations used for these 
experiments were comparable to previous work with this model 
[15,16]. 
The observation of stable potential differences and tissue 
resistances demonstrates the continued viability of the mucosal 
preparations. In addition, the fact that electrical 
characteristics were unchanged during acid stimulation by carbachol 
and histamine suggests that acid secretion contributes little to 
the transmucosal potential difference exhibited by mammalian 
gastric mucosa. This is consistent with Rehm's hypothesis that 
this electrical gradient is primarily dependent on an active 
chloride pump distinct from the cation exchange which drives acid 
secretion [ 17] . Recent studies of chloride fluxes in 
omeprazole-treated bullfrog gastric mucosa have further 
substantiated Rehm's model [18]. 
The doses of 10~ histamine and 10-8M cholecystokinin chosen for 
this study are maximal for this system while 3 x 10-7M carbachol and 
10-9M cholecystokinin represent ED
50 
doses [ 16]. Histamine and 
cholecystokinin concentrations were initially maximized to optimize 
the likelihood of demonstrating pepsinogen or acid secretory 
effects with these agents. ED
50 
doses of carbachol and CCK were 
subsequently chosen to facilitate inhibition by omeprazole. The 
omeprazole dose utilized here is comparable to and consistent with 
that used in other in vitro systems [18,19]. 
Carbamylcholine stimulated the secretion of both acid and 
pepsinogen. However, histamine stimulated acid secretion in this 
system without any observable effect on pepsinogen secretion. 
Cholecystokinin, in contrast, was a potent pepsigogue for the 
intact fundic mucosal sheet despite its inability to alter acid 
secretion. Omeprazole is a powerful proton pump inhibitor which 
decreases acid secretion in vitro even below unstimulated levels 
[ 20] . 
Omeprazole decreased acid secretion by the isolated fundic mucosal 
sheet to undetectable levels. Despite total inhibition of acid 
secretion, basal pepsinogen secretion continued unabated in the 
presence of omeprazole and omeprazole-treated mucosae responded 
normally to 10-9M cholecystokinin. Furthermore, al though omeprazole 
also abolished any measurable acid secretory response to 
carbamylcholine, the pepsigogic potency of this cholinergic agonist 
was identical to that seen in preparations not treated with 
omeprazole. 
The results of the carbachol, cholecystokinin and histamine 
experiments are consistent with previous studies in the isolated 
mucosal sheet ( 15] and in isolated gastric gland suspensions 
[21-23]. These data suggest that although pepsigogic stimulation 
may sometimes coincide with the stimulation of acidsecretion, 
increased acid secretion is neither necessary nor sufficient to 
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increase pepsinogen secretion, even in intact mucosa. 
Furthermore, the absence of any effect of omeprazole on basal 
pepsinogen secretion or on its stimulation by carbachol or 
cholecystokinin suggests that pepsinogen secretion is 
independent of even a minimal tonic level of acid secretion. 
It therefore seems unlikely that parietal cell acid secretion 
is related to chief cell pepsinogen secretion or to the 
release of pepsinogen from the fundic mucosa in any direct or 
causal fashion. Previous observations in vivo and in isolated 
stomach preparations of close parallels between acid and 
pepsin secretion [6,7] and inhibition of pepsin secretion by 
H2 blockers [8-10] and proton pump inhibitors [11,12] cannot 
be denied. However, the results of this study would seem to 
render the "acid washout effect" an untenable hypothesis. 
Alternative explanations for reports of simultaneous increases 
in acid and pepsin secretion must therefore be postulated. 
Some agents (e.g. carbamylcholine) may have parallel effects 
on parietal cells and chief cells by coincidence or by virtue 
of sharing similar receptor and/or intracellular second 
messenger systems. Alternatively, agents which do not act on 
the chief cell directly may cause in vivo release of 
pepsinogen by stimulating submucosal neurons to release such 
primary pepsigogues as acetylcholine or cholecystokinin. Such 
effects would be absent in isolated glands or mucosa! sheets 
from which the submucosa and serosa have been removed. 
Furthermore, luminal acid may itself be a potent pepsigogue 
in vivo [24]. While it might be argued that this observation 
reflects release rather than secretion, the report that this 
response is blocked by atropine suggests that it is unlikely 
to represent toxic chief cell lysis [25]. Similar activity 
has been demonstrated in isolated gastric glands [26] and in 
rabbit mucosa! biopsies [27]. An increase in gastric acid 
secretion by an acid-agonist or a decrease by an acid-blocking 
agent might therefore alter pepsinogen secretion not because 
the experimental agent acts on the chief cell but through 
changes in local hydrogen ion concentration. Such effects are 
eliminated in the Ussing chamber by autotitration to a 
constant "luminal" pH. 
Acid in the duodenum has also been reported to release such 
pepsigogues as CCK [ 28] and vasoactive intestinal peptide 
[29]. Acid-pepsinogen parallels in vivo might also be 
mediated by these processes. 
These results show that, while agents such as carbamylcholine 
may stimulate acid and pepsinogen secretion together, acid 
secretion is, in fact, neither necessary nor sufficient for 
basal or stimulated pepsinogen secretion in isolated guinea 
pig fundic mucosae. Thus, if acid and pepsin secretion change 
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simultaneously in vivo, explanations other than "acid washout" 
must be sought [30]. 
In addition to illuminating the processes of mammalian 
secretion, the demonstration of the independence of pepsin 
secretion from parietal cell function is of potential clinical 
significance for the treatment of gastric ulcer disease, 
towhich abnormalities in pepsin production have been linked 
[31-33]. Although gastric ulcers are clearly not a disease 
of overproduction of acid, most treatment modalities for 
patients with gastric ulcers still aim at preventing or 
neutralizing this acid. These results suggest that attempts 
to block acid secretion may not prevent the release of 
pepsinogen, a likely cofactor for at least some mucosal 
lesions. 
It is impossible to ignore the likelihood that the secretion 
of a major proteolytic enzyme in such large quantities may 
play a role in the pathogenesis of gastrointestinal mucosal 
disease. Further delineation of the exact secretory mechanism 
for pepsin is required to allow formulation of 
pharmacotherapeutic probes to ablate intragastric peptic 
activity. 
SUMMARY 
In vivo observations have suggested that acid secretion may 
potentiate pepsinogen release. We measured pepsinogen and 
acid secretion by guinea pig fundic mucosal sheets stimulated 
by 10-4M histamine, 10-8M and 10-9M cholecystokinin, and 3xl0-7M 
carbamylcholine and then investigated the effects of 10-
4M 
omeprazole on basal, carbachol-stimulated, and 
cholecystokinin- stimulated secretion. Histamine increased 
basal acid secretion five-fold (p<0.01) without altering 
pepsinogen secretion. Cholecystokinin did not stimulate acid 
secretion but increased persinogen secretion by factors of 
23 .1 at 10-8M and 9 .1 at 10- M (both p<O. 01) . Carbamylcholine 
increased acid secretion and pepsinogen secretion by factors 
of 4.0 and 10.9, respectively (both p<0.01). Pretreatment 
with 10-4M omeprazole abolished basal and carbachol-stimulated 
acid secretion. However, pepsinogen secretion was unaffected 
(p>0.05). Furthermore, omeprazole treated tissues increased 
pepsinogen secretion by factors of 10. O with 3xl0-7M carbachol 
and 9 .1 with 10-9M cholecystokinin (both p<O. 01) . Thus, basal 
and secretagogue-stimulated pepsinogen secretion appear 
independent of acid secretion in intact guinea pig mucosa. 
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CHAPTER 15 
Effects of Cholecystokinin and 
Cholinergic Receptor Blockade on 
Guinea Pig Pepsinogen Secretion 
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INTRODUCTION 
Cholecystokinin is one of many peptides that stimulate 
mammalian pepsinogen secretion in pharmacologic doses in 
vitro. Although cholecystokinin has been reported to 
stimulate pepsinogen secretion in isolated rabbit and rat 
gastric gland and cell preparations [1,2,3], the 
concentrations employed have generally been high. Furthermore, 
isolated intact frog esophageal mucosa, which has been an 
important model for pepsinogen secretion, does not respond to 
CCK at all (4]. CCK has been variously reported to stimulate 
( 5], to have no effect on ( 6], and even to inhibit [ 7] 
pepsinogen secretion in man. The disparity and inconsistency 
of these findings has cast doubt on the role of 
cholecystokinin in the physiologic regulation of mammalian 
pepsinogen secretion. 
In separate studies, cholecystokinin has been reported to 
decrease pentagastrin-stimulated pepsinogen secretion in 
humans, possibly by a competitive inhibition (6,7]. Questions 
of specificity of action and primary role for CCK have 
therefore been addressed. Thus, Praissman and Walden (8] found 
significant differences in the affinity of labelled CCK and 
gastrin for guinea pig fundic glands. In addition, they 
noted differences in binding and dissociative behavior by 
Scatchard plot analysis. They inferred the existence of a 
common binding site with differences in affinities rather 
than two separate receptors. The demonstration of apparent 
competitive inhibition of pentagastrin in vivo by CCK together 
with the possibility of a single common receptor might 
therefore lead to the speculation that CCK stimulates 
pepsinogen secretion through gastrin receptors as opposed to 
specific CCK receptors. 
L364, 718 is a potent new non-peptide cholecystokinin 
antagonist which is highly specific for peripheral 
cholecystokinin receptors ( 9] . The purpose of this study was 
two-fold: first, to determine whether intact guinea pig fundic 
mucosa would secrete pepsinogen in response to CCK-8 in a dose 
dependent manner, and second to determine whether pepsinogen 
secretion could be inhibited by specific blockade of the CCK-8 
receptor using a high affinity, high specificity antagonist, 
L364,178. To answer these questions, I used isolated intact 
sheets of guinea pig fundic mucosa mounted in Ussing chambers, 
a newly developed model for mammalian pepsinogen secretion 
[ 10, 11] . The effects of carbamylcholine, atropine, 
pentagastrin and gastrin-I were also studied to further 
validate the model and to demonstrate the viability and 
responsiveness of the preparations and confirm the specificity 




Six untasted Hartley strain guinea pigs weighing 150-200 grams 
were decapitated and 1 cm2 pieces of gastric fundic mucosa, 
stripped of its serosa and smooth muscle, were extracted by 
homogenization and freeze thawing in a solution of 0.1% Triton 
X dissolved in O.OlM HCl with a pH of 2.0. After 
centrifugationat 1700 g and decanting, the supernatant 
extracts were assayed for peptic activity as were the gastric 
contents of each animal. In addition, samples of gastric 
juice from these animals were titrated with 0.1 M NaOH to a 
pH of 3, 5 and 7 and assayed after 40 minute incubations at 
37°C in order to investigate the pH stability of guinea pig 
pepsin. 
Mucosal Preparations (Previously described in detail) 
Each preparation was allowed to equilibrate until potential 
difference, tissue resistance and acid secretion had achieved 
a steady plateau for at least 30 minutes. (This generally 
required about two hours.) All fluids were then changed and 
0.3% casein hydrolysate (Sigma, st. Louis) was added to the 
luminal side to saturate protein binding sites. Samples 
(lOOul) of the luminal solution were taken every twenty 
minutes thereafter. Experimental agents were added to the 
submucosal solution at twenty minute intervals after the 
first two time points (forty minutes). 
In extensive preliminary investigations (data not shown), I 
have demonstrated that these preparations regularly maintain 
steady electrical characteristics and a constant rate of acid 
and pepsinogen secretion for up to 180 minutes after the 
post-equilibration fluid change. 
EXPERIMENTAL DESIGN 
Cholecystokinin-8 (Sincalide) was obtained from Squibb 
Diagnostics (New Brunswick, NJ) , carbamylcholine and gastrin-I 
from Sigma (St. Louis) and pentagastrin (Peptavulon) from 
Ayerst (NY, NY). Dose response curves for pepsinogen 
secretion were generated for each secretagogue using 
concentrations from 10·1°M to 3 x 10~ for CCK-8, from 10.7M to 
3 x 10~ for carbachol, and from 10·8M to 10~ for 
pentagastrin. In addition, gastrin-I was tested at 10~. 
Each preparation was studied in the unstimulated state, after 
addition of dithiothreitol (vehicle for CCK, gastrin-I and 
pentagastrin preparations) and for up to four secretagogue 
concentrations in increasing doses. Sufficient experiments 
were done with varying concentrations of secretagogues so that 
at least seven observations were available for each 
-215-
secretagogue dose. 
In addition, to evaluate the possibility that tachyphylaxis 
might interfere with the efficacy of the secretagogue doses 
in this sequential dose response model, the effects of 10-9M 
cholecystokinin in six preparations not previously treated 
with carbachol were compared with the effects of the same dose 
of CCK in preparations used in the sequential dose response 
experiments. A similar comparison was made between three 
preparations treated with 10~ carbachol 20 minutes after 3 
x 10-7M carbachol and three not so pretreated. 
Six preparations were then treated with 10-5M L364, 718 (gift 
from Dr. V.J. Lotti, Merck, Sharpe and Dahme, West Point, 
Pa.). This was followed twenty minutes later by the addition 
of 3 x 10-9M CCK (near-maximal) and twenty minutes after that 
by 3 x 10-7M carbamylcholine (ED
50
). The bathing fluids were 
not changed during this experimental period. An additional 
six preparations were similarly treated with 10-5M 
atropine, followed at twenty minute intervals by 3 x 10-7M 
carbamylcholine and 10-9M cholecystokinin. 
Dithiothreitol (BioRad Laboratories, Richmond,CA) was added 
to the nutrient solution to a concentration of 0.001% in all 
experiments in which cholecystokinin, gastrin-I, and 
pentagastrin were used to prevent oxidation of these agents 
[ 13] . 
Pepsinogen Assay (Previously described in detail) 
DATA ANALYSIS 
Acid secretion was measured continuously using pH stat 
technique and is reported here as the peak rate of acid 
secretion over each twenty minute interval. Pepsinogen 
secretion, on the other hand, was measured incrementally by 
subtracting each sampled pepsinogen concentration from that 
in the sample taken twenty minutes previously. Pepsinogen 
secretory rates therefore reflect mean rates over each twenty 
minute period rather than peak rates as with acid secretion. 
The twenty minute intervals for measurement were used after 
each addition of secretagogue or inhibitor as well as during 
basal measurements. 
The rates of acid and pepsinogen secretion in each preparation 
were then expressed as multiples of the basal (unstimulated) 
rate in each experiment. This was measured during the first 
forty minutes of the experimental period. Non-normal data 
distribution required nonparametric data analysis. Dose 
response data (7-13 experiments per data point) were ranked 
and analysis of variance was performed on the ranks to 
demonstrate that these groups of experiments contained 
statistically meaningful data. Least significant difference 
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(LSD) tests were then performed at a 95% confidence level on 
the ranked data ( 14] . A computerized statistical analysis 
package (Statistical Analysis System, SAS Institute, Cary, 
North Carolina) was used for statistical computation. ED
50 doses for carbachol and CCK were estimated from best fit 
linear regressions performed on scatterplots including all 
measured secretory rates for all dose response experiments. 
For inhibitory experiments (6 experiments each), data within 
each sequence of experiments was handled similarly to the dose 
response data. Two sample Wilcoxon rank-sum tests were then 
used to compare inhibitor-treated agonist stimulation with 
uninhibited agonist stimulation from separate experiments. 
A two sample Wilcoxon rank-sum test was also used to assess 
the statistical significance of the response to the single 
dose of gastrin-I tested. 
RESULTS 
The pepsinogen content of the guinea pig gastric mucosa was 
700 ± 50 units gm·1 wet weight (n=6, mean± SEM) or 21.6 ± 1.6 
units cm·2 (mean ± SEM). The peptic activity of six guinea pig 
gastric juice specimens averaged 23. 5 ± 4. 2 units m1"1 • 
Initial studies of the pH stability of the peptic activity in 
guinea pig gastric juice demonstrated significant inactivation 
at neutral pH. After titration to pH 5, the peptic activity 
recoverable from the same samples was only 18.7 ± 3.1 units 
ml"1 • Titration to pH 7 further diminished this activity 
toll.5 ± 3.6 units ml~. 
Preliminary experiments also demonstrated a 30% increase in 
recovered peptic activity when 0.3% casein hydrolysate was 
added to the luminal solution to prevent non-specific binding 
to glass surfaces. This had no effect on acid secretory rates 
or the electrical characteristics of the membrane. 
All further experiments were accordingly performed with 0.3% 
casein hydrolysate in the luminal saline and with the pH of 
the luminal saline maintained at 5 by pH stat technique. 
Under these conditions, the basal rate of pepsinogen secretion 
was 0.068 ± 0.017 units cm·2 hr·1 (n=58, mean± SEM). The basal 
acid secretory rate was O. 56 ± o. 01 ueq H+ cm·2 hr·1 • The 
equilibrium transmucosal PD ranged from 20 mV to 35 mV for 
these preparations and the tissue resistance from 30 ohm-cm2 
to 110 ohm-cm2 • 
Dose-response experiments demonstrated pepsigogic stimulation 
by CCK-8 with an ED
50 
of 10·9M and maximal activity at 10~ 
(Fig. 1) . Analysis of variance yielded p<O. 0001. LSD testing 
showed all doses of CCK tested (but not OTT alone) to be 
significantly different from unstimulated secretion with 95% 
confidence. CCK-8 had no discernible effect on acid secretion 
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or the electrical characteristics of the membranes. The 
dithiothreitol in the nutrient solution had no significant 
effect on basal acid or pepsinogen secretion or the electrical 
characteristics of the membrane. Tachyphylaxis studies with 
10~ CCK-8 demonstrated that 6 preparations not previously 
treated with a lower dose of CCK-8 stimulated pepsinogen 
secretion by a factor of 9.3 ± 3.1, not significantly 
different from the 12. 1 ± 3. 3 fold increase seen in the 
sequential dose response experiments. 
Carbamylcholine stimulated both pepsinogen secretion and acid 
secretion maximally at 10~ (Fig. 2,3). Analysis of variance 
confirmed the significance of these results to p<0.0001. LSD 
testing with 95% confidence confirmed that all doses of 
carbachol except 10·1M caused significantly different acid and 
pepsinogen secretion from basal. Of 11 mucosal sheets exposed 
to this concentration, seven increased acid and pepsinogen 
secretion while four were unaffected. Carbachol at 3 x 10·1M 
concentrations produced a mean decrease of -2 mV in the 
potential difference (p<O.l) and no measurable alteration in 
tissue resistance. 
At 10~ and 3 x 10~ concentrations, the mean decreases in 
potential difference were -4 mv and -7 mV respectively (both 
p<0.05) with increases in tissue resistance by a factor of 1.4 
± 0.3 and 1.8 ± 0.5 respectively (both p<0.05). 
In tachyphylaxis studies using carbachol at 10~ 
concentrations, three preparations treated initially with this 
concentration of carbachol stimulated acid secretion by 
factors of 3.5, 6.4 and 4 respectively (mean 4.7) while three 
preparations pretreated with 3x10·1M carbachol increased acid 
secretion by factors of 5.0, 4.5 and 4.1 (mean 4.5). 
Similarly, pepsinogen secretion increased by factors of 11.1, 
30 and 22.3 over basal (mean 21.1) in preparations treated 
initially with 10~ carbachol while preparations pretreated 
with 3x10·1Mcarbachol then increased pepsinogen secretion by 
factors of 18.2, 28.5 and 14.3 (mean 20.3) over basal. 
Pentagastrin had no measurable effect on acid or pepsinogen 
secretion or electrical characteristics in concentrations from 
10·9M through 10~ (data not shown) . Gastrin-I at 10~ 
increased acid secretion by a factor of 1.12 ± 0.04 (p<0.05) 
but had no measureable effect on pepsinogen secretion or on 
the electrical characteristics of the tissues. 
L364, 718 at 10·5M had no significant effect on basal acid 
secretion or on transmucosal potential difference or 
resistance. Preparations pretreated with L364,718 continued 
basal rates of pepsinogen secretion and were uniformly unable 
to increase pepsinogen secretion in response to a near maximal 
dose of CCK-8 (Fig. 4) . The same tissues which had been 
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pretreated with L364,718 and which were unresponsive to CCK-8 
subsequently responded to 3 x 10·1M carbamylcholine with 
pepsinogen secretory activity not significantly different from 
control preparations stimulated with carbamylcholine (Fig. 4). 
L364, 718-treated preparations also responded to 3 x 10·1M 
carbachol by increasing acid secretion by a factor of 5.0 ± 
1. 3. This was not significantly different from the acid 
secretory response of control preparations on stimulation 
with 3 x 10·1M carbachol ( 5. 9 ± 1. 8 fold) . Each preparation 
exhibited unchanged electrical parameters consistent with 
viability throughout these experiments. Analysis of variance 
yielded p<0.0001 for both acid and pepsinogen secretory 
patterns while LSD testing showed only carbachol stimulation 
to yield secretion significantly different from basal 
secretion. 
Atropine at 10·5M did not alter acid or pepsinogen secretion 
or tissue electrical characteristics. After treatment with 
10·5M atropine, preparations did not increase the secretion of 
acid (1.0 ± 0.1 times unstimulated) or pepsinogen (1.0 ± 0.2 
times unstimulated) when treated with 3 x 10·1M carbamylcholine 
(Fig. 5). The subsequent addition of 10~ cholecystokinin to 
these preparations increased pepsinogen secretion by a factor 
of 10 .1 ± 2. 7 (not significantly different from control 
preparations which increased by 12.1 ± 3.3) without changing 
acid secretion (Fig. 5). Again, electrical parameters 
remained steady throughout. Analysis of variance confirmed 





























us OTT -10 3x-10 -9 3x-9 -8 3x-8 
CCK-8 (log molar) 
Figure 1. Increasing concentrations of CCK-8 stimulate 
pepsinogen secretion. Values shown represent mean± SEM for 
seven to thirteen preparations and are all significantly 
different from unstimulated (US) (p<O. 05) except for the 






























us -7 3x-7 -6 3x-6 
carbachol (log molar) 
Figure 2. carbamylcholine stimulates pepsinogen secretion. 
All values differ significantly from unstimulated (US) 
(p<O. 05) except that for carbachol at 10"7M. Values shown 
represent means± SEM for 7 to 13 preparations. 
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Figure 3. Carbamylcholine stimulates acid secretion. All 
values differ significantly from unstimulated (US) (p<0.05) 
except that for carbachol at 10·1M. Values shown represent 


































Figure 4. Preparations treated with 10"5M L364, 718 do not 
secrete pepsinogen in response to 3 x 10~ CCK-8 but do 
respond to 3 x 10·1M carbamylcholine. (Values are means ± SEM, 
n=6). The values shown for CCK and carbachol alone come from 
separate control preparations, normalized to their basal 
secretory rates. (n=6) Non-parametric analysis demonstrates 
no difference between the responses to carbachol in control 
and experimental preparations but significant differences 
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minutes I 3x10-7M 10-9M 
I 
Figure 5. Mucosae treated with 10·5M atropine do not secrete 
pepsinogen when exposed to 3 x 10·1M carbamylcholine but 
respond to 10"9M CCK-8. (Values are means ± SEM, n=6). Values 
for carbachol and CCK-8 shown come from separate control 
preparations (n=6). CCK responses are statistically 
equivalent with or without atropine while the carbachol 
responses differ significantly (p < o. 01) . US represents 
unstimulated or basal secretion. 
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DISCUSSION 
Ussing chamber preparations of amphibian gastric mucosa are 
an established model for the study of gastric physiology 
(15,16] and preparations of frog esophagus have been shown to 
secrete pepsinogen in similar conditions [4,17]. There are, 
however, to my knowledge no studies of pepsinogen secretion 
in intact mammalian tissues in the Ussing chamber. 
Rutten and Ito (12] have described the preparation of guinea 
pig gastric mucosa for the Ussing chamber. The viability and 
utility of this model for the study of acid secretion (18] and 
gastric erosion ( 19] have been demonstrated. The basal 
electrical characteristics and acid secretory rates of the 
tissues used for these experiments were similar to those 
previously described and have previously been well 
characterized (12,19]. The present study extends this model 
to the measurement of pepsinogen secretion. Sampling 
intervals of twenty minutes were chosen based on time sequence 
data (20,21] which suggests maximal secretion over this period 
after pepsigogic stimulation in guinea pig gastric glands and 
isolated chief cells. The luminal pH of 5 was chosen for these 
experiments to avoid the inactivation of pepsin at high pH and 
the underestimation of acid secretion by autotitration at low 
pH (5). 
The mucosa of the frog esophagus has been reported to contain 
0.52 - 2.32 mg/cm2 of pepsinogen depending on the season (17]. 
If the Sigma pepsinogen preparation used to standardize these 
reports was of approximately the same purity as that used by 
us, then the guinea pigs studied here had less than one 
hundredth of the pepsinogen present in the frog esophagus. 
The pepsinogen assay used for these experiments was therefore 
adapted to the detection of nanogram quantities of pepsinogen 
as secreted by guinea pig fundic mucosa. The assay was 
sensitive and precise under these conditions to 0.005 units 
of peptic activity/ml and was useful from 0.01 units/ml to 10 
uni ts/ml. The 125I-albumin assay is considerably more 
sensitive and precise than the colorimetric hemoglobin-based 
method of Anson and Mirsky (23] frequently used to measure 
secreted pepsinogen. In addition, large numbers of samples 
can be easily processed using this technique. Albumin bound 
to 131 I has been used ( 22] for the measurement of peptic 
activity in human urine but 125I-albumin has a longer half life 
(60 days) and it can be measured with relative simplicity by 
gamma counting. An assay has also been described based on 
14-C methylated hemoglobin ( 24] . Al though this technique 
might be similarly modified to adjust its sensitivity, the 
albumin-based assay is less expensive and does not require 
liquid scintillation counting. In addition, albumin 
precipitates more easily than hemoglobin with trichloracetic 
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acid so that a brief centrifugation may be substituted for 
filtration to remove the undigested label. 
The stable electrical characteristics and carbachol-responsive 
acid secretion of the guinea pig mucosae mounted in Ussing 
chambers indicate that these tissues were viable. However, 
unstimulated guinea pig mucosae secreted approximately 0.3% 
of their total pepsinogen content per hour. This is only 
slightly lower than and roughly comparable to the 0.4-3.0% per 
hour reported for guinea pig gastric glands [20], guinea pig 
chief cells [21] and rabbit gastric glands [24]. 
Frog esophageal mucosa, on the other hand has been reported 
to release 1.6-1.9% of total pepsinogen content per hour in 
Ussing chambers [17]. The etiology of this higher amphibian 
basal secretory rate is unclear. 
The present study shows that CCK-8 can stimulate peRsinogen 
secretion in vitro at concentrations as low as 10- M while 
carbachol was clearly effective at 3 x 10-7M in this 
preparation and appeared variably effective at 10-7M. The 
variable efficacy of 10-7M carbachol is consistent with 
previous studies on acid secretion in guinea pig mucosal 
sheets [18]. 
Raufman [21] has characterized pepsinogen secretion in 
dispersed guinea pig chief cells in response to CCK-8 and 
carbachol. CCK-8 produced detectable stimulation of 
pepsinogen secretion at 30 pM and maximal stimulation at 3 uM 
in Raufman's data while carbachol was initially effective at 
0.3 uM and appeared maximal at 30 uM. Although such doses are 
similar to those employed in this study, maximal stimulation 
in the guinea pig chief cells produced secretion only six-fold 
over basal, comparable to studies in isolated rabbit and rat 
glands [24,25,26] but significantly lower than the twenty 
eight to forty-fold increases over basal demonstrated in our 
preparation. This may stem from some combination of an 
increased responsiveness to pepsigogic stimuli and lower basal 
rates of pepsinogen release from undamaged mucosae. Isolated 
gastric gland and cell suspensions require prolonged 
mechanical and enzymatic disruption which may damage membrane 
receptors or otherwise injure the chief cell. The sequential 
use of increasing agonist concentrations in the same 
preparation to study dose responsiveness raises the 
possibility that tachyphylaxis might have interfered with the 
accuracy of the carbachol and cholecystokinin data reported 
here. However, 10-6M carbachol was not less potent when 
administered after 3xl0-7M carbachol than when administered 
separately and 10-9M CCK was not less potent in sequential 
dosing than when administered alone. 
In addition, the equivalent effects of 3xl0-7M carbachol and 
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10~ and 10·8M CCK in dose response studies and when used as 
positive controls for inhibitor studies also argues against 
significant tachyphylaxis. Furthermore, even if ECSO values 
had been underestimated by this technique, this would have no 
implication for the fundamental findings of receptor 
specificity which this investigation is intended to address. 
Frog esophageal mucosa mounted in Ussing chambers has been 
reported not to respond to cholecystokinin at all [4]. This 
may represent a species difference since the histology of 
pepsinogen secretion differs considerably between amphibians 
and mammals. Frog stomachs, for instance, secrete both acid 
and pepsinogen from a single cell type, the oxynticopeptic 
cell [ 27] . Such anatomic variation may signal important 
physiologic differences as well. The interpretation of 
amphibian studies and their extrapolation to mammalian 
physiologic processes may therefore require caution. 
In these studies, L364,718 blocked CCK-stimulated pepsinogen 
secretion in the intact mammalian mucosal sheets without 
interfering with another calcium-mediated pepsigogue, 
carbachol. L364,718 has previously been shown in vitro and 
in vivo to be highly specific for peripheral CCK receptors, 
binding neither to central nervous system CCK receptors nor 
to receptors for gas tr in and other peptide hormones [ 9] . 
That the observed L364,718 suppression of CCK-responsiveness 
represents a toxic effect is highly unlikely given the 
maintenance of normal acid secretion, basal levels of pepsin 
secretion, and unchanged electrical characteristics of the 
L364,718-treated tissues as well as their unimpaired ability 
to secrete acid and pepsinogen in response to cholinergic 
stimuli. 
The demonstrated atropine blockade of cholinergic stimulation 
of acid and pepsinogen secretion without alteration of the 
secretagogue effect of cholecystokinin further validates this 
model for the study of pepsinogen secretion. In addition, 
this confirms that the carbamylcholine release of pepsinogen 
used as a control for viability in the L364,718 experiments 
is a receptor-mediated effect rather than a toxic lysis of 
chief cells. 
The inability of this preparation to produce a measurable 
response to pentagastrin, a potent secretagogue in vivo, or 
to gastrin-I, which did stimulate acid secretion slightly but 
had no effect on pepsinogen secretion, is disappointing but 
not unexpected. Pentagastrin and gastrin have been reported 
by several investigators to be at best minimally effective in 
rabbit isolated glands [2,24,28]. Pentagastrin produced only 
a slight increase in acid secretion in another study of guinea 
pig gastric mucosal sheets [18]. The question of why in vitro 
preparations are not more responsive to gastrin remains 
unanswered. However, cholecystokinin is unlike gastrin and 
clearly does stimulate pepsinogen secretion in vitro. 
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Furthermore, this response is blocked by a CCK-receptor 
specific blocking agent. 
Our data, therefore, supports the hypothesis that 
cholecystokinin stimulates pepsinogen secretion in this mQdel 
via its own receptor rather than through cross reactivity with 
a gastrin receptor. Unlike its frog esophageal counterpart, 
the intact guinea pig fundic mucosa! sheet is highly sensitive 
to cholecystokinin. (The Ussing chamber-mounted guinea pig 
gastric mucosa also seems much more responsive to 
CCK-stimulated pepsinogen secretion than other in vitro 
mammalian models, perhaps because dispersed glands and cells 
may "leak" pepsinogen from damaged chief cells and 
artifactually increase basal measurements.) These data 
suggest that cholecystokinin potently stimulates pepsinogen 
secretion in mammals at relatively low concentrations. 
Furthermore, the pepsigogic effect of CCK seems mediated by 
a specific peripheral CCK receptor. Cholecystokinin is likely 
to play a role in the physiologic regulation of pepsinogen 
secretion in guinea pigs and may be hypothesized to be 
important in humans as well. 
SUMMARY 
Although cholecystokinin (CCK) has been reported to stimulate 
pepsinogen secretion, this action has been poorly 
characterized. To assess the ability of CCK to regulate 
mammalian pepsinogen secretion, guinea pig fundic mucosa was 
incubated in Ussing chambers with CCK-8, carbamylcholine and 
pentagastrin, and with cholinergic and CCK antagonists. CCK-8 
stimulated pepsinogen secretion at 10-1°M, with an ED
50 
of 10~ 
and maximally (26-fold over basal) at 10·8M. Carbachol 
stimulated pepsinogen and acid secretion with an ED
50 
of 
3xl0-7M and maximally at 10~. Pentagastrin ( 10~-10~) did 
not affect acid or pepsinogen secretion while gastrin-I (10~) 
stimulated acid secretion slightly but did not alter 
pepsinogen secretion. L364, 718 ( 10·5M), a specific CCK 
peripheral receptor antagonist, abolished all pepsigogic 
effects of 3xl0~ CCK-8 without altering basal acid or 
pepsinogen secretion or mucosa! electrical characteristics. 
L364,718-treated tissues unresponsive to CCK-8 nevertheless 
secreted pepsinogen and acid in response to 3xl0-7M carbachol 
identically to control carbachol-treated preparations. 
Atropine (10"5M) blocked response to 3xl0-7M carbachol without 
inhibiting 10·9M CCK stimulation. These results support a 
specific receptor-mediated role for cholecystokinin in the 
physiologic regulation of guinea pig pepsinogen secretion. 
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CHAPTER 16 
Pepsinogen Release and Acid 
Secretion from Human and Guinea 
Pig Gastric Mucosa Compromised by 
Hypoxia, Endotoxin or Critical Illness 
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INTRODUCTION 
Stress gastritis and acute gastric ulceration represent 
fundamental problems for critically ill patients. 60-100% of 
patients with life-threatening illnesses, major burns or 
severe injury develop gastric erosions or ulcerations [ 1, 2, 3]. 
About 20% have clinical bleeding ( 3, 4]. Acid control via 
antacids and H
2
-blockers does not always prevent these 
phenomena [3,4,5] and significant side effects and 
complications are associated with such prophylaxis (6,7,8,9]. 
In addition, critically ill or injured patients do not 
generally secrete abnormally large quantities of acid 
[2,4,10,11]. Thus, although acid may contribute to stress 
gastritis and ulceration, acid hypersecretion itself may not 
be the primary or only cause of these lesions. 
Pepsin is a powerful proteolytic enzyme with potent mucolytic 
and barrier-breaking properties (12,13]. Both epidemiologic 
(14,15,16,17] and experimental (18,19,20] evidence has linked 
pepsin to ulcerogenesis. Furthermore, pepsin secretion is 
independent of acid secretion [ 21, 22, 23, 24, 25] and recent 
evidence suggests that certain isozymes of pepsin may degrade 
gastric mucus even at a neutral pH (16,26]. Gastric antacids 
may thus not block all peptic activity. 
It was my hypothesis that chief cells exposed to noxious 
stimuli would release stored pepsinogen, thereby producing a 
potentialcofactor for the development of acute gastric lesions 
in the critically ill, septic or hypoxic patient. Gastric 
acid and pepsin release were therefore investigated in vitro 
in response to hypoxia, a common problem in severely ill 
patients (27], and to gram negative endotoxin at 
concentrations similar to those recorded in clinical sepsis 
[ 28, 29] • These studies utilized intact guinea pig fundic 
mucosal sheets mounted in Ussing chambers, a model for gastric 
acid and pepsinogen secretion (25]. To suggest the clinical 
relevance of these observations, I also present data on peptic 
activity in the gastric juice of critically ill patients. 
Although preliminary and difficult to interpret because of 
biological and ethical complexities, the finding of 
substantially increased peptic activity in clinical as well 
as in vitro situations may lend cogency to the hypothesis. 
METHODS 
Ussing Preparations 
Fundic mucosa from 200 gram Hartley female guinea pigs was 
stripped of its serosa and mounted in Ussing chambers as 
previously described (25,30]. For endotoxin studies, the 
submucosa was bathed in mammalian Ringers solution (122 mM 
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NaCl, 25 mM NaHC0
3
, 5 mM KCl, 1.3 mM MgS04 , 2.0 mM CaCl2 , 1.0 mM KH PO , 20 mM glucose) and gassed with 95% 0
2 
and 5% CO2 (buff~r~d pH 7.4, osmolarity 293 mosm/1). The luminal side 
of the tissue was gassed with pure oxygen and bathed in 154 
mM NaCl (308 mosm/1) to which was added 0.03% casein 
hydrolysate(Polypep, Sigma, st. Louis) to saturate protein 
binding sites in the chamber. Luminal pH was maintained at 
5.0 by titration with 5 mM NaOH via an autotitrator 
(Radiometer Copenhagen). Acid secretion was calculated from 
the rate of alkaline autotitration. The luminal solution was 
sampled (100 ul) at twenty minute intervals for pepsinogen. 
Potential difference (PD) and tissue resistance were monitored 
using a voltage/current clamp (DVC 1000 World Precision 
Instruments, New Haven CT) connected to the chamber by silver 
chloride electrodes in series with 4 M KCl half cells and 4 
M KCl 5% agar bridges. All fluids were maintained at 37°C by 
a circulating heated water bath. For studies on the effects 
of hypoxia, the submucosa was bathed in a crystalloid solution 









) with 20 mM glucose and 10 mM HEPES 
(pH 7. 35, osmolarity 291 mosm/1). Both sides of the membrane 
were initially gassed with pure oxygen. 
EXPERIMENTAL DESIGN 
Hypoxia studies 
Eighteen preparations were stripped, mounted and incubated 
with pure (100%) oxygen. The submucosal side of the tissues 
was bathed in HEPES-buffered balanced salt solution while 
normal saline with casein hydrolysate was placed on the 
luminal side. Tissues were allowed to recover until PD, 
resistance and acid secretion had been steady for at least 
thirty minutes (typically 120 to 180 minutes). All solutions 
were then changed and experiments were initiated after an 
additional 20minute equilibration period. Six control 
preparations were then maintained on pure oxygen for 100 
minutes. Six were switched to pure nitrogen after 40 minutes 
and six to room air (approximately 78% nitrogen and 22% 
oxygen). In each case, the rate of gas circulation was kept 
constant by gas flow regulators (Cole-Parmer, Illinois). All 
gases were similarly humidified by passage through distilled 
water. Tissues were studied for one hour after the gas 
change. 
Endotoxin Studies 
Eight preparations were allowed to equilibrate for at least 
120 minutes after mounting, until the electrical 
characteristics and acid secretion of the tissue had been 
steady for at least 30 minutes. Solutions were then changed 
and experiments commenced after 20 additional minutes of 
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equilibration. After 40 minutes of basal measurements, 0.01 
units/ml of endotoxin {Shigella flexnerii lipopolysaccharide, 
sigma, st. Louis) were added to the submucosal solution. 
Forty minutes later, 0.1 units/ml of endotoxin were added to 
the submucosal solution and measurements were made for an 
additional 40 minutes. 
At the conclusion of hypoxia and endotoxin experiments, 
tissues were fixed in the chamber with buffered formalin and 
3% buffered glutaraldehyde. Light microscopy was performed 
after staining with hematoxylin and eosin. Tissues for 
transmission electron microscopy were oriented using a 
dissecting microscope, embedded in expox 812 {E.F. Fullam, 
Inc., Latham, NY, USA) and sectioned at one micron thickness. 
These one micron thick sections werestained with basic fuschin 
and toluidine blue and examined by light microscopy for 
orientation and subselection of representative areas for 
ultrathin section. Ultrathin sections on copper grids were 
stained with osmium tetroxide and uranyl acetate and examined 
using a Phillips 300 electron microscope. 
Human studies 
Gastric juice from the nasogastric tubes of twenty randomly 
selected critically ill patients were assayed for pepsin and 
tested for pH and occult blood {by guaiac testing) . All these 
patients received standard doses of H
2 
blockers and antacids. 
Gastric fluid was also sampled from 20 randomly selected 
routine surgical patients with nasogastric tubes who were also 
receiving antacids and H
2 
blockers. Each routine patient 
appeared clinically to be convalescing well and subsequently 
recovered without complication. Nasogastric sampling was 
performed over 48 hours after surgery to obviate any effect 
of anesthesia and samples were taken at least two hours after 
antacid administration. Patient diagnoses are shown in Table 
1. 
Pepsinogen Assay 
Pepsinogen was assayed in samples from the Ussing chamber by 12!5I-albumin digestion as recently described [ 25] . Briefly, 
samples were acidified by the addition of a 0.031 M HCl / 0.05 
M KCl buffer, incubated at 37°C for twenty four hours with 12!5I-albumin, and then precipitated using 5% trichloroacetic 
acid {TCA) {0.33 M). Digested fragments of labelled albumin 
remaining in the supernatant were quantitated by 
gammascintigraphy after centrifugation at 1500 g and 
decanting. Each assay was standardized using purified porcine 
pepsinogen {Sigma) of known activity {3400 u/mg). one unit 
of peptic activity is defined as the amount needed to produce 
a change in absorbance at 280 nM of 0.001 per minute at pH 2.0 
at 37°C, measured as TCA-soluble products, using hemoglobin as 
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substrate. 
Fresh gastric Juice was centrifuged at 1500 g for 15 minutes 
to remove mucus and debris. The assay was modified for the 
higher peptic activity of gastric juice by shortening. the 
incubation with labelled substrate to 40 minutes. 2% 
unlabelled albumin was also added to the reaction mixture to 
slow the degradation of 1~I-albumin. Similar modifications of 
this assay have recently been described for measurement of 
pepsin in guinea pig gastric juice [25] and in isolated 
gastric gland preparations [24]. 
STATISTICAL ANALYSIS 
Acid secretion was measured continuously in Ussing chamber 
studies, using pH stat technique, and is reported here as peak 
acid secretion over each 20 minute interval. Pepsinogen 
secretion, however, was calculated incrementally by 
subtracting each sampled pepsinogen concentration from that 
of the prior sample. Pepsinogen secretory rates therefore 
reflect mean rates over each 20 minute period rather than peak 
rates as with acid. Statistical analysis for hypoxia studies 
was by unpaired t-testcomparing experimental values to those 
observed in control tissues. Statistical analysis for 
endotoxin experiments was by paired t-test in which each 
preparation served as its own control. Electrical 
characteristics and rates of acid and pepsinogen release for 
each time period were compared with basal parameters and rates 
recorded over the first forty minutes after equilibration of 
each preparation. Al though secretory rates expressed as 
multiples of basal levels of secretion are discussed in the 
text and portrayed graphically, raw data is shown with its 
statistical analysis in Table 2. 
Human data was analyzed by Wilcoxon rank sum tests to compare 
age, gastric pH, and pepsinogen concentration between ICU and 
"control" patients. A chi square test was used to compare the 
incidence of heme positive nasogastric aspirates between the 
two groups. Finally, Pearson correlation coefficients were 
determined for all 40 patients to seek correlations between 
gastric bleeding and intragastric pH and peptic activity. A 
computerized statistical package (Statistical Analysis System, 




Initial equilibrium potential differences (PD) of the eighteen 
oxygenated preparations for hypoxia studies were -24.5 ± 2.7 
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mv(range -16 mV to -35 mV). Equilibrium tissue resistance 
averaged 64 ± 7 ohm-cm2 • Basal acid secretion was 0.65 ± 0.06 
eq H+cm·2hr·1 • Basal pepsinogen release was O. 09 ± O. 06 
units-cm·2hr·1 • Control tissues maintained steady acid (Fig. 
1) and pepsinogen release (Fig. 2) and constant electrical 
characteristics (data not shown) for the full 100 minute 
period. 
Tissues exposed to pure nitrogen decreased PD to O within 5 
minutes while resistance increased 7.2-fold (both p<0.001). 
These values remained constant for the remainder of the 
experimental period (Table 2). Acid secretion became 
unmeasurable within five minutes after nitrogen anoxia (Fig. 
1). Luminal pepsinogen release over the three serial twenty 
minute intervals of nitrogen perfusion averaged 16.4 ± 2.9, 
15.1 ± 3.4 and 15.0 ± 3.2 times basal levels of pepsinogen 
release respectively (Fig. 2). 
Tissues gassed with room air also decreased PD and increased 
resistance within minutes of the change from oxygen (Table 2) . 
However, electrical characteristics generally became steady 
at -8. 2 ± 3 .1 mv and 244 ± 21 ohms-cm2 within 20 minutes 
(p<0.001). The PD then slowly declined by 3-4 mv over the 
remainder of the experimental period. Resistance did not 
change significantly from its initially increased value. Acid 
secretion continued at a decreased (p<0.001) rate (Fig. 1) 
while pepsinogen release rose to 4. 5 ± 1. 4 times basal 
(p<0.025) after 20 minutes of room air perfusion and then to 
11.1 ± 5.1 and 13.5 ± 7.8 times basal over the next two 20 
minute intervals (both p<0.005) (Fig. 2) .Light and 
transmission electron microscopy of control (pure oxygen) 
preparations demonstrated essentially normal gastric histology 
except for some separation between glandular uni ts. The 
lumens of the gastric glands were clear and lined by normal 
microvilli on electron microscopic study. Cell borders within 
glands were well apposed with intact tight junctions. Random 
glandular uni ts from control and experimental preparations are 
shown in Figure 3 to illustrate morphologic differences. Room 
air-treated preparations were more edematous by light 
microscopy with focal areas of nuclear and even cellular 
disruption. Parietal cells appeared more consistently damaged 
than granule-containing cells (mucus cells and chief cells). 
Electron microscopy demonstrated diminished numbers of luminal 
microvilli as well as some luminal debris. Al though the tight 
junctions were intact, significant spreading was observed 
between the cells, with an appearance somewhat like 
acantholysis. There were occasional degenerative cytoplasmic 
vacuoles with flocculent electron densities in retiform 
patterns (Fig. 3b). Nitrogen-treated tissues did not 
demonstrate the marked edema characteristic of endotoxin- and 
room air-treated preparations but were characterized by 
widespread loss of tissue architecture and cellular 
disruption. Electron microscopy demonstrated changes similar 
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to those observed in room air treated tissues but diffusely 
throughout the tissue as well as total degeneration of some 
cellular membranes, disruption of intercellular junctions, and 
abundant luminal debris including intact cellular organelles. 
Even relatively normal appearing cells had almost no 
microvilli and exhibited frequent nuclear clearing of 
chromatingranules. The damage was so widespread that 
differential_ patterns of damage to parietal cells and 
granule-containing cells could not be determined for 
nitrogen-gassed tissues (Fig. 3c). 
Endotoxin studies 
Before exposure to endotoxin, mucosae exhibited PD of -35.5 ± 1.6 mv (ranginj from -28 mv to -39 mv) and resistances of 
112 + 14 ohm-cm . Tissues secreted acid at O. 89 + O. 06 
ueq-cm-2hr-1 and pepsinogen at O. 17 ± 0. 07 uni ts-cm-2-hr-1-:- The 
effects of endotoxin are shown in Table 2. Pepsinogen release 
increased 3.3-fold during exposure to 0.01 u/ml of endotoxin 
(p<0.05). The addition of 0.1 u/ml of endotoxin increased 
pepsinogen release to 6.1-fold over basal (p<0.05) (Fig. 4). 
Acid secretion decreased to 82.1% of the basal rate with the 
0.01 u/ml dosage and was further inhibited to 67.4% of basal 
with 0.1 u/ml of endotoxin (both p<0.001) (Fig. 5). PD 
decreased dose-dependently with endotoxin exposure, achieving 
statistical significance (p<0.001) at the higher dose. 
Resistance increased with endotoxin, almost doubling at the 
high dose (p<O. 001) (Table 2) . 
Histologic study of the endotoxin-treated tissues demonstrated 
marked tissue edema with scattered foci of pyknosis and cell 
lysis. As in the room air-treated tissues, a significant 
amount of debris was observed in some glandular lumens as well 
as some loss of microvilli. Some nuclear clearing was 
observed. The majority of the mucosal cells, however, 
retained intact nuclei and appeared histologically normal 
(Fig. 3d). 
Human studies 
Demographic characteristics and data from the human studies 
are shown in Table 3. Despite some overlap (Fig. 5), mean 
intragastric peptic activity was approximately 18-fold higher 
in the critically ill patients (p<0.0001). Furthermore, the 
presence of occult blood correlated with intragastric peptic 
activity (r=0.59, p<0.0001) but not with gastric pH (r=0.04, 
p=O. 6) . 
DISCUSSION 
The intact guinea pig fundic mucosa! sheet is an established 
model for the study of gastric mucosal injury [30] and acid 
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(31] and pepsinogen secretion (25]. Basal electrical 
characteristics, and acid and pepsinogen secretory rates for 
endotoxin-treated tissues compare with previous data (25]. 
Controls for hypoxia experiments received no CO
2 to maintain comparability with the room air and. nitrogen conditions. 
Without co, these control tissues secreted less acid and had 
lower PD b~t increased resistance. Pepsinogen secretion was 
also slightly lower without CO
2 
but this did not achieve 
statistical significance (Table 2) . The changes in acid 
secretion and electrical parameters without CO
2 
are consistent 
with amphibian data (32,33] while the less significant change 
in pepsinogen secretion suggests that parietal and chief cells 
may have different CO
2 
requirements. 
Hypoxia and endotoxin each produced dose-responsive increases 
inpepsinogen release and electrical resistance while 
inhibiting acid secretion and decreasing PD. The observed 
alterations in ion transport are expected since acid secretion 
and chloride transport (reflected by PD) are energy dependent, 
requiring aerobic metabolism and sensitive to toxic stimuli. 
Similar changes in ion transport have previously been 
documented in anoxic amphibian gastric mucosa although 
pepsinogen secretion was not measured in that study ( 34]. 
Endotoxin also inhibits acid production by feline gastric 
fistulas [35] while the PD of ex vivo canine gastric flaps is 
lower during gram negative septicemia (36]. 
Pepsinogen release has not been previously studied in vitro 
under these conditions. The histologic appearance of the 
hypoxic, anoxic and endotoxin-treated tissues, together with 
the decrease in proton and chloride transport, suggests that 
the increased pepsinogen release after hypoxia or endotoxin 
exposure is likely to reflect leakage of intracellular 
pepsinogen stores from damaged chief cells. The pattern of 
increasing pepsinogen release with decreasing acid secretion 
may represent a general and non-specific response of gastric 
mucosa to noxious stimuli. 
Extrapolation to the clinical setting is desireable but must 
be cautious. The endotoxin concentrations used for these 
studies are found in septic human patients (28,29]. Although 
oxygen concentrations bubbled through a salt solution in vitro 
cannot be directly compared with interstitial oxygen tensions 
in vivo, visceral hypoxia is common in critical illness (27]. 
Gastricfundic mucosa is also more sensitive to hypoxia than 
many other tissues (37]. The in vitro conditions reported 
here may therefore be relevant to patient care. 
The data from human samples, which demonstrates an 18-fold 
increase in intragastric peptic activity in critically ill 
patients, is obviously preliminary. Its interpretation 
involves assumptions about the validity of patient selection 
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and sampling and the possibility of alternative mechanisms in 
whole organisms. 
The peptic activity in the gastric juice of my "control" 
patients is higher than that reported by Domschke [38) in the 
gastric juice of normal volunteers but lower than the normal 
range reported by Hirschowitz [39). Differences in assay 
technique and standardization between laboratories may account 
for these variations, while clearly additional investigations 
will require comparison with truly asymptomatic normal 
volunteers assayed in my laboratory as well as serial samples 
from each patient. 
Nevertheless, even the preliminary data now available strongly 
suggests that pepsinogen concentrations are abnormally 
elevated in the gastric juice of some critically ill patients. 
Other studies have documented elevated intragastric peptic 
activity in neurosurgical patients [40) and those with liver 
dysfunction [ 41). Stress [ 42, 43), adrenergic stimulation 
[44,45,46) and alterations in gastric emptying and fluid 
secretion might alter measured peptic activity, but seem 
unlikely to produce an increase of this magnitude. Thus, 
while the mechanism of theobserved increase in intragastric 
pepsinogen concentration in critical illness requires further 
investigation, both the in vitro results and the human data 
are consistent with the hypothesis that noxious stimuli may 
damage chief cells and release stored pepsinogen. 
Finally, if pepsinogen is indeed released under these 
circumstances, then the clinical relevance of gastric 
pepsinogen in acid-blocked patients must be addressed. Walker 
and Taylor [47) have demonstrated by several methods that from 
28%-80% of gastric juice peptic activity is retained at 
neutral pH. At least part of this "alkali-resistance" is 
believed due to a specific pepsin isozyme which retains 
activity at pH over 5.0 and is highly mucolytic [12,13,26). 
This isozyme has been shown to be secreted disproportionately 
by patients exposed to trauma [48) or with peptic ulcers [16) 
as well as in response to vagal stimulation [44). In addition, 
the neutralization of the gastric lumen with nasogastric 
antacids is likely to have less effect in the immediate 
microenvironment of the gastric mucosa. Behind the gastric 
mucus layer, the gastric pits may still be acid. Finally, Che 
[49) has suggested that released pepsinogen may be activated 
within the interstitium of the gastric mucosa and thus cause 
pathology even before its release into the gastric lumen. 
The proton is probably a significant cofactor in acute 
gastric mucosal pathology in critically ill patients, but acid 
hypersecretion is not the primary defect. Ethical imperatives 
prohibited interfering with antacid and H -blocking therapy 
forformal acid secretory studies but lu~inal pH did not 
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correlate with gastric bleeding in this study. Furthermore, 
gastric aspirates from patients with trauma, major burns, 
neurosurgical problems and sepsis prior to the introduction 
of current antiulcer prophylaxis also contained less acid than 
normal [10,41,50]. 
Conventional prophylaxis against gastritis may derive some of 
its potency from peptic inhibition. Elevating intragastric 
pH does inhibit or denature some pepsin isozymes [51]. 
Furthermore, H-2 blockers inhibit pepsin secretion in vivo in 
man [38,39] while antacids bind and thus inhibit luminal 
pepsin (52]. However, anti-acid prophylaxis may be 
undesireable. Gastric neutralization is associated with 
significant bacteriologic problems [7,8,9] while H-2 blockade 
itself has complications ( 6]. Intervention directed 
specifically at blocking pepsinogen release or binding luminal 
pepsin may prevent erosions with less side effects. The 
present results suggest that gastric fundic mucosa responds 
to noxious stimuli by decreasing active ion transport but 
increasing pepsinogen release. Although the latter probably 
reflects a pathologic rather than physiologic process, 
pepsinogen released in this manner may contribute to the 
development of acute gastric mucosa! lesions in critically ill 
or severely stressed patients. Pepsin blocking agents such 
as bismuth [ 53, 54] or sucralfate ( 55] may improve current 
prophylaxis against acute gastric mucosa! lesions while 
decreasing its morbidity. 
Table 1 
Diagnoses of Patients studied 
ICU Patients 
Mandibulectomy, rad neck dissection 
Massive MI, intraaortic balloon pump 
Colectomy, portal 5-FU infusion 
Head injury 
Thoracic aortic dissection 
Severe pancreatitis 





Emergency portocaval shunt 
Radical neck dissection 
Emergency coronary bypass 
after myocardial infarction 
Cholecystectomy, sepsis 
epinephrine, dobutamine drips 
Abdominal aortic aneurysm resection 
Hemicolectomy, pneumonia, sepsis 
Drug overdose 
Pneumonia, Ogilvie's syndrome 





Neg neck exploration 
Appendectomy 
Appendectomy 




Lower GI bleeding 
Hemicolectomy 
Lower GI bleeding 
Lower GI bleeding 
2 weeks after 
gastrojejunostomy 
Coma 








PD RESISTANCE PEPSIN ACID 
(-mv) (ohms/cm2) (u/cm2/hr) (ueqH+/cm2/hr)
 
ENOOTOXIN EXPTS (5% CO2) 
0 u/ml endotoxin 35.5+1.6 112+ 13 0.17+0.
07 0.89+0.06 
0.01 u/ml endotoxin 34.1+1. 4 135+16** 0.57+
0.21* 0.74+0.07** 
0.10 u/ml endotoxin 29. 9+1. 3* 190+26** 1.04+0.
55* 0.60+0.09** 
OXYGEN EXPTS (0% CO2) 
100% 02 24.5+2.7 64+7 0.09+0.
07 0.65+0.06 
Room air 3.1+2.8** 244+21** 0.33+
0.08** 0.20+0.03** 
100% N2 0.5+0.5** 460+37** 0. 57+0.
 10** O.OOS+0.005** 
*p<0.05 **p<0.001 
Age M/F 
Routine 58+6 17/3 
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Figure 2. Eighteen tissues were initially equilibrated on 
pure oxygen. six were then continued on oxygen (indicated by 
filled squares) while six were then treated with room air 
(indicated by open triangles) and six were gassed with pure 
nitrogen (indicated by open circles). Values shown represent 
peptic activity in the luminal solutions of these preparations 
normalized to each preparation's basal pepsinogen secretory 
rate (mean± standard error). 
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Figure 3. Transmission electron micrographs of representative 
glandular units from oxygenated (a), room air treated (b), 
nitrogen treated (c), and endotoxin treated (d) mucosal 
sheets. (original magnification 7,300X) Insets (22500X) 
demonstrate luminal microvillar morphology. (a) Transmission 
electron micrograph of mucosa maintained on pure oxygen 
demonstrates viable glandular histology with minimal edema and 
numerous microvilli lining the lumen. The cells shown are 
mostly surface and mucus neck cells. (b) Electron micrograph 
of room air-gassed tissue illustrates cellular damage seen in 
some areas of the mucosa. Al though nucleii and cell membranes 
appear basically intact and tight junctions persist, some 
separation is seen between cell membranes basal to the tight 
junction. Microvilli are reduced but present. Numerous 
mitochondria suggest parietal cells. (c) Electron micrograph 
of nitrogen-gassed tissue reveals loss of normal cytoskeletal 
structure with nuclear clearing, vacuolization and cellular 
debris in the gland lumen. Microvilli are absent from the 
lumen. Preserved mitochondrial structures suggest that the 
cells seen are parietal cells. (d) Endotoxin-exposed tissues 
appear less edematous with smaller glandular lumens and less 
interstitial space. Nuclei appear morphologically normal in 
most cells and cytoskeletal structure is generally intact. 
However, some cellular damage is observed. Microvilli are 
decreased but present. These may represent surface cells. 
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Figure 4. Mucosal preparations (n=S) were monitored under 
basal conditions for forty minutes, then treated with 0.01 
units/ml of endotoxin for forty minutes, and finally exposed 
to 0.1 units/ml of endotoxin for an additional forty minutes. 
Values shown represent the increase in pepsinogen secretion 
observed in each twenty minute interval expressed as multiples 














Effects of endotoxin on acid secretion 
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Figure 5. Mucosa! preparations (n=8) were monitored under 
basal conditions for forty minutes, then treated with 0.01 
units/ml of endotoxin for forty minutes, and finally exposed 
to 0.1 units/ml of endotoxin for an additional forty minutes. 
Values shown represent the increase in acid secretion observed 
in each twenty minute interval expressed as multiples of the 
basal secretory rate (mean± standard error). 
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Figure 6. Intragastric peptic activity of twenty 
ill patients is compared to that of twenty 
convalescing patients. Each data point represents 
activity of a gastric sample from a single patient 
triplicate. Means and 95% confidence intervals for 








Despite blockade and neutralization of gastric acid, acute 
gastric lesions cause substantial morbidity and mortality in 
critically ill patients. Pepsinogen release in response to 
noxious stimuli such as hypoxia and endotoxin might contribute 
to mucosa! damage. Guinea pig fundic mucosa was mounted in 
Ussing chambers. Acid secretion, pepsinogen release, 
potential difference (PD) and resistance were monitored. 
Gassing with room air or nitrogen diminished acid secretion 
and PD but increased pepsinogen release 9.7- and 15.5-fold 
respectively (both p<0.001). similarly, endotoxin (0.01 and 
0.1 units/ml) dose-dependently inhibited acid secretion and 
PD but increased pepsinogen release 3.3- and 6.1-fold (both 
p<0.05). Endotoxic and air-gassed tissues were edematous with 
scattered cellular damage by light and transmission electron 
microscopy; nitrogen-exposed membranes appeared necrotic. 
Pepsin release may therefore have resulted from cell damage 
rather than exocytosis. Intragastric peptic activity in 
critically ill H
2
-receptor blocked patients (n=20) was 5490 ± 
1701 u/ml. The gastric juice of H
2
-blocked convalescing 
surgical patients (n=20) contained 315 ± 101 u/ml. (p<0.0001) 
Occult blood correlated with intragastric peptic activity 
(r=0.59, p<0.0001) but not with gastric pH (r=0.04, p=0.6) 
These data suggest that the complex of pathophysiologic 
abnormalities common in critical illness cause substantial 
pepsin release. The efflux of this potent mucolytic barrier 
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Conclusion 
This thesis provides a broad historical background of digestion 
and the contextual relationship of pepsinogen to the 
understanding of digestive physiology. It describes the 
specific roles of two persons, Schwann and Langley, in the 
discovery of a specific ferment in the gastric mucosa and juice. 
The methodology section includes the validation and development 
of isolated gastric glands, parietal cells and Ussing chamber 
systems for use in these studies. In addition, it describes 
novel techniques--the microtitre plate for measurement of 
secretion and an isotopic technique for the quantitative of the 
relatively small pepsinogen signal generated by mammalian 
mucosa. 
The initial chapters of the experimental section serve to 
validate the system and confirm existing information. The 
subsequent search for a specific pepsinogen inhibitor, however, 
proved difficult. Studies with the putative calmodulin 
antagonist trifluperazine provided data which was probably 
spurious and reflective of either cell damage or multiple 
nonspecific effects. The methylated synthetic prostaglandin El 
analogue (misoprostol) proved itself to be an agonist of 
pepsinogen secretion rather than the contrary, although it 
inhibited acid secretion as expected. In the subsequent study, 
it was apparent that blocking the parietal cell proton pump 
specifically had no inhibitory effect on pepsinogen secretion. 
Indeed, it required a specific CCK receptor inhibitor (L364718) 
to inhibit CCK stimulated pepsinogen secretion. Studies with 
both acid (histamine) and pepsinogen (CCK and carbachol) 
agonists demonstrated the very specific nature of CCK receptor 
blockade on chief cell function. The final study of the 
experimental section was undertaken in an attempt to relate 
events present in critically ill patients to an experimental 
mucosal membrane model. Thus endotoxemia and hypoxia were shown 
to generate substantial release of pepsinogen concomitant with 
morphological evidence of mucosal damage. Similarly, in a group 
of critically ill patients, a marked increase in pepsinogen 
levels in gastric juice was noted. While the latter data are no 
way conclusive, they are consistent with the possible 
relationship between pepsinogen release and events noted to 
occur in the gastric mucosa of critically ill patients. 
This thesis demonstrates that chief cell function may be studied 
using isolated gastric gland preparations and isolated mucosal 
membrane models. It provides clear evidence that both cyclic 
AMP and calcium calmodulin systems are involved in the secretion 
of pepsinogen. It refutes the possibility that a calcium 
calmodulin antagonist trifluperazine could be of use in the 
inhibition of pepsinogen secretion and demonstrates that the 
acid inhibitory antiulcer agent misoprostol (synthetic 
prostaglandin El analogue) increases pepsinogen secretion. 
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Of particular interest, was the finding of a clear dissociation 
of chief cell function from parietal cell function. This 
observation may be of particular relevance in the therapeutic 
control of pepsinogen secretion. A further novel observation 
was the demonstration of the efficacy of the CCK receptor 
antagonist L364718 in the inhibition of CCK stimulated 
pepsinogen secretion. The possible therapeutic application of 
this observation may warrant further consideration. Finally, 
the proposal that events which occur in critically ill patients 
may in some way augment pepsinogen release has been addressed. 
Although no ideal model of such a situation exists, the studies 
described in this thesis indicate a major release of pepsinogen 
under conditions of hypoxemia and endotoxemia generated in a 
Ussing chamber mucosal membrane model. Similarly, elevation of 
pepsinogen levels on the gastric juice in critically ill 
patients, though not conclusive, may be construed as further 
evidence in support of the proposal. 
Pepsinogen is one of the most potent proteolytic enzymes and is 
found in substantial quantities in the gastric mucosa. These 
studies draw specific attention to the important modulatory role 
of cholecystokinin in its secretion. In addition, they define 
the separation between the physiological control mechanisms of 
acid secretion and pepsinogen. Finally, they suggest that 
substantial release of pepsinogen occurs under pathological 
conditions in the gastric mucosa consistent with those present 
in critically ill patients. 
